The Australian Corneal Graft Registry 2015 Report by Williams, Keryn Anne et al.
  
   
 
THE AUSTRALIAN 
CORNEAL GRAFT REGISTRY 
 
 
 
2015 REPORT 
 
This report was published with assistance provided by The Australian 
Government Organ and Tissue Authority (DonateLife) 
  
  
  
 
 
 
THE AUSTRALIAN  
CORNEAL GRAFT REGISTRY 
 
2015 REPORT 
 
 
KA Williams, MC Keane, RA Galettis, VJ Jones, RAD Mills and DJ Coster 
Department of Ophthalmology, Flinders University 
South Australian Health and Medical Research Institute 
 
 
 
 
 
 
All rights reserved.   Adelaide, Australia: 2015.  
  
Acknowledgments 
 
We appreciate the co-operation of the following eye banks: 
Eye Bank of South Australia 
Lions New South Wales Eye Bank 
Lions Eye Bank of Western Australia 
Lions Eye Donation Service, Victoria 
Queensland Eye Bank 
 
This report was published with assistance provided by The Australian 
Government Organ and Tissue Authority (DonateLife) 
 
We acknowledge the assistance of the Australian Institute of Health and Welfare 
in keeping our records up-to-date via data linkage with the National Death Index 
 
The Australian Corneal Graft Registry operates under the guidelines and approval 
of the Southern Adelaide Clinical Human Research Ethics Committee 
Cover photography: Angela Chappell 
 
Contact Details: 
The Australian Corneal Graft Registry 
Department of Ophthalmology, Flinders University 
Flinders Medical Centre 
Bedford Park SA 5042 
Australia 
Telephone: +61 8 8204 5321 
Fax: +61 8 8277 0899 
Email: keryn.williams@flinders.edu.au  
  
Introduction 
 
 
The Australian Corneal Graft Registry (ACGR) opened in May 1985 
and has now been operating for 30 years. Over the years, we have 
collected information on more than 30,000 corneal grafts. 
At registration, we seek information on the donor, eye bank practices, 
the recipient, the surgeon, the graft type and the operative procedure. 
Follow-up then occurs at approximately yearly intervals for an 
indefinite period, and ceases upon graft failure, or the death or loss-to-
follow-up of the patient. At each round of follow-up, we request 
information on the survival of the graft, the visual outcomes, and any 
relevant post-operative events and treatments. 
The data are entered into an Access database and checked for 
consistency. Descriptive, univariate and multivariate analyses are 
subsequently performed using SPSS and Stata software, and the 
report is eventually collated. As has been the case in the past, a pdf of 
the final report is placed in a permanent, open-access institutional 
repository, so that it can be accessed freely.  
Because we have observed a significant change in the pattern of 
practice of corneal transplantation over the past 10-15 years, the 
structure of this report has been altered to reflect these changes. To 
ensure currency of practice, we have analysed grafts registered on or 
after 01-01-2000, with a census date of 31-03-2014. All grafts have 
thus been performed in "the modern era". Penetrating keratoplasties 
(PKs), traditional lamellar keratoplasties (TLKs), deep anterior lamellar 
keratoplasties (DALKs), and the various forms of endothelial cell 
keratoplasty (DSEKs/DSAEKs and DMEKs) have been examined 
separately, and then comparisons amongst procedures have been 
performed. 
We thank our many contributors for their tireless efforts on our behalf. 
We hope you enjoy reading this report and that it may be useful in 
your clinical practice. 
  
  
How to read our Kaplan-Meier Plots of 
Graft Survival  
1. The vertical axis shows the probability of graft survival. "Perfect" 
survival (no failures) equates to a probability of 1.0. It may help to 
think of this as 100% survival. 
2. The horizontal axis shows time elapsed from the date of graft. 
This is shown as years post graft, although the analysis is performed 
on daily graft survival. 
3. The p-values shown have been calculated by log-rank analysis 
and reflect a comparison of the behaviour of the curves as a whole 
(taking all available data into consideration), rather than at any one 
time-point. 
4. The numbers of recipients being followed at given times after 
graft are shown below the curves in the “Number at risk” table. At time 
zero, all followed patients in the given cohort are at risk. At the 
furthermost point on the right hand side of any curve the patient(s) 
who have been followed for the longest time are at risk. 
We suggest that you interpret the survival curves with this in mind. A 
sudden "dip" in survival at the far right of a given curve may merely 
mean, for example, that one of only two grafts that have been followed 
for this length of time has failed. When the survival curve drops to 
zero, this means that all grafts that have reached this length of follow-
up have failed. It does not mean that all grafts in this stratum have 
failed, or will fail.  
For example, a single graft may have been followed for 2 years, at 
which point it failed, while 20 grafts may have been followed for 1 year 
and 364 days and are all surviving at last follow-up. No other grafts 
have been followed for as long as the one that has failed, so the 
survival curve will drop to zero at this point. However, had the graft 
failed at 1 year and 364 days, the curve would not meet the horizontal 
axis, as there would be 20 other surviving grafts followed for the same 
amount of time.  
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 Abbreviations/Acronyms 
Abbreviations/Acronyms 
 
ACGR = Australian Corneal Graft Registry 
Where abbreviations or acronyms are used to refer to types of graft: 
PK = Penetrating keratoplasty 
DALK = Deep anterior lamellar keratoplasty 
DS(A)EK = Descemet’s stripping endothelial keratoplasty, Descemet’s stripping 
automated endothelial keratoplasty and unspecified endothelial grafts 
DMEK = Descemet’s membrane endothelial keratoplasty 
TLK = Traditional lamellar keratoplasty 
Limbal = Limbal stem cell transplant 
Misc. = Miscellaneous corneal transplant, not otherwise categorised  
Where acronyms are used to refer to visual acuity: 
VA = Visual acuity 
CF = Count fingers at 1 metre 
HM = Hand movement 
LP = Light perception 
NLP = No light perception 
Where acronyms are used in statistical reporting: 
p = Probability 
df = Degrees of freedom 
SE = Standard error 
CI = Confidence interval  
TVC = Time varying coefficient 
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1 Overview of the Australian Corneal Graft 
Registry 
 
At the time of census (31-03-2014), 28,276 grafts had been registered, of which 22,725 
(80%) had been followed at least once. Table 1.1 shows the number of each type of 
graft that had been registered, had follow-up information provided and remained “active” 
(the graft had not failed and the recipient is not known to have died, or been lost to 
follow-up by the surgeon). 
Table 1.1 Registered, followed and active grafts, 1985 onwards 
 Registered Followed Active 
    
Penetrating 22737 (80.4%) 18968 (83.5%) 5550 (62.2%) 
DALK 1040 (3.7%) 575 (2.5%) 769 (8.6%) 
DS(A)EK 2701 (9.6%) 1801 (7.9%) 2051 (23.0%) 
DMEK 425 (1.5%) 238 (1.0%) 298 (3.3%) 
Traditional lamellar 1285 (4.5%) 1072 (4.7%) 234 (2.6%) 
Limbal 74 (<1%) 62 (<1%) 10 (<1%) 
Miscellaneous 14 (<1%) 9 (<1%) 6 (<1%) 
Total 28276 (100.0%) 22725 (100.0%) 8918 (100.0%) 
    
*DS(A)EK = DSEK, DSAEK and unspecified endothelial grafts. Miscellaneous grafts are scleral patch grafts, 
generally used to cover tubes needed for glaucoma treatment. 
Figure 1.1 shows the survival curves for each of the five main types of graft, for all 
followed grafts. 
Figure 1.1 Type of graft, 1985 onwards 
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1.1 Synopsis of the Report Database 
 
This report focuses on the outcomes of grafts performed since the year 2000. At the 
census date for this report, 16,334 grafts performed from 2000 onwards, had been 
registered. Of these, follow-up information had been provided for 11,471 grafts (70%). 
Table 1.2 shows the number of each type of graft that had been registered, had follow-
up information provided and remained “active” in the database. Table 1.3, on page 3, 
shows the status of these grafts, in more detail.  
Table 1.2 Registered, followed and active grafts, 2000 onwards 
 Registered Followed Active 
    
Penetrating 11431 (70.0%) 8301 (72.4%) 5016 (59.9%) 
DALK 1039 (6.4%) 574 (5.0%) 769 (9.2%) 
DS(A)EK 2701 (16.5%) 1801 (15.7%) 2051 (24.5%) 
DMEK 425 (2.6%) 238 (2.1%) 298 (3.6%) 
Traditional lamellar 699 (4.3%) 532 (4.6%) 226 (2.7%) 
Limbal 30 (<1%) 21 (<1%) 7 (<1%) 
Miscellaneous 9 (<1%) 4 (<1%) 6 (<1%) 
Total 16334 (100.0%) 11471 (100.0%) 8373 (100.0%) 
    
 
  
  
Table 1.3 Synopsis of the database, including registered, followed, surviving and active grafts, 2000 onwards 
 
PK DALK DS(A)EK DMEK TLK Limbal Misc. Total 
Number of grafts registered 11431 (100%) 1039 (100%) 2701 (100%) 425 (100%) 699 (100%) 30 (100%) 9 (100%) 16334 (100%) 
                  
Number of grafts followed 8301 (72.6%) 574 (55.2%) 1801 (66.7%) 238 (56.0%) 532 (76.1%) 21 (70.0%) 4 (44.4%) 11471 (70.2%) 
Failed 1639 (14.3%) 66 (6.4%) 383 (14.2%) 102 (24.0%) 132 (18.9%) 6 (20.0%) 1 (11.1%) 2329 (14.3%) 
  Recipient still alive 1315 (11.5%) 65 (6.3%) 351 (13.0%) 99 (23.3%) 101 (14.4%) 6 (20.0%) 1 (11.1%) 1938 (11.9%) 
  Recipient subsequently died 324 (2.8%) 1 (0.1%) 32 (1.2%) 3 (0.8%) 31 (4.4%) 0 (0.0%) 0 (0.0%) 391 (2.4%) 
Lost post follow-up 2139 (18.7%) 103 (9.9%) 92 (3.4%) 1 (0.2%) 144 (20.6) 7 (23.3%) 1 (11.1%) 2487 (15.2%) 
Surviving at recipient death 1507 (13.2%) 16 (1.5%) 149 (5.5%) 12 (2.8%) 113 (16.2%) 5 (16.7%) 0 (0.0%) 1802 (11.0%) 
  Died prior to follow-up** 463 (4.1%) 6 (0.6%) 54 (2.0%) 8 (1.9%) 50 (7.0%) 1 (3.3%) 0 (0.0%) 581 (3.6%) 
Followed, surviving and active 3016 (26.4%) 389 (37.4%) 1177 (43.6%) 123 (28.9%) 143 (44.3%) 3 (10.0%) 2 (22.2%) 4853 (29.7%) 
                  
Number of grafts not followed 3130 (27.4%) 465 (44.8%) 900 (33.3%) 187 (44.0%) 167 (23.9%) 9 (30.0%) 5 (55.6%) 4863 (29.8%) 
Lost prior to follow-up 1130 (9.9%) 85 (8.2%) 26 (1.0%) 12 (2.8%) 84 (12.0%) 5 (16.7%) 1 (11.1%) 1343 (8.2%) 
Not yet followed but active 2000 (17.5%) 380 (36.6%) 874 (32.4%) 175 (41.2%) 83 (11.9%) 4 (13.3%) 4 (44.4%) 3520 (21.6%) 
                  
Graft surviving when last seen 9792 (85.7%) 973 (93.6%) 2318 (85.8%) 323 (76.0%) 567 (81.1%) 24 (80.0%) 8 (88.9%) 14005 (85.7%) 
Graft lost when surviving 3269 (28.6%) 188 (18.1%) 118 (4.4%) 13 (3.1%) 228 (32.6%) 12 (40.0%) 2 (22.2%) 3830 (23.4%) 
  Lost prior to follow-up 1130 (9.9%) 85 (8.2%) 26 (1.0%) 12 (2.8%) 84 (12.0%) 5 (16.7%) 1 (11.1%) 1343 (8.2%) 
  Lost post follow-up 2139 (18.7%) 103 (9.9%) 92 (3.4%) 1 (0.2%) 144 (20.6%) 7 (23.3%) 1 (11.1%) 2487 (15.2%) 
Recipient died with surviving graft 1507 (13.2%) 16 (1.5%) 149 (5.5%) 12 (2.8%) 113 (16.2%) 5 (16.7%) 0 (0.0%) 1802 (11.0%) 
  Recipient died pre follow-up 463 (4.1%) 6 (0.6%) 54 (2.0%) 8 (1.9%) 50 (7.0%) 1 (3.3%) 0 (0.0%) 581 (3.6%) 
  Recipient died post follow-up 1044 (9.1%) 10 (1.0%) 95 (3.5%) 4 (0.9%) 63 (9.2%) 4 (13.3%) 0 (0.0%) 1221 (7.5%) 
         
Currently active grafts  5016 (43.9%) 769 (74.0%) 2051 (75.9%) 298 (70.1%) 226 (56.2%) 7 (23.3%) 6 (66.7%) 8373 (51.3%) 
Not yet followed but active 2000 (17.5%) 380 (36.6%) 874 (32.4%) 175 (41.2%) 83 (11.9%) 4 (13.3%) 4 (44.4%) 3520 (21.6%) 
Followed, surviving and active 3016 (26.4%) 389 (37.4%) 1177 (43.6%) 123 (28.9%) 143 (44.3%) 3 (10.0%) 2 (22.2%) 4853 (29.7%) 
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1.1.1 Changing practice: annual increase in corneal graft registrations 
 
The number of grafts registered with the Australian Corneal Graft Registry each year 
remained stable between the years 2000 and 2006, with an average of 960 grafts being 
registered annually. A substantial increase of more than 20 percent was seen in 2007 to 
2009, and the number of grafts being registered has continued to increase annually 
since then, as shown in Figure 1.1.1.  
These increases coincide with the introduction of new transplantation techniques - firstly 
Descemet’s stripping endothelial keratoplasty (DSEK) in 2006, and then Descemet’s 
membrane endothelial keratoplasty (DMEK) in 2008.  
Figure 1.1.1 Number of grafts registered with the ACGR per year, 2000 onwards 
 
Note: not all forms relating to grafts performed in 2013, and only a small number of 
forms relating to grafts performed in 2014, had been received by the census date. At 
30th April 2015, 1611 grafts had been registered for 2012, 1541 grafts for 2013 and 
1533 grafts for 2014.  
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1.1.2 Changing practice: the introduction of partial-thickness keratoplasties 
 
The introduction of new types of partial-thickness corneal grafts in recent years has led 
to a major shift away from full-thickness penetrating keratoplasty. Figure 1.1.2 shows 
registrations stratified by graft type between 2000 and 2013. Data from 2014 were 
excluded due to the low number of grafts registered at the census date. 
Figure 1.1.2 Graft type by year of registration, 2000 onwards 
 
 
After a gradual increase from 2000 to 2008, the proportion of deep anterior lamellar 
keratoplasties (DALKs) has remained stable. 
There has been a major shift towards endothelial keratoplasty, with the proportion of 
DS(A)EKs increasing since their introduction in 2006. This proportion remained stable 
between 2010 and 2012, however 2013 saw an increase in these grafts. When these 
figures are considered in conjunction with the DMEKs registered, almost half (48% in 
2013) of all registered grafts are now endothelial keratoplasties, while penetrating 
keratoplasties now account for less than 40%.  
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1.1.3 Comparison of desired outcome for different types of keratoplasty 
 
Surgeons indicated whether a graft was performed for: “improved visual acuity”, “pain 
relief”, “cosmesis”, “tectonic/structural repair”, or a combination of these reasons. Data 
were provided for 15,655 grafts (96%). Improved visual acuity was a desired outcome in 
92% of these grafts, pain relief in 17%, structural repair in 10%, and cosmesis in 3%. 
Desired outcome varied depending on graft type. The desired outcome most often 
selected for penetrating keratoplasty, deep anterior lamellar keratoplasty, Descemet’s 
stripping (automated) endothelial keratoplasty and Descemet’s membrane endothelial 
keratoplasty, was improvement in visual acuity. This was an aim in 93%, 97%, 97% and 
99% of grafts being performed in each group (either as an individual aim or in 
conjunction with other desired outcomes), respectively. Traditional lamellar keratoplasty 
was most often performed to provide structural repair (68%). Figure 1.1.3 shows the 
desired outcomes indicated by surgeons, for each type of graft.  
 
Figure 1.1.3 Reason for graft stratified by graft type 
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1.1.4 Comparison of overall graft survival for different types of keratoplasty  
 
Figure 1.1.4 shows the survival curves for each of the five major types of graft, 
performed since 2000. Follow-up is longer for penetrating, traditional lamellar and deep 
anterior lamellar grafts, as endothelial grafts were only introduced in 2006. These plots 
are not stratified by indication for graft, which varies considerably across graft types. 
Figure 1.1.4 Type of graft, 2000 onwards 
 
 
Number at risk (at years post graft) 
Identity Initially 1 3 6 9 12 
Penetrating 8301 6744 3115 1150 314 26 
Traditional lamellar 532 292 128 42 10 1 
DALK 574 436 99 14 8 2 
DS(A)EK 1801 958 275 1 n/a n/a 
DMEK 238 60 2 n/a n/a n/a 
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Corneal Graft Survival – 2000 Onwards 
Type of Graft 
 
 Probability of Graft Survival 
 Penetrating: 0.94 at 1 year 
  Mean Survival 8.60 years 0.82 at 3 years 
  (SE= 0.11, 95% CI: 8.38, 8.81) 0.68 at 6 years 
  Median Survival 9.89 years 0.54 at 9 years 
   0.35 at 12 years 
    
 Traditional lamellar: 0.82 at 1 year 
  Mean Survival 6.97 years 0.73 at 3 years 
  (SE= 0.40, 95% CI: 6.19, 7.75) 0.56 at 6 years 
  Median Survival 8.45 years   
     
    
 DALK: 0.93 at 1 year 
  Mean Survival 9.22 years 0.87 at 3 years 
  (SE= 0.67, 95% CI: 7.90, 10.53)   
  Median Survival 9.07 years   
    
 DS(A)EK: 0.84 at 1 year 
  Mean Survival 4.05 years 0.69 at 3 years 
  (SE= 0.11, 95% CI: 3.84, 4.26)   
  Median Survival 4.68 years   
     
    
 DMEK: 0.58 at 1 year 
  Mean Survival 1.61 years   
  (SE= 0.12, 95% CI: 1.38, 1.84)   
  Median Survival 1.94 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
Primary graft failure was reported in 54 penetrating keratoplasty (0.5%), 11 traditional 
lamellar keratoplasties (1.6%), 10 deep anterior lamellar keratoplasties (1.0%), 145 
Descemet’s stripping (automated) endothelial keratoplasties (5.4%), and 58 Descemet’s 
membrane endothelial keratoplasties (13.6%). Primary graft failure was reported for two 
pairs of cornea (i.e. both corneas from the same donor), however there was no 
indication that this was due to any insufficiencies in donor screening or eye bank 
procedures. 
When conducting survival analysis, comparisons across groups containing very small 
numbers, or very small proportions of the study population, are not considered reliable 
or informative. With this in mind, we have only analysed comparisons between 
categories for which data on more than 20 followed grafts were available for DALK, 
DS(A)EK and traditional lamellar grafts, and data on more than 50 followed grafts were 
available for penetrating keratoplasties (20 in subcategory analyses).  
Further analyses in this report are limited to these four types of graft. This is due to the 
low numbers of DMEK, limbal and miscellaneous grafts registered, and with follow-up 
information available, during this time frame.
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2 Penetrating Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 8,301 
penetrating keratoplasties for which follow-up information was available. Kaplan-Meier 
survival analyses were conducted using IBM SPSS for Windows (Version 21.0), to 
compare the graft survival across groups for a range of variables relating to the corneal 
donor, graft recipient, surgical procedure, surgeon, and follow-up care. 
2.1 Donor and Eye Banking Factors 
 
Table 2.1 shows the number of grafts within each of the variable sub-groups, for the 
donor and eye banking factors examined. The sum for each variable equals the total 
number of grafts (11,431 registered and 8,301 followed) and the percentages, which 
should be summed vertically for each variable, total 100. 
Table 2.1 Donor and eye banking factors 
 
Penetrating Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank A 4196 (37%) 2882 (35%) 
  Eye bank B 2512 (22%) 1973 (24%) 
  Eye bank C 2790 (24%) 2096 (25%) 
  Eye bank D 900 (8%) 513 (6%) 
  Eye bank E 1024 (9%) 829 (10%) 
  Not advised1 9 (<1%) 8 (<1%) 
   
Storage medium   
  Optisol 9723 (85%) 7521 (91%) 
  Organ culture 1514 (13%) 604 (7%) 
  Moist pot 18 (<1%) 15 (<1%) 
  Superseded 166 (1%) 151 (2%) 
  Not advised 10 (<1%) 10 (<1%) 
   
Death-to-enucleation time   
  ≤ 3 hours 1455 (13%) 1134 (14%) 
  4 to 6 hours 2279 (20%) 1722 (21%) 
  7 to 9 hours 2683 (23%) 2008 (24%) 
  10 to 12 hours 2589 (23%) 1931 (23%) 
  ≥ 13 hours 2357 (21%) 1457 (18%) 
  Not advised 68 (<1%) 49 (<1%) 
   
Interstate transportation   
  No 10819 (95%) 7851 (95%) 
  Yes 603 (5%) 442 (5%) 
  Not advised1 9 (<1%) 8 (<1%) 
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Sex of donor   
  Female 4175 (37%) 3026 (36%) 
  Male 7230 (63%) 5253 (63%) 
  Not advised 26 (<1%) 22 (<1%) 
   
Age group   
  <10 years 50 (<1%) 39 (<1%) 
  10 to 19 years 367 (3%) 242 (3%) 
  20 to 29 years 519 (5%) 366 (4%) 
  30 to 39 years 650 (6%) 445 (5%) 
  40 to 49 years 1250 (11%) 909 (11%) 
  50 to 59 years 2186 (19%) 1578 (19%) 
  60 to 69 years 2788 (24%) 1942 (23%) 
  70 to 79 years 2586 (23%) 1974 (24%) 
  80 to 89 years 989 (9%) 766 (9%) 
  ≥ 90 years 24 (<1%) 20 (<1%) 
  Not advised 22 (<1%) 20 (<1%) 
   
Cause of death   
  Cardiac event 3211 (28%) 2433 (29%) 
  Malignancy 3164 (28%) 2161 (26%) 
  Trauma 1344 (12%) 929 (11%) 
  Respiratory event 973 (9%) 767 (9%) 
  Intracranial/cerebral haemorrhage 1964 (17%) 1443 (17%) 
  Other specified 696 (6%) 519 (6%) 
  Live donor 16 (<1%) 14 (<1%) 
  Not advised2 63 (<1%) 35 (<1%) 
   
Multi-organ donor status   
  No 10089 (88%) 7351 (89%) 
  Yes 1342 (12%) 950 (11%) 
   
Central corneal endothelial cell density  
  <2500 cells/mm² 336 (3%) 211 (3%) 
  2500 to 2999 cells/mm² 1382 (12%) 807 (10%) 
  3000 to 3499 cells/mm² 1601 (14%) 841 (10%) 
  ≥ 3500 cells/mm² 417 (4%) 221 (3%) 
  Not advised 7695 (67%) 6221 (75%) 
   
Total 11431 (100%) 8301 (100%) 
   
 
1 
Five autografts with no eye bank given, two international donors 
 
2 
ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly lower (p<0.05) for grafts performed using donor 
tissue from State 4, stored in organ culture, retrieved ≥13 hours after donor death, from 
younger donors, and from donors where cause of death was from malignancy or 
trauma. Follow-up was significantly higher for grafts with donor tissue endothelial cell 
counts of <2500 cells/mm².  
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2.1.1 Penetrating graft survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks 
around Australia. Figure 2.1.1 shows the comparison of graft survival for corneas 
provided by each of these eye banks. Data were not available for 8 cases.  A significant 
difference was found across eye banks (Log Rank Statistic=23.46; df=4; p<0.001). 
However, this variable was not retained in the multivariate analysis (see section 2.7) 
indicating that this is not an independent factor significantly affecting graft survival. 
Figure 2.1.1 Australian eye bank 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Eye bank A 2882 1082 393 85                                                                                                                                                                                      3
Eye bank B 1973 763 271 83 6 
Eye bank C 2096 624 206 54 5 
Eye bank D 513 263 127 40 6 
Eye bank E 829 375 151 51 6 
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Penetrating Corneal Graft Survival 
Eye Bank 
 
 Probability of Graft Survival 
 Eye bank A: 0.94 at 1 year 
  Mean Survival 7.96 years 0.83 at 3 years 
  (SE= 0.19, 95% CI: 7.59, 8.32) 0.68 at 6 years 
  Median Survival 8.69 years 0.48 at 9 years 
    
 Eye bank B: 0.96 at 1 year 
  Mean Survival 9.12 years 0.84 at 3 years 
  (SE= 0.22, 95% CI: 8.69, 9.54) 0.72 at 6 years 
  Median Survival 11.25 years 0.59 at 9 years 
    
 Eye bank C: 0.93 at 1 year 
  Mean Survival 8.18 years 0.79 at 3 years 
  (SE= 0.25, 95% CI: 7.56, 8.66) 0.64 at 6 years 
  Median Survival 10.14 years 0.51 at 9 years 
    
 Eye bank D: 0.91 at 1 year 
  Mean Survival 8.73 years 0.80 at 3 years 
  (SE= 0.28, 95% CI: 8.19, 9.28) 0.69 at 6 years 
  Median Survival 11.63 years 0.61 at 9 years 
    
 Eye bank E: 0.94 at 1 year 
  Mean Survival 9.10 years 0.84 at 3 years 
  (SE= 0.26, 95% CI: 8.58, 9.62) 0.71 at 6 years 
  Median Survival 11.78 years 0.60 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.2 Penetrating graft survival: influence of interstate transportation 
 
For the majority of transplants, donor corneas are sourced in the same State as the 
surgery occurs. However, in some cases corneas are transported interstate via air 
freight. Figure 2.1.2 shows the comparison of graft survival for grafts where the surgery 
was performed in the same State as the donor cornea was sourced, compared to those 
where the donor cornea was from interstate. The 8 grafts where donor State data were 
not available were excluded from the analysis. A significant difference was found 
between groups (Log Rank Statistic=18.56; df=1; p<0.001). This variable was retained 
in the multivariate analysis (see section 2.7), despite indication for graft also being 
included, indicating that this is an independent factor significantly affecting graft survival. 
Those grafts where the donor cornea had been transported interstate had poorer 
survival.  
Figure 2.1.2 Interstate transportation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Different State 442 169 59 21 2 
Same State 7851 2941 1089 291 24 
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Penetrating Corneal Graft Survival 
Interstate Transportation 
 
 Probability of Graft Survival 
 Different State: 0.89 at 1 year 
  Mean Survival 7.71 years 0.73 at 3 years 
  (SE= 0.33, 95% CI: 7.06, 8.35) 0.60 at 6 years 
  Median Survival 10.18 years 0.54 at 9 years 
    
 Same State: 0.94 at 1 year 
  Mean Survival 8.65 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.43, 8.87) 0.69 at 6 years 
  Median Survival 9.85 years 0.54 at 9 years 
   0.36 at 12 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
 
In the multivariate analysis, interstate transportation was shown to have a significant 
effect (p<0.001), which varied over time, on graft survival. The final model also 
accounted for the effect of indication for graft, graft size, lens status pre- and post-graft, 
graft year, donor age group, experience of surgeon and percentage of follow-up, 
presence of raised intraocular pressure, pre-graft vascularisation, pre-graft inflammation 
and/or steroid use, post-graft microbial keratitis, and post-graft rejection episode(s). 
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2.1.3 Penetrating graft survival: influence of death to enucleation time 
 
Donor corneas are retrieved as soon as possible following donor death. Retrieval is 
recommended within the first 18 hours and 95% of donor eyes were enucleated within 
this time-frame. Times are rounded to the nearest hour and the median time from donor 
death to enucleation was 9 hours (range 0-33 hours). Data were not available for 49 
grafts.  
Figure 2.1.3 shows a comparison of graft survival depending on time from donor death 
to enucleation, stratified into three-hourly groups. No significant difference was found 
across time groups (Log Rank Statistic=9.37; df=4; p=0.052). While this difference was 
not significant at the p<0.05 level, it met the p<0.08 criterion to be included in the 
multivariate analysis (see section 2.7). This variable was not retained in the final model, 
indicating that it is not an independent factor significantly affecting graft survival. 
Figure 2.1.3 Time from donor death to enucleation 
 
 
 
 
 
 
 Penetrating Keratoplasty 
17 Australian Corneal Graft Registry Report 2015 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
3 hours or less 1134 464 175 56 5 
4 to 6 hours 1722 654 255 60 8 
7 to 9 hours 2008 744 287 86 8 
10 to 12 hours 1931 748 274 71 4 
13 hours or more 1457 484 152 36 1 
 
 
 
 
Penetrating Corneal Graft Survival 
Death to Enucleation Time 
 
 Probability of Graft Survival 
 3 hours or less: 0.95 at 1 year 
  Mean Survival 9.18 years 0.85 at 3 years 
  (SE= 0.25, 95% CI: 8.70, 9.66) 0.72 at 6 years 
  Median Survival 10.27 years 0.59 at 9 years 
    
 4 to 6 hours: 0.94 at 1 year 
  Mean Survival 8.69 years 0.82 at 3 years 
  (SE= 0.23, 95% CI: 8.24, 9.14) 0.69 at 6 years 
  Median Survival 10.38 years 0.55 at 9 years 
    
 7 to 9 hours: 0.94 at 1 year 
  Mean Survival 8.42 years 0.82 at 3 years 
  (SE= 0.21, 95% CI: 8.02, 8.83) 0.67 at 6 years 
  Median Survival 9.68 years 0.54 at 9 years 
    
 10 to 12 hours: 0.95 at 1 year 
  Mean Survival 8.21 years 0.82 at 3 years 
  (SE= 0.17, 95% CI: 7.87, 8.55) 0.69 at 6 years 
  Median Survival 9.68 years 0.52 at 9 years 
    
 13 hours or more: 0.93 at 1 year 
  Mean Survival 8.07 years 0.81 at 3 years 
  (SE= 0.24, 95% CI: 7.60, 8.54) 0.67 at 6 years 
  Median Survival 9.39 years 0.51 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.4 Penetrating graft survival: influence of modern corneal storage media 
 
In Australia, two storage media are commonly used to preserve donor corneas prior to 
transplantation. Data were not analysed for 176 grafts where the donor eye was stored 
in a moist pot, a now superseded storage media (e.g. K-Sol, Dextran, M-K medium) was 
used, or the eye bank did not specify which medium was used. Figure 2.1.4 shows the 
comparison of graft survival for corneas stored in Optisol medium (Bausch and Lomb), 
compared to organ culture medium. No significant difference was found between media 
(Log Rank Statistic=0.87; df=1; p=0.352). 
Figure 2.1.4 Corneal storage media (modern media only) 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Optisol 7521 2916 1123 296 22 
Organ culture 604 137 n/a n/a n/a 
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Penetrating Corneal Graft Survival 
Modern Corneal Storage Media 
 
 Probability of Graft Survival 
 Optisol: 0.94 at 1 year 
  Mean Survival 8.85 years 0.83 at 3 years 
  (SE= 0.12, 95% CI: 8.42, 8.88) 0.69 at 6 years 
  Median Survival 9.85 years 0.54 at 9 years 
    
 Organ culture: 0.93 at 1 year 
  Mean Survival 4.49 years 0.81 at 3 years 
  (SE= 0.09, 95% CI: 4.30, 4.68)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.5 Penetrating graft survival: influence of storage time to graft – Optisol 
medium 
 
Corneas stored in Optisol medium are most often used within 5 days of storage and are 
rarely stored for longer than 7 days. Figure 2.1.5 shows the comparison of graft survival 
across storage time for just those corneas stored in Optisol medium. Data were not 
provided for 1814 grafts and these were excluded from the analysis. A significant 
difference was found across groups (Log Rank Statistic=8.69; df=2; p=0.013).  
This variable was not included in the initial multivariate analysis (see section 2.7), due to 
high levels of missing data: 9% of grafts were stored in other media, while 24% of grafts 
stored in Optisol had no data available (22% of all grafts), resulting in only 69% of all 
grafts having data for this variable. Alternative multivariate modelling was attempted, 
both by adding this variable to the already established model and by including it from 
the beginning. In neither case was this variable retained in the resulting model, 
indicating that it is not an independent factor significantly affecting graft survival. 
Figure 2.1.5 Time from storage to graft, Optisol medium storage  
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
5 days or less 4264 1658 661 187 14 
6 or 7 days 1140 424 175 49 4 
More than 7 days 303 30 23 5 n/a 
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Penetrating Corneal Graft Survival 
Storage Time to Graft: Optisol 
 
 Probability of Graft Survival 
 5 days or less: 0.95 at 1 year 
  Mean Survival 8.76 years 0.84 at 3 years 
  (SE= 0.15, 95% CI: 8.47, 9.05) 0.69 at 6 years 
  Median Survival 10.00 years 0.55 at 9 years 
    
 6 or 7 days: 0.94 at 1 year 
  Mean Survival 8.13 years 0.79 at 3 years 
  (SE= 0.22, 95% CI: 7.77, 8.56) 0.66 at 6 years 
  Median Survival 9.68 years 0.53 at 9 years 
    
 More than 7 days: 0.93 at 1 year 
  Mean Survival 7.28 years 0.60 at 3 years 
  (SE= 0.38, 95% CI: 6.53, 8.03) 0.60 at 6 years 
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.6 Penetrating graft survival: influence of storage time to graft – organ culture 
medium 
 
Organ culture storage can allow preservation times of up to four weeks. Figure 2.1.6 
shows the comparison of graft survival across storage time for those corneas stored in 
organ culture medium. Data were not provided for 325 grafts and these were excluded 
from the analysis. No significant difference was found across groups (Log Rank 
Statistic=0.59; df=2; p=0.745).  
Figure 2.1.6 Time from storage to graft, organ culture medium storage 
 
 
Number at risk (at years post graft) 
Identity Initially 1 3 
Less than 2 weeks 95 69 17 
2 to 3 weeks 132 101 20 
More than 3 weeks 52 42 11 
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Penetrating Corneal Graft Survival 
Storage Time to Graft: Organ Culture 
 
 Probability of Graft Survival 
 Less than 2 weeks: 0.87 at 1 year 
  Mean Survival 4.25 years   
  (SE= 0.26, 95% CI: 3.74, 4.75)   
  Median Survival n/a   
    
 2 to 3 weeks: 0.89 at 1 year 
  Mean Survival 4.36 years 0.76 at 3 years 
  (SE= 0.21, 95% CI: 3.95, 4.76)   
  Median Survival n/a   
    
 More than 3 weeks: 0.93 at 1 year 
  Mean Survival 4.47 years   
  (SE= 0.32, 95% CI: 3.83, 5.10)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.7 Penetrating graft survival: influence of donor sex 
 
Historically, a higher proportion of corneal donors are male and this was also the case 
in the current cohort. Data were not available for 22 grafts. Figure 2.1.7 shows the 
comparison of graft survival depending on donor sex. No significant difference was 
found between groups (Log Rank Statistic=0.58; df=1; p=0.445).  
Figure 2.1.7 Donor sex 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female 3026 1062 388 109 5 
Male 5253 2042 757 203 21 
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Penetrating Corneal Graft Survival 
Donor Sex 
 
 Probability of Graft Survival 
 Female: 0.94 at 1 year 
  Mean Survival 8.82 years 0.82 at 3 years 
  (SE= 0.19, 95% CI: 8.44, 9.20) 0.70 at 6 years 
  Median Survival 10.38 years 0.58 at 9 years 
    
 Male: 0.94 at 1 year 
  Mean Survival 8.49 years 0.83 at 3 years 
  (SE= 0.13, 95% CI: 8.22, 8.75) 0.68 at 6 years 
  Median Survival 9.56 years 0.52 at 9 years 
   0.36 at 12 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.8 Penetrating graft survival: influence of donor age (years) 
 
Figure 2.1.8 shows the comparison of graft survival depending on donor age, stratified 
by 10 year age groups. Donors aged under 10 years or over 90 years are rare. Due to 
low numbers (n=39 and n=20 respectively) these data were combined with the adjacent 
age groups. Data were not available for a further 20 grafts. A significant difference was 
found across groups (Log Rank Statistic=121.26; df=7; p<0.001). This variable was 
retained in multivariate analysis (see section 2.7) indicating that this is an independent 
factor significantly affecting graft survival.  
Figure 2.1.8 Donor age 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
0 to 19 years 281 113 46 10 1 
20 to 29 years 366 176 67 21 2 
30 to 39 years 445 180 77 22 4 
40 to 49 years 909 391 143 38 4 
50 to 59 years 1578 614 261 72 5 
60 to 69 years 1942 688 232 61 5 
70 to 79 years 1974 687 244 72 2 
80 to 99 years 786 255 76 16 3 
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Penetrating Corneal Graft Survival 
Donor Age 
 
 Probability of Graft Survival 
 0 to 19 years: 0.97 at 1 year 
  Mean Survival 10.13 years 0.92 at 3 years 
  (SE= 0.55, 95% CI: 9.06, 11.20) 0.82 at 6 years 
  Median Survival 13.19 years   
    
 20 to 29 years: 0.96 at 1 year 
  Mean Survival 9.81 years 0.90 at 3 years 
  (SE= 0.34, 95% CI: 9.15, 10.47) 0.80 at 6 years 
  Median Survival 11.24 years 0.71 at 9 years 
    
 30 to 39 years: 0.94 at 1 year 
  Mean Survival 9.74 years 0.83 at 3 years 
  (SE= 0.41, 95% CI: 8.94, 10.54) 0.76 at 6 years 
  Median Survival 11.63 years 0.66 at 9 years 
    
 40 to 49 years: 0.96 at 1 year 
  Mean Survival 9.39 years 0.90 at 3 years 
  (SE= 0.25, 95% CI: 8.90, 9.87) 0.77 at 6 years 
  Median Survival 11.42 years 0.67 at 9 years 
    
 50 to 59 years: 0.95 at 1 year 
  Mean Survival 8.92 years 0.83 at 3 years 
  (SE= 0.21, 95% CI: 8.52, 9.33) 0.74 at 6 years 
  Median Survival 10.77 years 0.62 at 9 years 
     
 60 to 69 years: 0.94 at 1 year 
  Mean Survival 7.81 years 0.81 at 3 years 
  (SE= 0.22, 95% CI: 7.38, 8.23) 0.64 at 6 years 
  Median Survival 8.20 years 0.43 at 9 years 
     
 70 to 79 years: 0.93 at 1 year 
  Mean Survival 7.59 years 0.79 at 3 years 
  (SE= 0.17, 95% CI: 7.26, 7.91) 0.62 at 6 years 
  Median Survival 8.37 years 0.48 at 9 years 
     
 80 to 99 years: 0.92 at 1 year 
  Mean Survival 7.84 years 0.73 at 3 years 
  (SE= 0.35, 95% CI: 7.15, 8.52) 0.59 at 6 years 
  Median Survival 7.87 years 0.44 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
A clear division between the 50-59 and 60-69 year age groups is seen in Figure 2.1.8. 
An analysis was thus performed using this dichotomous split (see Figure 2.1.9 overleaf). 
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2.1.8.1 Penetrating graft survival: influence of donor age 60+ 
 
Figure 2.1.9 shows the comparison of graft survival depending on whether or not the 
donor was aged less than 60 years (Log Rank Statistic=104.52; df=1; p<0.001).  
Figure 2.1.9 Donor age - 60 years or older 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Under 60 years 3579 1474 594 163 16 
60 years or older 4702 1630 552 149 10 
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Penetrating Corneal Graft Survival 
Donor Age 60+ 
 
 Probability of Graft Survival 
 Under 60 years: 0.95 at 1 year 
  Mean Survival 9.53 years 0.87 at 3 years 
  (SE= 0.16, 95% CI: 9.21, 9.85) 0.76 at 6 years 
  Median Survival 11.42 years 0.65 at 9 years 
    
 60 years or older: 0.93 at 1 year 
  Mean Survival 7.83 years 0.79 at 3 years 
  (SE= 0.15, 95% CI: 7.54, 8.12) 0.62 at 6 years 
  Median Survival 8.27 years 0.46 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
 
In the multivariate analysis, donor age group was shown to have a significant 
independent effect (p<0.001) on graft survival. Donors aged “60 to 69 years”, had 
significantly poorer survival than those in the “20 to 29 years” and “40 to 49 years” 
groups (p=0.043 and p=0.006, respectively). Donors aged “70 to 79 years”, had 
significantly poorer survival than those in the “0 to 19 years”, “20 to 29 years” and “40 to 
49 years” groups (p=0.031, p=0.026 and p=0.002, respectively). Donors aged “80 to 99 
years”, had significantly poorer survival than those in the “0 to 19 years”, “20 to 29 
years”, “40 to 49 years”, 50 to 59 years” and “60 to 69 years” groups (p=0.004, p=0.004, 
p<0.001, p=0.005 and p=0.041, respectively). 
The final model also accounted for the effect of indication for graft, graft size, lens status 
pre- and post-graft, graft year, experience of surgeon and percentage of follow-up, 
presence of raised intraocular pressure, pre-graft vascularisation, interstate 
transportation, pre-graft inflammation and/or steroid use, post-graft microbial keratitis, 
and post-graft rejection episode(s). 
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2.1.9 Penetrating graft survival: influence of cause of donor death 
 
Few causes of death exclude a person from becoming a corneal donor. Figure 2.1.10 
shows the comparison of graft survival depending on cause of donor death. Cause of 
death was unknown for 57 grafts and these were excluded from the analysis. A 
significant difference was found across groups (Log Rank Statistic=37.95; df=5; 
p<0.001). This variable was not retained in the multivariate analysis (see section 2.7) 
indicating that this is not an independent factor significantly affecting graft survival. 
Figure 2.1.10 Cause of donor death 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Cardiac event 2427 954 358 92 8 
Malignancy 2161 728 237 55 4 
Trauma 929 408 168 47 6 
Respiratory event 767 256 93 24 2 
Intracranial/cerebral haemorrhage 1441 548 219 67 1 
Other 519 200 70 28 5 
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Penetrating Corneal Graft Survival 
Cause of Donor Death 
 
 Probability of Graft Survival 
 Cardiac event: 0.94 at 1 year 
  Mean Survival 8.60 years 0.82 at 3 years 
  (SE= 0.19, 95% CI: 8.22, 8.98) 0.69 at 6 years 
  Median Survival 10.18 years 0.56 at 9 years 
    
 Malignancy: 0.93 at 1 year 
  Mean Survival 7.82 years 0.79 at 3 years 
  (SE= 0.20, 95% CI: 7.43, 8.21) 0.64 at 6 years 
  Median Survival 8.77 years 0.49 at 9 years 
    
 Trauma: 0.96 at 1 year 
  Mean Survival 9.59 years 0.88 at 3 years 
  (SE= 0.28, 95% CI: 9.04, 10.14) 0.75 at 6 years 
  Median Survival 13.19 years 0.60 at 9 years 
    
 Respiratory event: 0.94 at 1 year 
  Mean Survival 7.81 years 0.80 at 3 years 
  (SE= 0.31, 95% CI: 7.20, 8.43) 0.63 at 6 years 
  Median Survival 8.27 years 0.46 at 9 years 
    
 Intracranial/cerebral haemorrhage: 0.94 at 1 year 
  Mean Survival 8.38 years 0.84 at 3 years 
  (SE= 0.19, 95% CI: 8.01, 8.76) 0.70 at 6 years 
  Median Survival 10.18 years 0.57 at 9 years 
    
 Other: 0.95 at 1 year 
  Mean Survival 9.28 years 0.86 at 3 years 
  (SE= 0.37, 95% CI: 8.56, 10.00) 0.74 at 6 years 
  Median Survival 12.21 years 0.59 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
“Other” included donors who died from diseases of the liver, kidney, pancreas, gastro-
intestinal tract, encephalopathy, sepsis, and rare diseases. It also included 188 cases, 
where the donor was listed as dying from brain damage or brain death. It is possible 
that a large proportion of this latter group had undergone some form of trauma. 
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2.1.10 Penetrating graft survival: influence of multi-organ donor status 
 
Over the time frame examined in this report (2000-2013), 11.7% of transplanted 
corneas were from multi-organ donors, compared to 4.4% of corneas pre 2000. Figure 
2.1.11 shows the comparison of graft survival depending on whether the donor cornea 
was obtained from a multi-organ donor. A significant difference was found between 
groups (Log Rank Statistic=20.00; df=1; p<0.001). This variable was not retained in the 
multivariate analysis (see section 2.7) indicating that this is not an independent factor 
significantly affecting graft survival.  
Figure 2.1.11 Multi-organ donor status 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No 7351 2737 1008 274 26 
Yes 950 378 142 40 n/a 
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Penetrating Corneal Graft Survival 
Multi-organ Donor 
 
 Probability of Graft Survival 
 No: 0.94 at 1 year 
  Mean Survival 8.48 years 0.82 at 3 years 
  (SE= 0.11, 95% CI: 8.25, 8.70) 0.68 at 6 years 
  Median Survival 9.68 years 0.53 at 9 years 
   0.34 at 12 years 
    
 Yes: 0.96 at 1 year 
  Mean Survival 9.00 years 0.89 at 3 years 
  (SE= 0.23, 95% CI: 8.56, 9.45) 0.75 at 6 years 
  Median Survival 11.82 years 0.63 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.1.11 Penetrating graft survival: influence of donor central corneal endothelial 
cell density 
 
Information on donor central corneal endothelial cell count (ECC) has been requested 
by the registry in recent years. ECC was reported for one quarter (25%) of followed 
penetrating grafts. Reported ECC ranged from 1625 to 4951 cells/mm². Comparison of 
graft survival across donor ECC groups is shown in Figure 2.1.12. No significant 
difference was found across groups (Log Rank Statistic=3.82; df=3; p=0.282). 
Figure 2.1.12 Endothelial cell density 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 
Less than 2500 cells/mm² 211 80 8 
2500 – 2999 cells/mm² 807 259 18 
3000 – 3499 cells/mm² 841 254 11 
3500 or more cells/mm² 221 48 2 
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Penetrating Corneal Graft Survival 
Endothelial Cell Density 
 
 Probability of Graft Survival 
 Less than 2500 cells/mm²: 0.93 at 1 year 
  Mean Survival 5.24 years 0.76 at 3 years 
  (SE= 0.26, 95% CI: 4.74, 5.75)   
  Median Survival 5.80 years   
    
 2500 – 2999 cells/mm²: 0.93 at 1 year 
  Mean Survival 5.57 years 0.80 at 3 years 
  (SE= 0.15, 95% CI: 5.29, 5.86)   
  Median Survival 6.52   
    
 3000 – 3499 cells/mm²: 0.94 at 1 year 
  Mean Survival 5.36 years 0.83 at 3 years 
  (SE= 0.16, 95% CI: 5.05, 5.66)   
  Median Survival 5.98 years   
     
 3500 or more cells/mm²: 0.95 at 1 year 
  Mean Survival 5.31 years 0.78 at 3 years 
  (SE= 0.18, 95% CI: 4.96, 5.66)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.2 Recipient Factors 
 
Table 2.2 shows the number of grafts within each of the recipient variable sub-groups. 
The sum for each variable equals the total number of grafts (11,431 registered and 
8,301 followed) and the percentages, which should be summed vertically for each 
variable, total 100. 
Table 2.2 Recipient factors 
 
Penetrating Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Australian State where graft was performed   
  State F 4238 (37%) 2919 (35%) 
  State G 2452 (21%) 1919 (23%) 
  State H 2489 (22%) 1870 (23%) 
  State J 1143 (10%) 650 (8%) 
  State K 874 (8%) 734 (9%) 
  State L 235 (2%) 209 (3%) 
   
Recipient sex   
  Female 5275 (46%) 3942 (47%) 
  Male 6156 (54%) 4359 (53%) 
   
Recipient age group   
  <10 years 40 (<1%) 24 (<1%) 
  10 to 19 years 408 (4%) 269 (3%) 
  20 to 29 years 1456 (13%) 985 (12%) 
  30 to 39 years 1346 (12%) 923 (11%) 
  40 to 49 years 1201 (11%) 776 (9%) 
  50 to 59 years 1447 (13%) 1034 (12%) 
  60 to 69 years 1685 (15%) 1195 (14%) 
  70 to 79 years 2148 (19%) 1684 (20%) 
  80 to 89 years 1520 (13%) 1262 (15%) 
  ≥ 90 years 177 (2%) 147 (2%) 
  Not advised 3 (<1%) 2 (<1%) 
   
Pre-graft neovascularisation   
  No 8059 (71%) 5918 (71%) 
  Yes 3372 (29%) 2383 (29%) 
   
Pre-graft inflammation and/or steroid use   
  No 8328 (73%) 6150 (74%) 
  Yes 3023 (26%) 2109 (25%) 
  Not advised 80 (<1%) 42 (<1%) 
   
Presence of raised intraocular pressure   
  Never raised 8430 (74%) 6856 (83%) 
  History of raised IOP only 1490 (13%) 1119 (13%) 
  IOP raised at graft 191 (2%) 143 (2%) 
  Not advised 320 (3%) 183 (2%) 
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Previous ipsilateral intraocular surgery   
  None 5957 (52%) 3888 (47%) 
  Yes, including history of previous graft/s 3159 (28%) 2178 (26%) 
  Yes, with no history of previous graft/s 2283 (20%) 2219 (27%) 
  Not advised 32 (<1%) 14 (<1%) 
   
Prior existing contralateral graft   
  No 9163 (80%) 6638 (80%) 
  Yes 2268 (20%) 1663 (20%) 
   
Change in lens status   
  Phakic/phakic 5656 (49%) 3892 (47%) 
  Any/aphakic 509 (4%) 373 (4%) 
  Phakic/pseudophakic 1186 (10%) 920 (11%) 
  Not phakic/pseudophakic 4080 (36%) 3116 (38%) 
   
Total 11431 (100 %) 8301 (100 %) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly more likely (p<0.05) to have been received for 
grafts performed in female recipients, older recipients, recipients with no pre-graft 
vascularisation, recipients with no history of inflammation and/or steroid use, grafts that 
had a history of previous ipsilateral surgery, and grafts that had a change of lens status 
pre- to post-graft. Follow-up was significantly lower for grafts performed in recipients 
from State 1 and State 4. 
Ninety-two penetrating keratoplasties had been converted from a planned deep anterior 
lamellar keratoplasty. Twelve eyes undergoing penetrating keratoplasty had a history of 
corneal cross-linking.  
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Table 2.3 shows the number of grafts reported for each indication for graft, and also 
shows further sub-group breakdowns for each indication group. This breakdown is 
shown for all 11431 registered grafts as well as for the 8301 followed grafts. The total 
for each of the indication groups is the sum of the sub-categories shown below.  
Table 2.3 Indication for graft 
 
Penetrating Corneal Graft 
Indication for Graft 
 
 Registered (%) Followed (%) 
Keratoconus 3584 (31%) 2462 (30%) 
  Uncomplicated 3336 (29%) 2331 (28%) 
  With hydrops 242 (2%) 127 (2%) 
   
  Keratoglobus* 6 (<1%) 4 (<1%) 
   
Failed previous graft 3159 (28%) 2180 (26%) 
   
Bullous keratopathy 1748 (15%) 1447 (17%) 
  Pseudophakic 1448 (13%) 1217 (15%) 
  Aphakic 176 (2%) 130 (2%) 
  Phakic 124 (1%) 100 (1%) 
   
Corneal dystrophy 1310 (11%) 1087 (13%) 
  Fuchs’ endothelial 1163 (10%) 983 (12%) 
  Granular 39 (<1%) 28 (<1%) 
  Lattice 26 (<1%) 17 (<1%) 
  Macular 25 (<1%) 16 (<1%) 
  Polymorphous 15 (<1%) 13 (<1%) 
  Crystalline 14 (<1%) 11 (<1%) 
  Reis-Bücklers 6 (<1%) 5 (<1%) 
  Meesmann 1 (<1%) 1 (<1%) 
  Unspecified 21 (<1%) 13 (<1%) 
   
Herpetic eye disease 367 (3%) 262 (3%) 
  Inactive HSV, no perforation 199 (2%) 140 (2%) 
  Herpes Zoster, no perforation 28 (<1%) 20 (<1%) 
  Inactive HSV, or HZO, with perforation 63 (<1%) 46 (<1%) 
  Active HSV, with perforation  61 (<1%) 43 (<1%) 
  Active HSV, no perforation 16 (<1%) 13 (<1%) 
   
Corneal scars and opacities 169 (1%) 115 (1%) 
  With cataract 26 (<1%) 20 (<1%) 
  From trachoma 18 (<1%) 11 (<1%) 
  Other 18 (<1%) 11 (<1%) 
  Unspecified 107 (<1%) 73 (<1%) 
   
Corneal ulcers/perforation 230 (2%) 168 (2%) 
  Perforated 212 (2%) 155 (2%) 
  No perforation 18 (<1%) 13 (<1%) 
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Trauma 291 (3%) 194 (2%) 
  Burns 31 (<1%) 25 (<1%) 
  Beta radiation 4 (<1%) 4 (<1%) 
  With perforation 3 (<1%) 1 (<1%) 
  Unspecified 253 (2%) 163 (2%) 
   
Non-herpetic infections 206 (2%) 137 (2%) 
  Microbial keratitis/abscess 106 (<1%) 71 (<1%) 
  Pseudomonas infection 33 (<1%) 19 (<1%) 
  Mycotic/fungal ulcer 32 (<1%) 24 (<1%) 
  Acanthamoeba keratitis 20 (<1%) 13 (<1%) 
  Other 15 (<1%) 10 (<1%) 
   
Corneal degenerations 116 (1%) 95 (1%) 
   
Other** 251 (2%) 154 (2%) 
   
Total 11431(100%) 8301 (100%) 
   
 
*In April 2015, Gomes et al [see reference 1], published a global consensus statement 
on the diagnosis and treatment of keratoconus and other ectatic diseases. The Gomes 
et al (2015) paper states that “Keratoconus and keratoglobus are different clinical 
entities”. The data published in this report were prepared prior to the release of this 
consensus paper and so sees keratoglobus still included with keratoconus. This will be 
altered in future analyses. All four of the followed grafts performed in eyes with 
keratoglobus were surviving at the time of last follow-up. 
**Other included: Interstitial keratitis (63), descemetocoele (33), ICE syndrome (31), 
corneal melt (26), Peters’ anomaly (12), lipid keratopathy (9), congenital glaucoma (7), 
aniridia (5), band keratopathy (5), pterygium (5), autograft (4), irregular astigmatism (4), 
limbal stem cell deficiency (4), mucopolysaccharidosis (4), epithelial downgrowth (3), 
squamous cell carcinoma (3), unspecified keratitis (3), blood staining (2), congenital 
cataract (2), congenital rubella (2), corneal staphyloma (2), glaucoma (2), Stevens-
Johnson syndrome (2), superative keratitis (2), unknown (2), amyloidosis (1), congenital 
microphthalmia (1), corneal instability (1), cystinosis (1), exudative macular 
degeneration (1), ichthyosis (1), iris prolapse (1), keratoconjunctivitis (1), limbal dermoid 
(1), neuroparalytic keratitis (1), phthisis (1), porphyria (1), retinal detachment (1), vitamin 
A deficiency (1).  
Chi² analysis indicated that follow-up was significantly more likely to have been received 
at least once for grafts performed for bullous keratopathy or corneal dystrophy 
(p<0.001). 
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2.2.1 Penetrating graft survival: influence of Australian State where graft was 
performed 
 
Figure 2.2.1 shows the comparison of graft survival depending on the Australian State 
in which the transplantation occurred. A significant difference was found across groups 
(Log Rank Statistic=24.10; df=5; p<0.001). This variable was not retained in the 
multivariate analysis (see section 2.7) indicating that this is not an independent factor 
significantly affecting graft survival.  
Figure 2.2.1 Australian State where graft was performed 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
State F 2919 1094 397 87 3 
State G 1919 738 260 77 5 
State H 1870 551 185 47 6 
State J 650 316 144 43 6 
State K 734 333 134 47 5 
State L 209 83 30 13 1 
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Penetrating Corneal Graft Survival 
Australian State Where Graft was Performed 
 
 Probability of Graft Survival 
 State F: 0.94 at 1 year 
  Mean Survival 7.95 years 0.83 at 3 years 
  (SE= 0.19, 95% CI: 7.59, 8.31) 0.68 at 6 years 
  Median Survival 8.69 years 0.48 at 9 years 
    
 State G: 0.95 at 1 year 
  Mean Survival 9.17 years 0.85 at 3 years 
  (SE= 0.22, 95% CI: 8.74, 9.60) 0.72 at 6 years 
  Median Survival 11.25 years 0.59 at 9 years 
    
 State H: 0.94 at 1 year 
  Mean Survival 8.29 years 0.80 at 3 years 
  (SE= 0.25, 95% CI: 7.79, 8.79) 0.65 at 6 years 
  Median Survival 8.53 years 0.63 at 9 years 
    
 State J: 0.91 at 1 year 
  Mean Survival 8.50 years 0.78 at 3 years 
  (SE= 0.25, 95% CI: 8.00, 8.99) 0.67 at 6 years 
  Median Survival 11.24 years 0.60 at 9 years 
    
 State K: 0.95 at 1 year 
  Mean Survival 9.24 years 0.85 at 3 years 
  (SE= 0.28, 95% CI: 8.69, 9.78) 0.72 at 6 years 
  Median Survival 11.78 years 0.61 at 9 years 
     
 State L: 0.91 at 1 year 
  Mean Survival 7.96 years 0.76 at 3 years 
  (SE= 0.47, 95% CI: 7.04, 8.88) 0.63 at 6 years 
  Median Survival 10.18 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
Examination of the difference across recipient States suggests that they may be related 
to differing proportions of interstate donors, recipients with keratoconus or high-risk 
indications, and level of follow-up received. When these factors were controlled in the 
multivariate analysis, recipient State was no longer found to have a significant effect on 
corneal graft survival. 
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2.2.2 Penetrating graft survival: influence of recipient sex 
 
Comparison of graft survival between male and female recipients is shown in Figure 
2.2.2. No significant difference was found between groups (Log Rank Statistic=0.19; 
df=1; p=0.667). 
Figure 2.2.2 Recipient sex 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female 3942 1542 599 172 13 
Male 4359 1573 551 142 13 
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Penetrating Corneal Graft Survival 
Recipient Sex 
 
 Probability of Graft Survival 
 Female: 0.94 at 1 year 
  Mean Survival 8.54 years 0.83 at 3 years 
  (SE= 0.15, 95% CI: 8.25, 8.84) 0.68 at 6 years 
  Median Survival 10.12 years 0.54 at 9 years 
    
 Male: 0.94 at 1 year 
  Mean Survival 8.66 years 0.82 at 3 years 
  (SE= 0.16, 95% CI: 8.34, 8.98) 0.69 at 6 years 
  Median Survival 9.89 years 0.55 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.2.3 Penetrating graft survival: influence of donor/recipient sex match/mismatch 
 
In further analysis, we examined whether there was any effect of a cornea being 
transplanted into a recipient of a different sex to the donor. Data were not available for 
22 grafts. Comparison of graft survival across groups based on donor/recipient sex 
combinations is shown in Figure 2.2.3. No significant difference was found across 
groups (Log Rank Statistic=2.69; df=3; p=0.443). 
Figure 2.2.3 Donor/recipient sex match/mismatch 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female/female 1422 521 199 56 3 
Female/male 1604 541 189 53 2 
Male/female 2510 1017 397 114 10 
Male/male 2743 1025 360 89 11 
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Penetrating Corneal Graft Survival 
Donor/Recipient Sex Match/Mismatch 
 
 Probability of Graft Survival 
 Female/female: 0.94 at 1 year 
  Mean Survival 8.91 years 0.83 at 3 years 
  (SE= 0.28, 95% CI: 8.35, 9.46) 0.71 at 6 years 
  Median Survival 10.38 years 0.60 at 9 years 
    
 Female/male: 0.93 at 1 year 
  Mean Survival 8.46 years 0.82 at 3 years 
  (SE= 0.22, 95% CI: 8.03, 8.90) 0.69 at 6 years 
  Median Survival 10.04 years 0.56 at 9 years 
    
 Male/female: 0.94 at 1 year 
  Mean Survival 8.34 years 0.82 at 3 years 
  (SE= 0.17, 95% CI: 8.00, 8.68) 0.67 at 6 years 
  Median Survival 9.24 years 0.51 at 9 years 
    
 Male/male: 0.95 at 1 year 
  Mean Survival 8.62 years 0.83 at 3 years 
  (SE= 0.20, 95% CI: 8.23, 9.01) 0.69 at 6 years 
  Median Survival 9.70 years 0.54 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.2.4 Penetrating graft survival: influence of recipient age (years) 
 
Figure 2.2.4 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. A significant difference was found across groups (Log Rank 
Statistic=268.71; df=8; p<0.001). Data for the “0-9 years” group was combined with the 
“10 to 19 years” group for analysis because of the low number of recipients in this group 
(n=24). Data were not available for 2 recipients. The variable of recipient age was not 
retained in the multivariate analysis (see section 2.7) indicating that this is not an 
independent factor significantly affecting graft survival.  
Figure 2.2.4 Recipient age 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
0 to 19 years 293 119 47 16 3 
20 to 29 years 985 360 140 38 3 
30 to 39 years 923 351 119 31 3 
40 to 49 years 776 347 143 56 5 
50 to 59 years 1034 467 204 60 4 
60 to 69 years 1195 523 193 56 4 
70 to 79 years 1684 630 237 44 2 
80 to 89 years 1262 301 65 13 2 
90 to 99 years 147 17 2 n/a n/a 
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Penetrating Corneal Graft Survival 
Recipient Age 
 
 Probability of Graft Survival 
 0 to 19 years: 0.92 at 1 year 
  Mean Survival 10.68 years 0.85 at 3 years 
  (SE= 0.41, 95% CI: 9.87, 11.49) 0.79 at 6 years 
  Median Survival n/a   
    
 20 to 29 years: 0.96 at 1 year 
  Mean Survival 11.24 years 0.91 at 3 years 
  (SE= 0.29, 95% CI: 10.68, 11.81) 0.84 at 6 years 
  Median Survival 13.19 years 0.77 at 9 years 
    
 30 to 39 years: 0.97 at 1 year 
  Mean Survival 10.41 years 0.92 at 3 years 
  (SE= 0.22, 95% CI: 9.98, 10.84) 0.84 at 6 years 
  Median Survival n/a 0.78 at 9 years 
    
 40 to 49 years: 0.94 at 1 year 
  Mean Survival 9.00 years 0.86 at 3 years 
  (SE= 0.28, 95% CI: 8.46, 9.54) 0.72 at 6 years 
  Median Survival 10.45 years 0.65 at 9 years 
    
 50 to 59 years: 0.94 at 1 year 
  Mean Survival 8.42 years 0.83 at 3 years 
  (SE= 0.21, 95% CI: 8.01, 8.83) 0.71 at 6 years 
  Median Survival 10.38 years 0.56 at 9 years 
     
 60 to 69 years: 0.94 at 1 year 
  Mean Survival 7.79 years 0.81 at 3 years 
  (SE= 0.21, 95% CI: 7.38, 8.20) 0.61 at 6 years 
  Median Survival 8.32 years 0.47 at 9 years 
     
 70 to 79 years: 0.92 at 1 year 
  Mean Survival 6.95 years 0.76 at 3 years 
  (SE= 0.17, 95% CI: 6.61, 7.30) 0.59 at 6 years 
  Median Survival 7.67 years 0.39 at 9 years 
     
 80 to 89 years: 0.94 at 1 year 
  Mean Survival 7.01 years 0.74 at 3 years 
  (SE= 0.34, 95% CI: 6.34, 7.67) 0.52 at 6 years 
  Median Survival 6.13 years   
     
 90 to 99 years: 0.85 at 1 year 
  Mean Survival 4.39 years 0.69 at 3 years 
  (SE= 0.38, 95% CI: 3.64, 5.13)   
  Median Survival 4.85 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability  
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2.2.5 Penetrating graft survival: influence of indication for graft 
 
Figure 2.2.5 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. A significant 
difference was found across groups (Log Rank Statistic=768.70; df=10; p<0.001). This 
variable was retained in multivariate analysis (see section 2.7) indicating that this is an 
independent factor significantly affecting graft survival.  
Figure 2.2.5 Indication for graft 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Failed previous graft 2180 735 259 79 8 
Keratoconus 2462 1020 399 114 10 
Bullous keratopathy 1447 447 126 31 3 
Corneal dystrophy 1087 582 247 62 3 
Corneal scar/opacity 115 41 14 2 n/a 
Ulcer/perforation 168 21 3 n/a n/a 
Herpetic eye disease 262 78 28 7 n/a 
Trauma 194 80 29 9 1 
Non-herpetic infection 137 28 5 2 n/a 
Corneal degeneration 95 20 9 4 1 
Other 154 63 31 4 n/a 
 
 Penetrating Keratoplasty 
49 Australian Corneal Graft Registry Report 2015 
 
Penetrating Corneal Graft Survival 
Indication for Graft 
 
 Probability of Graft Survival 
 Failed previous graft: 0.92 at 1 year 
  Mean Survival 6.95 years 0.72 at 3 years 
  (SE= 0.18, 95% CI: 6.60, 7.30) 0.53 at 6 years 
  Median Survival 6.63 years 0.38 at 9 years 
    
 Keratoconus: 0.98 at 1 year 
  Mean Survival 11.73 years 0.95 at 3 years 
  (SE= 0.18, 95% CI: 11.37, 12.08) 0.92 at 6 years 
  Median Survival 13.19 years 0.84 at 9 years 
    
 Bullous keratopathy: 0.94 at 1 year 
  Mean Survival 6.52 years 0.74 at 3 years 
  (SE= 0.20, 95% CI: 6.12, 6.91) 0.48 at 6 years 
  Median Survival 5.58 years 0.32 at 9 years 
    
 Corneal dystrophy: 0.97 at 1 year 
  Mean Survival 9.18 years 0.9 at 3 years 
  (SE= 0.25, 95% CI: 8.68, 9.67) 0.80 at 6 years 
  Median Survival 9.89 years 0.64 at 9 years 
    
 Corneal scar/opacity: 0.96 at 1 year 
  Mean Survival 7.68 years 0.94 at 3 years 
  (SE= 0.51, 95% CI: 6.69, 8.67) 0.71 at 6 years 
  Median Survival n/a   
     
 Ulcer/perforation: 0.72 at 1 year 
  Mean Survival 3.84 years 0.47 at 3 years 
  (SE= 0.44, 95% CI: 2.98, 4.70) 0.25 at 6 years 
  Median Survival 2.54 years   
     
 Herpetic eye disease: 0.91 at 1 year 
  Mean Survival 7.28 years 0.77 at 3 years 
  (SE= 0.45, 95% CI: 6.40, 8.16) 0.63 at 6 years 
  Median Survival 7.66 years   
    
 Trauma: 0.89 at 1 year 
  Mean Survival 7.47 years 0.78 at 3 years 
  (SE= 0.48, 95% CI: 6.53, 8.40) 0.60 at 6 years 
  Median Survival 7.08 years   
     
 Non herpetic infection: 0.74 at 1 year 
  Mean Survival 6.17 years 0.59 at 3 years 
  (SE= 0.69, 95% CI: 4.81, 7.53) 0.44 at 6 years 
  Median Survival 5.72 years   
     
 Corneal degeneration: 0.93 at 1 year 
  Mean Survival 9.51 years 0.84 at 3 years 
  (SE= 0.88, 95% CI: 7.79, 11.23) 0.79 at 6 years 
  Median Survival 12.33 years   
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 Other: 0.88 at 1 year 
  Mean Survival 6.80 years 0.76 at 3 years 
  (SE= 0.40, 95% CI: 6.02, 7.58) 0.66 at 6 years 
  Median Survival 7.95 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, indication for graft was shown to have a significant effect 
(p<0.001) on graft survival. This effect varied over time. The most common indication 
for graft was keratoconus, and these grafts have significantly better survival than those 
performed for any other indication (all comparisons p<0.01). 
The final model also accounted for the effect of graft size, lens status pre- and post-
graft, graft year, donor age group, experience of surgeon and percentage of follow-up, 
presence of raised intraocular pressure, pre-graft vascularisation, interstate 
transportation, pre-graft inflammation and/or steroid use, post-graft microbial keratitis, 
and post-graft rejection episode(s). 
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The analyses on pages 52 to 61 are of subcategories in individual indication for 
graft cohorts. The nature of the variables means that large percentages of the 
cohort do not have relevant data. These subgroup-analyses were therefore not 
included in multivariate analyses. The overarching variable “indication for graft” 
was included. 
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2.2.5.1 Penetrating graft survival: keratoconus 
 
Figure 2.2.6 shows the comparison of graft survival for first versus repeat grafts for 
keratoconus. A significant difference was found across groups (Log Rank 
Statistic=108.36; df=1; p<0.001).  
Figure 2.2.6 First versus subsequent grafts for keratoconus 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
First graft 2462 1020 399 114 10 
Second or subsequent graft 755 310 123 37 4 
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Penetrating Corneal Graft Survival 
First Versus Subsequent Grafts for Keratoconus 
 
 Probability of Graft Survival 
 First graft: 0.98 at 1 year 
  Mean Survival 11.73 years 0.95 at 3 years 
  (SE= 0.18, 95% CI: 11.37, 12.08) 0.92 at 6 years 
  Median Survival 13.19 years 0.84 at 9 years 
    
 Second or subsequent graft: 0.97 at 1 year 
  Mean Survival 9.10 years 0.86 at 3 years 
  (SE= 0.31, 95% CI: 8.50, 9.70) 0.73 at 6 years 
  Median Survival 10.18 years 0.54 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.2.5.2 Penetrating graft survival: influence of type of corneal dystrophy 
 
Figure 2.2.7 shows the comparison of survival for grafts for Fuchs’ endothelial dystrophy 
versus other corneal dystrophies. No significant difference was found across groups 
(Log Rank Statistic=0.01; df=1; p=0.937).  
Figure 2.2.7 Type of corneal dystrophy 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Other corneal dystrophy 103 49 18 5 n/a 
Fuchs’ endothelial dystrophy 984 855 229 57 2 
 
The 103 ‘other’ corneal dystrophies comprised: granular dystrophy (27), lattice 
dystrophy (17), macular dystrophy (16), posterior polymorphous dystrophy (13), 
Schnyder crystalline dystrophy (11), Reis-Bücklers dystrophy (5), Meesmann dystrophy 
(10) and congenital hereditary dystrophy (1). There were also 12 registrations for 
unspecified corneal dystrophy. 
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Penetrating Corneal Graft Survival 
Corneal Dystrophy 
 
 Probability of Graft Survival 
 Other corneal dystrophy: 0.97 at 1 year 
  Mean Survival 8.93 years 0.91 at 3 years 
  (SE= 0.63, 95% CI: 7.69, 10.17)   
  Median Survival 10.38 years   
    
 Fuchs’ endothelial dystrophy: 0.97 at 1 year 
  Mean Survival 9.14 years 0.90 at 3 years 
  (SE= 0.26, 95% CI: 8.60, 9.66) 0.80 at 6 years 
  Median Survival 9.89 years 0.64 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.2.5.3 Penetrating graft survival: influence of HSV eye disease at time of graft, 
1985 onwards 
 
Figure 2.2.8 shows the comparison of survival of grafts with active HSV infection at the 
time of graft, compared to those with inactive disease. Due to the low numbers of grafts 
performed in eyes with active disease, these analyses were conducted using data from 
all grafts in the Registry, from 1985 onwards. Grafts with active HSV exhibit poorer graft 
survival than those in eyes with inactive disease (Log Rank Statistic=12.70, df=1, 
p<0.001). 
Figure 2.2.8 Presence of active Herpes Simplex Virus (HSV), 1985 onwards 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 15 18 21 24 27 
No active HSV 635 274 148 88 50 27 15 7 n/a n/a 
Active HSV 163 60 31 20 13 9 5 2 1 1 
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Penetrating Corneal Graft Survival 
Active and Inactive HSV Eye Disease at Time of Graft 
 
 Probability of Graft Survival 
 No active HSV: 0.92 at 1 year 
  Mean Survival 13.56 years 0.84 at 3 years 
  (SE= 0.64, 95% CI: 12.31, 14.81) 0.75 at 6 years 
  Median Survival 13.59 years 0.67 at 9 years 
  0.56 at 12 years 
  0.48 at 15 years 
    
 Active HSV: 0.86 at 1 year 
  Mean Survival 11.62 years 0.64 at 3 years 
  (SE= 1.34, 95% CI: 8.98, 14.25) 0.53 At 6 years 
  Median Survival 10.83 years 0.51 At 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
 
Further analyses (data not shown) did not support any change in corneal graft survival 
across era (1985-99 versus 2000-13), for grafts performed for herpetic eye disease (Log 
Rank Statistic=1.51; df=1; p=0.219). 
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2.2.5.4 Penetrating graft survival: influence of non-herpetic infections, 1985 
onwards  
 
Analysis of data relating to non-herpetic infections was conducted from 1985 onwards, 
due to low numbers (Figure 2.2.9). A significant difference was found (Log Rank 
Statistic=52.59; df=4; p<0.001).  
Figure 2.2.9 Type of non-herpetic infection, 1985 onwards 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 15 
Microbial/Interstitial keratitis 253 121 62 24 13 n/a 
Pseudomonas keratitis 23 5 1 1 n/a n/a 
Fungal keratitis 46 7 3 n/a n/a n/a 
Acanthamoeba keratitis 26 9 6 4 1 n/a 
Other 54 10 6 6 5 3 
 
General bacterial abscesses are included within microbial keratitis. The 54 other non-
herpetic infections comprised 16 bacterial keratitis complicated by endophthalmitis, 
corneal perforations consequent upon infection, and infections caused by fusarium (7), 
syphilis (4), measles (3), adenovirus keratitis (3), M. tuberculosis (2), Staphylococcus 
(1), Streptococcus (1), scleritis (1), gonococcus (1), disciform conjunctivitis (1) and viral 
conjunctivitis (1). 
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Penetrating Corneal Graft Survival 
Non-herpetic Infections 
 
 Probability of Graft Survival 
 Microbial/Interstitial keratitis: 0.89 at 1 year 
  Mean Survival 10.37 years 0.84 at 3 years 
  (SE= 0.48, 95% CI: 9.42, 11.31) 0.76 at 6 years 
  Median Survival 13.40 years 0.69 at 9 years 
    
 Pseudomonas keratitis:   
  Mean Survival 6.00 years  n/a 
  (SE= 1.03, 95% CI: 3.98, 8.03)   
  Median Survival n/a   
    
 Fungal keratitis:   
  Mean Survival 3.61 years  n/a 
  (SE= 0.66, 95% CI: 2.31, 4.91)   
  Median Survival 1.53 years   
    
 Acanthamoeba keratitis:   
  Mean Survival 9.02 years  n/a 
  (SE= 1.29, 95% CI: 6.49, 11.56)   
  Median Survival n/a   
    
 Other: 0.63 at 1 year 
  Mean Survival 6.06 years   
  (SE= 1.24, 95% CI: 3.63, 8.48)   
  Median Survival 2.57 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.2.5.5 Penetrating graft survival: influence of the number of ipsilateral grafts 
 
For repeat grafts, survival was compared across groups based on the number of 
previous grafts in the same eye (range 1 to 12). Previous grafts may not have been 
penetrating keratoplasties. In three grafts (performed in two eyes), the eye had 
previously undergone a limbal graft. This limbal graft was surviving at the time of the 
penetrating graft, meaning that while the penetrating graft was classified as having been 
performed for the original indication, rather than for a failed previous graft, the recipient 
had had one or two previous graft/s.  
Survival decreased (Log Rank Statistic=112.43, df=3, p<0.001) as the number of grafts 
increased. The Kaplan Meier curve in Figure 2.2.10 also shows the survival of first 
grafts for any indication, to give context to the other survival rates; however these grafts 
are not included in the statistical comparison.  
Figure 2.2.10 Number of previous ipsilateral grafts 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
First graft for any indication 6120 2379 891 235 18 
One previous graft 1591 557 199 60 7 
Two previous grafts 375 117 41 12 1 
Three previous grafts 128 44 16 6 n/a 
Four or more previous grafts 87 18 3 1 n/a 
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Penetrating Corneal Graft Survival 
Number of Ipsilateral Grafts 
 
 Probability of Graft Survival 
 First graft for any indication: 0.95 at 1 year 
  Mean Survival 9.25 years 0.86 at 3 years 
  (SE= 0.13, 95% CI: 8.99, 9.51) 0.74 at 6 years 
  Median Survival 10.98 years 0.61 at 9 years 
    
 One previous graft: 0.92 at 1 year 
  Mean Survival 7.49 years 0.76 at 3 years 
  (SE= 0.22, 95% CI: 7.06, 7.92) 0.58 at 6 years 
  Median Survival 7.67 years 0.41 at 9 years 
    
 Two previous grafts: 0.90 at 1 year 
  Mean Survival 6.16 years 0.68 at 3 years 
  (SE= 0.35, 95% CI: 5.48, 6.46) 0.48 at 6 years 
  Median Survival 5.02 years   
    
 Three previous grafts: 0.88 at 1 year 
  Mean Survival 5.61 years 0.66 at 3 years 
  (SE= 0.43, 95% CI: 4.76, 6.46)   
  Median Survival 5.02 years   
    
 Four or more previous grafts: 0.75 at 1 year 
  Mean Survival 2.96 years   
  (SE= 0.37, 95% CI: 2.23, 3.70)   
  Median Survival 2.05 years   
     
 
 
This concludes the subgroup-analyses. Analyses from page 62 onwards are 
again performed on the full cohort. 
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2.2.6 Penetrating graft survival: influence of pre- and post-graft lens status 
 
Figure 2.2.11 shows the comparison of graft survival stratified by the change of lens 
status from pre- to post-graft. “Phakic/phakic” means the eye was phakic both before 
and after the graft. “Any/aphakic” means the eye was phakic, pseudophakic or aphakic 
before the graft and aphakic afterwards. “Phakic/pseudophakic” means the eye was 
phakic before the graft and pseudophakic afterwards, having undergone a triple 
procedure. “Not phakic/pseudophakic” means the eye was aphakic or pseudophakic 
before the graft and pseudophakic afterwards.  
A significant difference was found across groups (Log Rank Statistic=605.70; df=3; 
p<0.001). This variable was retained in the multivariate analysis (see section 2.7), 
indicating that this is an independent factor significantly affecting graft survival.  
Figure 2.2.11 Change in lens status from pre- to post-graft  
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Phakic/phakic 3892 1579 629 192 17 
Any/aphakic 373 102 28 7 1 
Phakic/pseudophakic 920 445 182 45 3 
Not phakic/pseudophakic 3116 989 311 70 5 
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Penetrating Corneal Graft Survival 
Pre- and Post-graft Lens Status 
 
 Probability of Graft Survival 
 Phakic/phakic: 0.96 at 1 year 
  Mean Survival 10.31 years 0.91 at 3 years 
  (SE= 0.16, 95% CI: 9.99, 10.62) 0.84 at 6 years 
  Median Survival 12.09 years 0.72 at 9 years 
    
 Any/aphakic: 0.85 at 1 year 
  Mean Survival 5.25 years 0.56 at 3 years 
  (SE= 0.34, 95% CI: 4.59, 5.92) 0.36 at 6 years 
  Median Survival 3.83 years   
    
 Phakic/pseudophakic: 0.95 at 1 year 
  Mean Survival 9.00 years 0.86 at 3 years 
  (SE= 0.26, 95% CI: 8.48, 9.52) 0.75 at 6 years 
  Median Survival 10.12 years 0.60 at 9 years 
    
 Not phakic/pseudophakic: 0.93 at 1 year 
  Mean Survival 6.59 years 0.73 at 3 years 
  (SE= 0.15, 95% CI: 6.29, 6.89) 0.51 at 6 years 
  Median Survival 6.10 years 0.33 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, lens status pre- and post-graft was shown to have a 
significant effect (p<0.001) on graft survival. The final model also accounted for the 
effect of indication for graft, graft size, graft year, donor age group, experience of 
surgeon and percentage of follow-up, presence of raised intraocular pressure, pre-graft 
neovascularisation, interstate transportation, pre-graft inflammation and/or steroid use, 
post-graft microbial keratitis, and post-graft rejection episode(s). 
There was no significant difference between the survival of grafts that were phakic pre- 
and post-graft and those that underwent a triple procedure (p=0.227), however, grafts 
that were phakic pre- and post-graft exhibited better graft survival than grafts in either of 
the two groups that were not phakic pre-graft (both p<0.001). Those that were aphakic 
post-graft also had significantly poorer survival than those that were pseudophakic post-
graft, regardless of whether they were phakic or not phakic pre-graft (both p<0.001).   
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2.2.7 Penetrating graft survival: influence of pre-graft corneal neovascularisation 
 
Figure 2.2.12 shows the comparison of graft survival between those recipients with 
corneal neovascularisation pre-graft and those without (Log Rank Statistic=300.83; 
df=1; p<0.001). This variable was retained in the multivariate analysis (see section 2.7), 
indicating that this is an independent factor significantly affecting graft survival. Grafts 
performed in neovascularised eyes showed diminished graft survival. 
Figure 2.2.12 Pre-graft corneal neovascularisation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No neovascularisation 5918 2372 898 236 19 
Neovascularisation 2383 743 252 78 7 
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Penetrating Corneal Graft Survival 
Pre-graft Neovascularisation 
 
 Probability of Graft Survival 
 No neovascularisation: 0.96 at 1 year 
  Mean Survival 9.37 years 0.87 at 3 years 
  (SE= 0.13, 95% CI: 9.11, 9.64) 0.75 at 6 years 
  Median Survival 11.17 years 0.62 at 9 years 
    
 Neovascularisation: 0.90 at 1 year 
  Mean Survival 6.73 years 0.70 at 3 years 
  (SE= 0.17, 95% CI: 6.39, 7.07) 0.52 at 6 years 
  Median Survival 6.16 years 0.36 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
In the multivariate analysis, pre-graft neovascularisation was shown to have a 
significant effect (p=0.002) on graft survival. The final model also accounted for the 
effect of indication for graft, graft size, lens status pre- and post-graft, graft year, donor 
age group, experience of surgeon and percentage of follow-up, presence of raised 
intraocular pressure, interstate transportation, pre-graft inflammation and/or steroid use, 
post-graft microbial keratitis, and post-graft rejection episode(s). 
A subgroup-analysis was conducted to examine the impact of the extent of 
neovascularisation on graft survival. The results can be found overleaf, on pages 
66 and 67. 
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2.2.7.1 Penetrating graft survival: influence of the extent of pre-graft 
neovascularisation 
 
Figure 2.2.13 indicates that graft survival is influenced by the degree of pre-graft corneal 
neovascularisation (Log Rank Statistic=69.99; df=3; p<0.001). The Kaplan Meier curve 
also shows the survival of avascular grafts, to give context to the other survival rates, 
but these grafts are not included in the statistical comparison. 
Figure 2.2.13 Extent of pre-graft neovascularisation 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
None 5918 2372 898 236 19 
One quadrant 810 295 109 27 4 
Two quadrants 708 216 64 20 n/a 
Three quadrants 305 98 38 17 2 
Four quadrants 560 134 41 14 1 
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Penetrating Corneal Graft Survival 
Pre-graft Neovascularisation 
 
 Probability of Graft Survival 
 None: 0.96 at 1 year 
  Mean Survival 9.37 years 0.87 at 3 years 
  (SE= 0.13, 95% CI: 9.11, 9.64) 0.75 at 6 years 
  Median Survival 11.17 years 0.62 at 9 years 
    
 One quadrant: 0.95 at 1 year 
  Mean Survival 7.66 years 0.78 at 3 years 
  (SE= 0.27, 95% CI: 7.14, 8.19) 0.63 at 6 years 
  Median Survival 8.13 years 0.59 at 9 years 
    
 Two quadrants: 0.92 at 1 year 
  Mean Survival 6.35 years 0.72 at 3 years 
  (SE= 0.26, 95% CI: 5.85, 6.86) 0.48 at 6 years 
  Median Survival 5.79 years 0.34 at 9 years 
    
 Three quadrants: 0.89 at 1 year 
  Mean Survival 6.74 years 0.69 at 3 years 
  (SE= 0.43, 95% CI: 5.90, 7.59) 0.51 at 6 years 
  Median Survival 6.11 years   
    
 Four quadrants: 0.81 at 1 year 
  Mean Survival 5.22 years 0.57 at 3 years 
  (SE= 0.29, 95% CI: 4.65, 5.78) 0.38 at 6 years 
  Median Survival 3.74 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
This concludes the subgroup analysis. Analyses from page 68 are again 
performed on the entire cohort.  
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2.2.8 Penetrating graft survival: influence of inflammation and/or steroid use at 
time of graft 
 
Figure 2.2.14 shows the comparison of graft survival between grafts performed in an 
eye with current inflammation and/or steroid use within the past two weeks, compared 
to those with neither of these factors (Log Rank Statistic=524.07; df=1; p<0.001). This 
information was not known for 42 grafts and these were excluded from the analysis. 
This variable was retained in the multivariate analysis (see section 2.7), indicating that 
this is an independent factor significantly affecting graft survival. Current inflammation 
and/or recent use of steroids was associated with poorer graft survival. 
Figure 2.2.14 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No inflammation/steroid use 6150 2521 976 270 22 
Inflammation/steroid use 2109 581 169 42 3 
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Penetrating Corneal Graft Survival 
Inflammation and/or Steroid Use at Time of Graft 
 
 Probability of Graft Survival 
 No inflammation/steroid use: 0.96 at 1 year 
  Mean Survival 9.36 years 0.88 at 3 years 
  (SE= 0.13, 95% CI: 9.11, 9.61) 0.76 at 6 years 
  Median Survival 10.98 years 0.62 at 9 years 
   0.40 at 12 years 
    
 Inflammation/steroid use: 0.87 at 1 year 
  Mean Survival 6.17 years 0.66 at 3 years 
  (SE= 0.20, 95% CI: 5.78, 6.56) 0.44 at 6 years 
  Median Survival 5.02 years 0.31 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
In the multivariate analysis, pre-graft inflammation and/or steroid use was shown to 
have a significant effect (p<0.001) on graft survival. This effect varied over time. The 
final model also accounted for the effect of indication for graft, graft size, lens status 
pre- and post-graft, graft year, donor age group, experience of surgeon and percentage 
of follow-up, presence of raised intraocular pressure, pre-graft vascularisation, interstate 
transportation, post-graft microbial keratitis, and post-graft rejection episode(s). 
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2.2.9 Penetrating graft survival: influence of the combination of history of raised 
intraocular pressure (IOP) and raised IOP at time of graft 
 
Figure 2.2.15 shows the comparison of graft survival across groups based on whether 
the recipient had a history of raised IOP and/or raised IOP at the time of graft, in the eye 
being grafted (Log Rank Statistic=402.25; df=2; p<0.001). This variable was retained in 
the multivariate analysis (see section 2.7), indicating that this is an independent factor 
significantly affecting graft survival.  
“IOP never raised” means there is no known history of raised IOP in the grafted eye and 
IOP was not raised at the time of graft. “History of raised IOP only” means IOP had 
been raised in the eye previously, but was not raised at the time of the graft. “IOP raised 
at time of graft” means the eye may or may not have had a history of raised IOP 
(including cases where this was unknown), but the IOP was raised at the time of graft. 
Where the surgeon was unable to state whether IOP had been raised in the past and/or 
at graft (excluding cases included in the “IOP raised at time of graft” group), these grafts 
were excluded from the analysis (183 cases). 
Figure 2.2.15 Raised intraocular pressure, in history and/or at time of graft 
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Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
IOP never raised 6856 2632 1008 276 22 
History of raised IOP only 1119 388 110 26 4 
IOP raised at time of graft 143 36 14 5 n/a 
 
 
 
Penetrating Corneal Graft Survival 
History of Raised IOP and/or Raised IOP at Time of Graft 
 
 Probability of Graft Survival 
 IOP never raised: 0.95 at 1 year 
  Mean Survival 9.37 years 0.86 at 3 years 
  (SE= 0.13, 95% CI: 9.07, 9.57) 0.75 at 6 years 
  Median Survival 10.98 years 0.61 at 9 years 
   0.43 at 12 years 
    
 History of raised IOP only: 0.92 at 1 year 
  Mean Survival 5.60 years 0.66 at 3 years 
  (SE= 0.20, 95% CI: 5.22, 5.99) 0.39 at 6 years 
  Median Survival 4.48 years 0.23 at 9 years 
    
 IOP raised at time of graft: 0.83 at 1 year 
  Mean Survival 5.52 years 0.57 at 3 years 
  (SE= 0.56, 95% CI: 4.41, 6.62)   
  Median Survival 3.85 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
In the multivariate analysis, raised intraocular pressure was shown to have a significant 
effect (p<0.001) on graft survival. This was the case for both grafts that had raised 
intraocular pressure at the time of graft (p=0.012) and those with a history of raised 
pressure which had been stabalised at the time of graft (p<0.001). The final model also 
accounted for the effect of indication for graft, graft size, lens status pre- and post-graft, 
graft year, donor age group, experience of surgeon and percentage of follow-up, pre-
graft vascularisation, interstate transportation, pre-graft inflammation and/or steroid use, 
post-graft microbial keratitis, and post-graft rejection episode(s). 
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2.2.10 Penetrating graft survival: influence of previous contralateral graft 
 
Figure 2.2.16 shows the comparison of graft survival between grafts where the recipient 
had undergone a previous contralateral graft and those where they had not (Log Rank 
Statistic=18.85; df=1; p<0.001). This variable was not retained in the multivariate 
analysis (see section 2.7) indicating that this is not an independent factor significantly 
affecting graft survival. 
Figure 2.2.16 Previous contralateral graft 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No contralateral graft 6638 2432 893 234 20 
Previous contralateral graft 1663 683 257 80 6 
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Penetrating Corneal Graft Survival 
Previous Contralateral Graft 
 
 Probability of Graft Survival 
 No contralateral graft: 0.94 at 1 year 
  Mean Survival 8.49 years 0.81 at 3 years 
  (SE= 0.13, 95% CI: 8.24, 8.73) 0.67 at 6 years 
  Median Survival 9.72 years 0.52 at 9 years 
   0.34 at 12 years 
    
 Previous contralateral graft: 0.96 at 1 year 
  Mean Survival 9.03 years 0.86 at 3 years 
  (SE= 0.22, 95% CI: 8.60, 9.47) 0.73 at 6 years 
  Median Survival 10.18 years 0.61 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
Note: Previous contralateral grafts could be of any type, not just PK. 
 
The majority (97%) of grafts performed for ulcer/perforation, herpetic infection, trauma 
and non-herpetic infection, which all have poor rates of survival, are only performed in 
one eye. These make up 12% of the grafts with no contralateral graft compared to <2% 
of those with a previous contralateral graft. Conversely, conditions such as keratoconus 
or Fuchs’ dystrophy, for which survival is much better, are often bilateral and thus make 
up larger proportions of the group with previous contralateral grafts (49% vs 41%). This 
is one possible reason why this variable was not retained in the multivariate analysis. 
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The analysis on pages 74 and 75 is conducted using data only from first grafts 
(no previous ipsilateral grafts). This subgroup-analysis was not included in 
multivariate analyses, as it only relates to data on 74% of grafts. 
2.2.11 Penetrating graft survival: influence of history of previous intraocular 
surgery in ipsilateral eye 
 
Figure 2.2.17 shows the comparison of graft survival between first grafts performed in 
an eye that had undergone previous intraocular surgery, compared with first grafts 
performed in an eye that had not (Log Rank Statistic=305.45; df=1; p<0.001). While 
surgeons were not asked to specify what type of previous surgery recipients had 
undergone, in the majority of cases (3418/4398, 78%) the lens status of the eye pre-
graft (pseudophakic or aphakic) indicated that they had undergone cataract extraction, 
with or without IOL insertion. Surgeons were unable to say if previous surgery had 
occurred in 13 first grafts and these were excluded from the analysis.  
Figure 2.2.17 History of previous intraocular surgery in the ipsilateral eye 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No previous surgery 3888 1629 646 179 14 
Previous surgery 2219 747 245 56 4 
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Penetrating Corneal Graft Survival 
History of Previous Surgery in the Ipsilateral Eye in First Grafts 
 
 Probability of Graft Survival 
 No previous surgery: 0.96 at 1 year 
  Mean Survival 10.38 years 0.91 at 3 years 
  (SE= 0.17, 95% CI: 10.06, 10.71) 0.84 at 6 years 
  Median Survival 12.33 years 0.72 at 9 years 
    
 Previous surgery: 0.93 at 1 year 
  Mean Survival 7.16 years 0.76 at 3 years 
  (SE= 0.19, 95% CI: 6.78, 7.53) 0.56 at 6 years 
  Median Survival 6.85 years 0.40 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.3 Graft Era 
 
Table 2.4 shows the number of grafts registered and followed, in blocks of two years. 
The percentages, which should be summed vertically, total 100. 
Table 2.4 Graft era 
 
Penetrating Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  2000 850 (7%) 766 (9%) 
  2001/2002 1754 (15%) 1573 (19%) 
  2003/2004 1753 (15%) 1481 (18%) 
  2005/2006 1835 (16%) 1530 (18%) 
  2007/2008 1742 (15%) 1350 (16%) 
  2009/2010 1366 (12%) 991 (12%) 
  2011/2012 1474 (13%) 600 (7%) 
  2013/2014 657 (6%) 10 (0%) 
   
Total 11431 (100 %) 8301 (100 %) 
   
 
Comparisons amongst the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly lower (p<0.001) for grafts performed since 2011. 
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2.3.1 Penetrating graft survival: influence of year of graft 
 
Figure 2.3.1 shows the comparison of graft survival between year of graft, stratified post 
2000 into two-year groups (Log Rank Statistic=70.23; df=6; p<0.001). Due to the low 
number of followed grafts (10), data for grafts performed in 2013\2014 were not 
included in the analysis. This variable was retained in the multivariate analysis (see 
section 2.7) indicating that this is an independent factor significantly affecting graft 
survival. 
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a 
replacement graft. A “lag time” operates at the furthest end of each curve in a Kaplan 
Meier plot. This effect is most pronounced in the early years following graft registration, 
when requests have not yet been made for follow-up information, and tends to reduce 
predictably over time. It can be seen, in the analysis below, that the survival curves tend 
to drop off suddenly, illustrating this skewing of the data. In consequence, the variable is 
treated as “time variant” in multivariate analyses, to statistically control for this effect. 
Figure 2.3.1 Year of graft 
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Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
2000 766 342 189 111 21 
2001/2002 1573 672 379 153 5 
2003/2004 1481 635 330 50 n/a 
2005/2006 1530 719 227 n/a n/a 
2007/2008 1350 587 25 n/a n/a 
2009/2010 991 160 n/a n/a n/a 
2011/2012 600 n/a n/a n/a n/a 
 
 
In the multivariate analysis, graft year was shown to have a significant effect (p<0.001) 
on graft survival. This effect varied over time. Using the year 2000 as referent, there 
was no difference in survival for grafts performed in either 2001/02 (p=0.319) or 
2003/04 (p=0.178). Graft survival was significantly improved for grafts performed in the 
years 2005/06, 2007/08 and 2009/10 (all p<0.05). There was no significant difference 
for grafts performed in 2011/12 compared to 2000 (p=0.552), however this is likely due 
to the effect of lag time on recent data.  
Figure 2.3.2 shows the comparisons of graft survival in greater detail, over the first three 
years post-graft, for each of the year groups where survival was found to be significantly 
different from grafts performed in the year 2000. Note: on these plots, the probability of 
survival is shown from 0.80, rather than starting at the usual origin of 0. 
Figure 2.3.2 Year of graft: significant differences in first 3 years of follow-up 
 
The final model also accounted for the effect of indication for graft, graft size, lens status 
pre- and post-graft, donor age group, experience of surgeon and percentage of follow-
up, presence of raised intraocular pressure, pre-graft vascularisation, interstate 
transportation, pre-graft inflammation and/or steroid use, post-graft microbial keratitis, 
and post-graft rejection episode(s). 
 
 
 
 
 Penetrating Keratoplasty 
80 Australian Corneal Graft Registry Report 2015 
 
 
 
 
Penetrating Corneal Graft Survival 
Era of Graft 
 
 Probability of Graft Survival 
 2000 : 0.94 at 1 year 
  Mean Survival 9.35 years  0.83 at 3 years 
  (SE= 0.24, 95% CI: 8.87, 9.83) 0.73 at 6 years 
  Median Survival 11.49 years  0.63 at 9 years 
   0.48 at 12 years 
    
 2001/2002: 0.95 at 1 year 
  Mean Survival 8.70 years 0.85 at 3 years 
  (SE= 0.16, 95% CI: 8.39, 9.01) 0.74 at 6 years 
  Median Survival 10.38 years 0.60 at 9 years 
    
 2003/2004: 0.94 at 1 year 
  Mean Survival 7.64 years 0.84 at 3 years 
  (SE= 0.13, 95% CI: 7.38, 7.90) 0.72 at 6 years 
  Median Survival 9.24 years 0.53 at 9 years 
    
 2005/2006 : 0.95 at 1 year 
  Mean Survival 6.59 years  0.84 at 3 years 
  (SE= 0.10, 95% CI: 6.39, 6.79) 0.68 at 6 years 
  Median Survival 8.29 years    
    
 2007/2008 : 0.95 at 1 year 
  Mean Survival 5.33 years  0.83 at 3 years 
  (SE= 0.09, 95% CI: 5.16, 5.51) 0.60 at 6 years 
  Median Survival 6.63 years    
    
 2009/2010 : 0.95 at 1 year 
  Mean Survival 3.81 years  0.75 at 3 years 
  (SE= 0.08, 95% CI: 3.66, 3.96)   
  Median Survival 4.41 years    
    
 2011/2012 : 0.89 at 1 year 
  Mean Survival years 2.48   
  (SE= 0.06, 95% CI: 2.37, 2.60)   
  Median Survival years 2.78   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.4 Surgery and Surgeon Factors 
 
Table 2.5 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report. The sum of these numbers for 
each variable equals the total number of grafts (11,431 registered and 8,301 followed) 
and the percentages, which should be summed vertically for each variable, total 100. 
Table 2.5 Surgery and surgeon factors 
 
Penetrating Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  Less than 8.0 mm 1730 (15%) 1267 (15%) 
  8.0 mm to <8.25 mm 4295 (38%) 3273 (39%) 
  8.25 mm to <8.5 mm 2228 (19%) 1562 (19%) 
  8.5 mm to <8.75 mm 1371 (12%) 961 (12%) 
  8.75 mm or more 1108 (10%) 756 (9%) 
  Not advised 689 (6%) 482 (6%) 
   
Surgeon volume   
  Fewer than 100 followed grafts 4340 (38%) 2628 (32%) 
  100+ followed grafts, <73% follow-up 3016 (26%) 1989 (24%) 
  100+ followed grafts, ≥73% follow-up 4075 (36%) 3684 (44%) 
   
Total 11431 (100 %) 8301 (100 %) 
   
 
73% was selected as the cut-off point for the follow-up categories as this (72.6%) was 
the average percentage of follow-up for all penetrating grafts. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly lower (p<0.05) for larger grafts. Due to the nature 
of the variable, follow-up was, logically, significantly higher for grafts performed by 
surgeons with 100+ followed grafts and ≥73% follow-up. 
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2.4.1 Penetrating graft survival: influence of graft size 
 
Figure 2.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. This information was not 
reported for 482 of the followed grafts. A significant difference was found across groups 
(Log Rank Statistic=141.37; df=5; p<0.001). This variable was retained in the final 
model, indicating that this is an independent factor significantly affecting graft survival. 
Figure 2.4.1 Graft size 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 7.75 mm 651 216 77 21 0 
7.75 mm to < 8 mm 616 230 77 21 4 
8 mm to < 8.25 mm 3273 1273 447 125 9 
8.25 mm to < 8.5 mm 1562 616 232 60 4 
8.5 mm to < 8.75 mm 961 373 147 44 6 
8.75 mm or more 756 257 108 27 2 
 
 
 
 Penetrating Keratoplasty 
83 Australian Corneal Graft Registry Report 2015 
 
Penetrating Corneal Graft Survival 
Graft Size 
 
 Probability of Graft Survival 
 Less than 7.75 mm: 0.88 at 1 year 
  Mean Survival 6.34 years 0.69 at 3 years 
  (SE= 0.25, 95% CI: 5.86, 6.82) 0.51 at 6 years 
  Median Survival 6.11 years 0.37 at 9 years 
    
 7.75 mm to  < 8 mm: 0.96 at 1 year 
  Mean Survival 8.40 years 0.82 at 3 years 
  (SE= 0.37, 95% CI: 7.68, 9.12) 0.67 at 6 years 
  Median Survival 9.39 years 0.51 at 9 years 
    
 8 mm to < 8.25 mm: 0.96 at 1 year 
  Mean Survival 9.18 years 0.86 at 3 years 
  (SE= 0.18, 95% CI: 8.83, 9.53) 0.73 at 6 years 
  Median Survival 10.68 years 0.60 at 9 years 
    
 8.25 mm to < 8.5 mm: 0.96 at 1 year 
  Mean Survival 8.97 years 0.86 at 3 years 
  (SE= 0.20, 95% CI: 8.58, 9.37) 0.74 at 6 years 
  Median Survival 10.41 years 0.60 at 9 years 
    
 8.5 mm to < 8.75 mm: 0.94 at 1 year 
  Mean Survival 8.29 years 0.80 at 3 years 
  (SE= 0.28, 95% CI: 7.74, 8.85) 0.64 at 6 years 
  Median Survival 10.18 years 0.53 at 9 years 
    
 8.75 mm or more: 0.87 at 1 year 
  Mean Survival 7.79 years 0.76 at 3 years 
  (SE= 0.27, 95% CI: 7.27, 8.32) 0.65 at 6 years 
  Median Survival 9.07 years 0.51 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
The size of penetrating grafts has increased in recent years, with grafts performed from 
2000 onwards significantly larger (p<0.001) than those performed pre-2000. Just 8% of 
grafts are now less than 7.75mm in diameter, compared with 21% pre-2000. 
In the multivariate analysis, graft size was shown to have a significant effect (p<0.001) 
on graft survival. Using grafts that were “7.75mm to < 8 mm” as referent, there were no 
differences in survival for grafts that were either “8 mm to <8.25 mm” (p=0.302) or “8.25 
mm to < 8.5 mm” (p=0.283). Graft survival was significantly poorer for grafts that were 
“less than 7.75 mm” (p=0.003), “8.5 mm to < 8.75 mm” (p=0.018), and “8.75 mm or 
more” (p=0.002).  
The final model also accounted for the effect of indication for graft, graft year, lens 
status pre- and post-graft, donor age group, experience of surgeon and percentage of 
follow-up, presence of raised intraocular pressure, pre-graft vascularisation, interstate 
transportation, pre-graft inflammation and/or steroid use, post-graft microbial keratitis, 
and post-graft rejection episode(s).  
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2.4.2 Penetrating graft survival: influence of the centre effect  
 
Figure 2.4.2 shows the comparison of graft survival for individual surgeons (shown in 
random order) for which there was follow-up information provided for 100 or more 
penetrating keratoplasties since the year 2000, and all other grafts (performed by 194 
surgeons) combined (Log Rank Statistic=264.13; df=18; p<0.001). This analysis 
indicates that there is a significant centre effect. This variable was not included in the 
multivariate analysis as it is collinear with the surgeon volume and follow-up variable 
shown in Figure 2.4.3. 
Figure 2.4.2 The centre effect 
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Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Fewer than 100 followed grafts 2628 857 281 72 5 
Surgeon 1 841 304 129 43 5 
Surgeon 2 383 216 118 31 2 
Surgeon 3 397 189 69 23 2 
Surgeon 4 672 180 51 3 n/a 
Surgeon 5 345 153 62 13 n/a 
Surgeon 6 291 81 18 5 n/a 
Surgeon 7 370 229 113 31 4 
Surgeon 8 431 250 103 29 2 
Surgeon 9 225 94 41 8 n/a 
Surgeon 10 315 126 45 19 1 
Surgeon 11 136 28 1 1 n/a 
Surgeon 12 260 90 28 6 1 
Surgeon 13 146 56 20 10 1 
Surgeon 14 315 105 27 3 n/a 
Surgeon 15 128 27 5 n/a n/a 
Surgeon 16 196 71 19 6 n/a 
Surgeon 17 103 13 n/a n/a n/a 
Surgeon 18 119 46 20 11 3 
 
Note: to preserve anonymity, high volume surgeons are intentionally listed in no 
particular order.  
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Penetrating Corneal Graft Survival 
The Centre Effect 
 
 Probability of Graft Survival 
 Fewer than 100 followed grafts: 0.91 at 1 year 
  Mean Survival 7.49 years 0.77 at 3 years 
  (SE= 0.19, 95% CI: 7.12, 7.86) 0.65 at 6 years 
  Median Survival 7.67 years 0.43 at 9 years 
    
 Surgeon 1: 0.95 at 1 year 
  Mean Survival 8.71 years 0.84 at 3 years 
  (SE= 0.31, 95% CI: 8.11, 9.31) 0.70 at 6 years 
  Median Survival 10.38 years 0.54 at 9 years 
    
 Surgeon 2: 0.96 at 1 year 
  Mean Survival 9.07 years 0.89 at 3 years 
  (SE= 0.36, 95% CI: 8.37, 9.77) 0.78 at 6 years 
  Median Survival 10.25 years 0.62 at 9 years 
    
 Surgeon 3: 0.96 at 1 year 
  Mean Survival 9.04 years 0.85 at 3 years 
  (SE= 0.33, 95% CI: 8.40, 9.68) 0.72 at 6 years 
  Median Survival n/a 0.62 at 9 years 
    
 Surgeon 4: 0.95 at 1 year 
  Mean Survival 7.18 years 0.80 at 3 years 
  (SE= 0.25, 95% CI: 6.69, 7.68) 0.64 at 6 years 
  Median Survival n/a   
     
 Surgeon 5: 0.98 at 1 year 
  Mean Survival 9.76 years 0.95 at 3 years 
  (SE= 0.32, 95% CI: 9.13, 10.38) 0.89 at 6 years 
  Median Survival 11.17 years   
     
 Surgeon 6: 0.92 at 1 year 
  Mean Survival 6.27 years 0.79 at 3 years 
  (SE= 0.35, 95% CI: 5.58, 6.95)   
  Median Survival 6.95 years   
     
 Surgeon 7: 0.95 at 1 year 
  Mean Survival 9.52 years 0.86 at 3 years 
  (SE= 0.29, 95% CI: 8.95, 10.08) 0.75 at 6 years 
  Median Survival n/a 0.68 at 9 years 
     
 Surgeon 8: 0.99 at 1 year 
  Mean Survival 10.92 years 0.96 at 3 years 
  (SE= 0.29, 95% CI: 10.34, 11.50) 0.89 at 6 years 
  Median Survival n/a 0.81 at 9 years 
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 Surgeon 9: 0.96 at 1 year 
  Mean Survival 7.71 years 0.82 at 3 years 
  (SE= 0.31, 95% CI: 7.10, 8.32) 0.74 at 6 years 
  Median Survival 8.69 years   
     
 Surgeon 10: 0.98 at 1 year 
  Mean Survival 10.08 years 0.96 at 3 years 
  (SE= 0.37, 95% CI: 9.36, 10.80) 0.74 at 6 years 
  Median Survival n/a   
     
 Surgeon 11: 0.96 at 1 year 
  Mean Survival 4.53 years 0.78 at 3 years 
  (SE= 0.56, 95% CI: 3.44, 5.63)   
  Median Survival 4.53 years   
     
 Surgeon 12: 0.96 at 1 year 
  Mean Survival 8.12 years 0.88 at 3 years 
  (SE= 0.53, 95% CI: 7.08, 9.15) 0.73 at 6 years 
  Median Survival 8.55 years   
     
 Surgeon 13: 0.88 at 1 year 
  Mean Survival 7.68 years 0.72 at 3 years 
  (SE= 0.56, 95% CI: 6.58, 8.77) 0.59 at 6 years 
  Median Survival 10.18 years   
     
 Surgeon 14: 0.98 at 1 year 
  Mean Survival 7.38 years 0.87 at 3 years 
  (SE= 0.34, 95% CI: 6.71, 8.04) 0.74 at 6 years 
  Median Survival 7.83 years   
     
 Surgeon 15: 0.88 at 1 year 
  Mean Survival 4.28 years 0.63 at 3 years 
  (SE= 0.32, 95% CI: 3.65, 4.92)   
  Median Survival 4.60 years   
     
 Surgeon 16: 0.93 at 1 year 
  Mean Survival 7.31 years 0.81 at 3 years 
  (SE= 0.48, 95% CI: 6.37, 8.25)   
  Median Survival 7.74 years   
     
 Surgeon 17: 0.96 at 1 year 
  Mean Survival 3.22 years   
  (SE= 0.15, 95% CI: 2.93, 3.50)   
  Median Survival n/a   
     
 Surgeon 18: 0.97 at 1 year 
  Mean Survival 9.35 years 0.82 at 3 years 
  (SE= 0.65, 95% CI: 8.08, 10.63) 0.72 at 6 years 
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.4.3 Penetrating graft survival: influence of surgeon volume (100+ followed PK 
grafts) grouped by level of follow-up  
 
Figure 2.4.3 shows the comparison of graft survival between grafts performed by 
surgeons with 100+ followed penetrating keratoplasties since 2000 with average or 
better (≥73%) follow-up, to those with lower than average follow-up (<73%), and to low 
volume surgeons (Log Rank Statistic=145.8; df=2; p<0.001). This variable was retained 
in the multivariate analysis (see section 2.7) indicating that this is an independent factor 
significantly affecting graft survival. 
Figure 2.4.3 Surgeon volume and level of follow-up 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Fewer than 100 followed grafts 2628 857 281 72 5 
100+ followed PK, low follow-up 1989 574 163 31 3 
100+ followed PK, high follow-up 3684 1684 706 211 18 
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Penetrating Corneal Graft Survival 
Surgeon Volume and Level of Follow-up  
 
 Probability of Graft Survival 
 Fewer than 100 followed grafts: 0.91 at 1 year 
  Mean Survival 7.49 years 0.77 at 3 years 
  (SE= 0.19, 95% CI: 7.12, 7.86) 0.59 at 6 years 
  Median Survival 7.67 years 0.43 at 9 years 
    
 100+ followed PK, low follow-up: 0.95 at 1 year 
  Mean Survival 7.57 years 0.80 at 3 years 
  (SE= 0.23, 95% CI: 7.11, 8.03) 0.64 at 6 years 
  Median Survival 8.33 years 0.44 at 9 years 
    
 100+ followed PK, high follow-up: 0.96 at 1 year 
  Mean Survival 9.52 years 0.87 at 3 years 
  (SE= 0.15, 95% CI: 9.22, 9.82) 0.76 at 6 years 
  Median Survival 11.42 years 0.63 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, experience of surgeon and percentage of follow-up was 
shown to have a significant effect (p<0.001) on graft survival. The effect varied over 
time. 
The level of follow-up influences the significant difference found between high and low 
volume surgeons. The difference between high volume surgeons with lower than 
average follow-up and low volume surgeons was significant (p=0.048), with low volume 
surgeons having poorer survival. Grafts performed by high volume surgeons with 
average or better follow-up had significantly better survival than those performed by 
surgeons with fewer than 100 followed penetrating keratoplasties since 2000, or high 
volume surgeons with low follow-up (p<0.001 in both cases).  
The final model also accounted for the effect of indication for graft, graft size, lens status 
pre- and post-graft, graft year, donor age group, presence of raised intraocular 
pressure, pre-graft vascularisation, interstate transportation, pre-graft inflammation 
and/or steroid use, post-graft microbial keratitis, and post-graft rejection episode(s). 
 
Further sub-group analyses were conducted on these data, individually 
examining the effect of this variable on grafts performed for keratoconus and on 
those performed for other indications. These analyses are shown on pages 90 to 
93.  
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2.4.3.1 Penetrating graft survival: influence of surgeon volume (100+ followed PK 
grafts) grouped by level of follow-up, first grafts for keratoconus only 
 
Figure 2.4.4 shows survival of grafts performed by surgeons with 100+ followed 
penetrating keratoplasties since 2000 with average or better (≥73%) follow-up, 
compared with those with lower than average follow-up (<73%) and low volume 
surgeons, for first grafts for keratoconus (Log Rank Statistic=27.24; df=2; p<0.001).  
Figure 2.4.4 Surgeon volume and level of follow-up, keratoconus only 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 100 followed grafts 608 230 89 29 2 
100+ followed PK, low follow-up 599 179 44 7 1 
100+ followed PK, high follow-up 1255 611 266 78 7 
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Penetrating Corneal Graft Survival 
Surgeon Volume and Level of Follow-up, for Keratoconus Only 
 
 Probability of Graft Survival 
 Less than 100 followed grafts: 0.96 at 1 year 
  Mean Survival 11.05 years 0.92 at 3 years 
  (SE= 0.36, 95% CI: 10.34, 11.77) 0.89 at 6 years 
  Median Survival 13.19 years 0.77 at 9 years 
    
 100+ followed grafts, low follow-up: 0.98 at 1 year 
  Mean Survival 10.96 years 0.93 at 3 years 
  (SE= 0.51, 95% CI: 9.96, 11.96) 0.89 at 6 years 
  Median Survival n/a   
    
 100+ followed grafts, high follow-up: 0.99 at 1 year 
  Mean Survival 11.64 years 0.98 at 3 years 
  (SE= 0.15, 95% CI: 11.34, 11.94) 0.95 at 6 years 
  Median Survival n/a 0.87 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
A significant difference was also found when analysing data relating solely to first grafts 
for keratoconus. Once again, high volume surgeons with good follow-up achieved better 
results than either of the other two groups (both p<0.001). However, in this subgroup, 
the difference between high volume surgeons with low follow-up and low volume 
surgeons was not statistically significant (p=0.373). 
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2.4.3.2 Penetrating graft survival: influence of surgeon volume (100+ followed PK 
grafts) grouped by level of follow-up, excluding first grafts for 
keratoconus 
 
Figure 2.4.5 shows survival of grafts performed by surgeons with 100+ followed 
penetrating keratoplasties since 2000 with average or better (≥73%) follow-up, 
compared with those with lower than average follow-up (<73%) and low volume 
surgeons (Log Rank Statistic=85.65; df=2; p<0.001), for grafts performed for any 
indication other than first grafts for keratoconus. 
Figure 2.4.5 Surgeon volume and level of follow-up, excluding keratoconus 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 100 followed grafts 2020 627 192 43 6 
100+ followed PK, low follow-up 1390 395 119 24 2 
100+ followed PK, high follow-up 2429 1073 440 133 11 
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Penetrating Corneal Graft Survival 
Surgeon Volume and Level of Follow-up, Excluding First Grafts for 
Keratoconus 
 
 Probability of Graft Survival 
 Less than 100 followed grafts: 0.89 at 1 year 
  Mean Survival 6.46 years 0.72 at 3 years 
  (SE= 0.17, 95% CI: 6.12, 6.79) 0.51 at 6 years 
  Median Survival 6.15 years 0.34 at 9 years 
    
 100+ followed grafts, low follow-up: 0.94 at 1 year 
  Mean Survival 6.59 years 0.75 at 3 years 
  (SE= 0.21, 95% CI: 6.18, 7.00) 0.54 at 6 years 
  Median Survival 6.63 years 0.34 at 9 years 
    
 100+ followed grafts, high follow-up: 0.94 at 1 year 
  Mean Survival 8.33 years 0.81 at 3 years 
  (SE= 0.17, 95% CI: 7.99, 8.67) 0.67 at 6 years 
  Median Survival 9.72 years 0.52 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
The significant difference shown for all data was also found when analysing data 
excluding first grafts for keratoconus. Once again, high volume surgeons with average 
or better follow-up achieved significantly better graft survival than those performed by 
surgeons with fewer than 100 followed penetrating keratoplasties or high volume 
surgeons with low follow-up (p<0.001 in both cases). A significant difference was also 
found between high volume surgeons with lower than average follow-up and low volume 
surgeons (p=0.020).  
This indicates that, surgeon volume (which could be seen to reflect experience) affects 
survival of grafts performed for reasons other than first grafts for keratoconus. 
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2.5 Operative Procedures at the Time of Graft 
 
Table 2.6 shows the number of grafts for which specified operative procedures were 
performed at the time of graft. The sum of these numbers for each variable equals the 
total number of grafts (11,431 registered and 8,301 followed) and the percentages, 
which should be summed vertically for each variable, total 100. 
Table 2.6 Operating procedures at the time of graft 
 
Penetrating Corneal Graft 
Operative Procedures at Graft 
 
 Registered (%) Followed (%) 
   
Peripheral iridectomy at graft   
  No 10434 (91%) 7630 (92%) 
  Yes 997 (9%) 671 (8%) 
   
Anterior vitrectomy at graft   
  No 10757 (94%) 7787 (94%) 
  Yes 674 (6%) 514 (6%) 
   
Total 11431 (100 %) 8301 (100 %) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly higher for grafts that had not undergone peripheral 
iridectomy at time of graft (p<0.001) and for those that had undergone anterior 
vitrectomy (p=0.032).  
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2.5.1 Penetrating graft survival: influence of peripheral iridectomy at time of graft 
 
Figure 2.5.1 shows survival for grafts where a peripheral iridectomy was performed at 
the time of graft, and those where one was not. A significant difference was found 
between groups (Log Rank Statistic=16.44; df=1; p<0.001). This variable was not 
retained in the multivariate analysis (see section 2.7), indicating that this is not an 
independent factor significantly affecting graft survival.  
Figure 2.5.1 Peripheral iridectomy at time of graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No peripheral iridectomy 7630 2868 1065 300 26 
Peripheral iridectomy 671 247 85 14 n/a 
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Penetrating Corneal Graft Survival 
Peripheral Iridectomy 
 
 Probability of Graft Survival 
 No peripheral iridectomy: 0.94 at 1 year 
  Mean Survival 8.73 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.50, 8.95) 0.69 at 6 years 
  Median Survival 10.18 years 0.56 at 9 years 
   0.37 at 12 years 
    
 Peripheral iridectomy: 0.90 at 1 year 
  Mean Survival 6.77 years 0.80 at 3 years 
  (SE= 0.21, 95% CI: 6.36, 7.18) 0.62 at 6 years 
  Median Survival 8.28 years 0.40 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.5.2 Penetrating graft survival: influence of anterior vitrectomy at time of graft 
 
Figure 2.5.2 shows the comparison of survival for grafts where an anterior vitrectomy 
was performed at the time of graft, to those where one was not. A significant difference 
was found across groups (Log Rank Statistic=78.03; df=1; p<0.001). This variable was 
not retained in the final model, indicating that this is not an independent factor 
significantly affecting graft survival. 
Figure 2.5.2 Anterior vitrectomy at time of graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No anterior vitrectomy 7787 2990 1112 303 25 
Anterior vitrectomy 514 125 38 11 1 
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Penetrating Corneal Graft Survival 
Anterior Vitrectomy 
 
 Probability of Graft Survival 
 No anterior vitrectomy: 0.94 at 1 year 
  Mean Survival 8.73 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.51, 8.95) 0.70 at 6 years 
  Median Survival 10.11 years 0.55 at 9 years 
   0.37 at 12 years 
    
 Anterior vitrectomy: 0.90 at 1 year 
  Mean Survival 6.26 years 0.64 at 3 years 
  (SE= 0.35, 95% CI: 5.59, 6.94) 0.47 at 6 years 
  Median Survival 5.46 years 0.33 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.6 Post-graft Events 
 
Table 2.7 shows the occurrence of post graft events, and Table 2.8 shows post-graft 
surgical procedures, as reported by follow-up practitioners. Please note: post-graft data 
may be incomplete when follow-up is based on a registration for a replacement graft. 
Table 2.7 Post-graft events 
 
Penetrating Corneal Graft 
Post-graft Events 
 
 Followed (%) 
Post-graft neovascularisation  
  No 7918 (95%) 
  Yes 383 (5%) 
  
Post-graft herpetic infection  
  No 8191 (99%) 
  Yes 110 (1%) 
  
Post-graft microbial keratitis  
  No 8069 (97%) 
  Yes 232 (3%) 
  
Post-graft synechia  
  No 8196 (99%) 
  Yes 105 (1%) 
  
Post-graft uveitis  
  No 8242 (99%) 
  Yes 59 (<1%) 
  
Post-graft rise in IOP  
  No 6795 (82%) 
  Yes 1506 (18%) 
  
At least one rejection episode  
  No 6948 (84%) 
  Yes 1353 (16%) 
  
Time to removal of all sutures  
  Less than 0.5 years 162 (2%) 
  0.5 years to < 1 year 1005 (12%) 
  1 year to < 1.5 years 1410 (17%) 
  1.5 years to < 2 years 859 (10%) 
  2 years or more 973 (12%) 
  Not yet removed/not advised 3892 (47%) 
  
Total 8301 (100 %) 
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Table 2.8: Post-graft surgical procedures 
 
Penetrating Corneal Graft 
Post-graft Surgical Procedures 
 
 Number 
Regrafted 1019 
Cataract removal and IOL insertion 620 
Cataract removal without IOL insertion 24 
IOL insertion (cataract removed prior to graft) 48 
IOL repositioned/removed/exchange 45 
Insertion of piggyback lens 27 
Implantable contact lens 11 
Relaxing incision 349 
YAG laser 324 
Suture adjustment 240 
Wound repair/resutured 239 
PRK laser 172 
Compression sutures 113 
LASIK 58 
Wedge resection 57 
Keratectomy 48 
Keratotomy 44 
Refractive keratoplasty 21 
Interface revision 20 
Trabeculectomy 105 
Cyclodiode 34 
Tube insertion (Molteno: 33, Barveldt:14) 47 
Other glaucoma surgery 33 
Vitrectomy 79 
Tarsorrhaphy 32 
Enucleation 25 
Evisceration 13 
Retinal detachment surgery 19 
Conjunctival flap 16 
Other* 226 
  
Total post-graft surgical procedures (number of grafts) 4728 (3045) 
  
Note: Cataract removal and IOL insertion are counted as two surgical procedures, even if done together. 
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*Other included: eyelid surgery (11), intravitreal injection (10), scar removal (9), 
corneal debridement (8), excimer laser (8), punctal occlusion (8), amniotic membrane 
transplantation (6), astigmatic cuts/incisions (6), ectropion repair (6), epiretinal 
membrane peel (6), punctal cautery (6), corneal glue (5), cryotherapy (5), pterygium 
excision (5), ptosis surgery (5), scleral patch graft (5), synechiolysis (5), 
dacryocystorhinostomy surgery (4), other laser (4), patch graft (4), pupilloplasty (4), 
silicone oil (4), strabismus surgery (4), anterior chamber reformation (3), anterior 
chamber tap (3), chalazion removal (3), conductive keratoplasty (3), graft-host junction 
revision (3), intra-corneal lens insertion (3), macular hole repair (3), removal of foreign 
body (3), anterior chamber washout (2), blepharoplasty (2), conjunctival graft (2), 
corneal biopsy (2), iridotomy (2), Jones tube insertion (2), keratoprosthesis (2), lash 
epilation (2), lesion excision (2), punctum snip (2), removal of limbal lesion (2), removal 
of vitreous haemorrhage (2), squint surgery (2), anti-VEGF injection (1), aspiration of 
lens (1), augmentative keratoplasty (1), basal cell carcinoma excision (1), canalicular 
repair (1), capsulotomy (1), conjunctival keratin removal (1), corneal cross-linking (1), 
drainage of choroidal effusion (1), eye muscle surgery (1), fasanella servat procedure 
(1), gas/fluid exchange (1), interface revision (1), intracameral antibiotics (1), iridioplasty 
(1), mucous membrane grafts upper and lower (1), paracentesis (1), periocular steroid 
injection (1), probing (1), punctate diothermy (1), pupilliary membrane removal (1), 
pupillary cerclage (1), removal of band keratopathy (1), removal of cyst/lateral canthus 
(1), removal of exposed scleral bullae (1), removal of filaments (1), removal of iris from 
graft-host junction (1), removal of pinguecula (1), removal of plaque in melanoma (1), 
removal of retro-corneal membrane (1), revision of wedge resection (1), repair iris 
prolapse (1), reposition iris (1), scleral buckle for retinal detachment (1), sub-retinal 
tissue plasminogen activator injection (1), superior lateral conjunctival resection (1), 
syringed tear ducts (1), vitreous tap (1). 
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2.6.1 Penetrating graft survival: influence of post-graft neovascularisation 
 
Figure 2.6.1 shows the influence of post-graft neovascularisation on graft survival. A 
significant difference was found across groups (Log Rank Statistic=65.36; df=1; 
p<0.001). This variable was not retained in the final model, indicating that this is not an 
independent factor significantly affecting graft survival. 
Figure 2.6.1 Post-graft neovascularisation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No neovascularisation 7918 2976 1114 307 25 
Neovascularisation 383 139 36 7 1 
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Penetrating Corneal Graft Survival 
Post-graft Neovascularisation 
 
 Probability of Graft Survival 
 No neovascularisation: 0.94 at 1 year 
  Mean Survival 8.70 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.47, 8.92) 0.70 at 6 years 
  Median Survival 10.11 years 0.55 at 9 years 
   0.36 at 12 years 
    
 Neovascularisation: 0.87 at 1 year 
  Mean Survival 6.89 years 0.69 at 3 years 
  (SE= 0.43, 95% CI: 6.05, 7.73) 0.49 at 6 years 
  Median Survival 5.79 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.6.2 Penetrating graft survival: influence of post-graft herpetic infection 
 
Figure 2.6.2 shows the influence of herpetic infection in a graft. A significant difference 
was found across groups (Log Rank Statistic=62.72; df=1; p<0.001). This variable was 
not retained in the final model, indicating that this is not an independent factor 
significantly affecting graft survival. It is possible that this is because 42% were herpetic 
recurrences in eyes grafted for herpetic eye disease, and this variable is co-linear with 
herpetic infection as an indication for graft. 
Figure 2.6.2 Post-graft herpetic infection 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No herpetic infection 8191 3079 1135 311 26 
Herpetic infection 110 36 15 3 n/a 
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Penetrating Corneal Graft Survival 
Post-graft Herpetic Infection 
 
 Probability of Graft Survival 
 No herpetic infection: 0.94 at 1 year 
  Mean Survival 8.66 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.44, 8.87) 0.69 at 6 years 
  Median Survival 10.04 years 0.55 at 9 years 
   0.35 at 12 years 
    
 Herpetic infection: 0.84 at 1 year 
  Mean Survival 4.92 years 0.51 at 3 years 
  (SE= 0.48, 95% CI: 3.98, 5.87)   
  Median Survival 3.85 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.6.3 Penetrating graft survival: influence of post-graft microbial keratitis 
 
Figure 2.6.3 shows the survival for grafts in which microbial keratitis occurred post-graft, 
including those where a stitch abscess occurred. A significant difference was found 
between groups (Log Rank Statistic=157.61; df=1; p<0.001). This variable was retained 
in the multivariate analysis (see section 2.7), indicating that this is an independent factor 
significantly affecting graft survival. Those grafts that had post-graft microbial keratitis 
had poorer graft survival. 
Figure 2.6.3 Post-graft microbial keratitis 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No microbial keratitis 8069 3045 1136 311 26 
Microbial keratitis 232 70 14 3 n/a 
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Penetrating Corneal Graft Survival 
Post-graft Microbial Keratitis 
 
 Probability of Graft Survival 
 No microbial keratitis: 0.94 at 1 year 
  Mean Survival 8.72 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.50, 8.94) 0.70 at 6 years 
  Median Survival 10.12 years 0.56 at 9 years 
   0.36 at 12 years 
    
 Microbial keratitis: 0.83 at 1 year 
  Mean Survival 4.66 years 0.57 at 3 years 
  (SE= 0.36, 95% CI: 3.96, 5.36)   
  Median Survival 3.50 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
In the multivariate analysis, post-graft microbial keratitis was shown to have a significant 
effect (p<0.001). The final model also accounted for the effect of indication for graft, 
graft size, lens status pre- and post-graft, graft year, donor age group, experience of 
surgeon and percentage of follow-up, presence of raised intraocular pressure, pre-graft 
vascularisation, interstate transportation, pre-graft inflammation and/or steroid use, and 
post-graft rejection episode(s). 
 
 
 
  
 Penetrating Keratoplasty 
110 Australian Corneal Graft Registry Report 2015 
2.6.4 Penetrating graft survival: influence of post-graft synechia 
 
Figure 2.6.4 shows the survival for grafts where the eye developed at least one 
synechia post-graft, compared to those where it did not. A significant difference was 
found between groups (Log Rank Statistic=41.53; df=1; p<0.001). This variable was not 
retained in the multivariate analysis (see section 2.7), indicating that this is not an 
independent factor significantly affecting graft survival.  
Figure 2.6.4 Post-graft synechia 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No synechia 8196 3079 1141 314 26 
Synechia 105 36 9 n/a n/a 
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Penetrating Corneal Graft Survival 
Post-graft Synechia 
 
 Probability of Graft Survival 
 No synechia: 0.94 at 1 year 
  Mean Survival 8.65 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.43, 8.87) 0.69 at 6 years 
  Median Survival 10.04 years 0.55 at 9 years 
   0.36 at 12 years 
    
 Synechia: 0.87 at 1 year 
  Mean Survival 4.53 years 0.63 at 3 years 
  (SE= 0.35, 95% CI: 3.84, 5.21)   
  Median Survival 4.45 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.6.5 Penetrating graft survival: influence of post-graft uveitis 
 
Figure 2.6.5 shows the comparison of survival of grafts in eyes which developed uveitis 
compared with those that did not. A significant difference was found across groups (Log 
Rank Statistic=11.64; df=1; p=0.001). This variable was not retained in the final model, 
indicating that this is not an independent factor significantly affecting graft survival. 
Figure 2.6.5 Post-graft uveitis 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No uveitis 8242 3097 1146 313 26 
Uveitis 59 18 4 1 n/a 
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Penetrating Corneal Graft Survival 
Post-graft Uveitis 
 
 Probability of Graft Survival 
 No uveitis: 0.94 at 1 year 
  Mean Survival 8.61 years 0.83 at 3 years 
  (SE= 0.11, 95% CI: 8.40, 8.83) 0.69 at 6 years 
  Median Survival 10.00 years 0.54 at 9 years 
   0.35 at 12 years 
    
 Uveitis: 0.86 at 1 year 
  Mean Survival 5.61 years   
  (SE= 0.69, 95% CI: 4.26, 6.97)   
  Median Survival 3.70 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.6.6 Penetrating graft survival: influence of post-graft raised IOP  
 
Figure 2.6.6 shows the comparison of graft survival for grafts where the eye was 
reported to have developed raised intraocular pressure post-graft to those where IOP 
was not reported as raised. A significant difference was found between groups (Log 
Rank Statistic=7.46; df=1; p=0.006). This variable was not included in the multivariate 
analysis as it is collinear with presence of graft rejection episodes, shown in Figure 
2.6.7.  
Figure 2.6.6 Post-graft raised intraocular pressure 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No raised IOP 6795 2411 879 243 19 
Raised IOP 1506 704 271 71 7 
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Penetrating Corneal Graft Survival 
Post-graft Raised IOP 
 
 Probability of Graft Survival 
 No raised IOP: 0.94 at 1 year 
  Mean Survival 8.83 years 0.83 at 3 years 
  (SE= 0.13, 95% CI: 8.58, 9.08) 0.70 at 6 years 
  Median Survival 10.21 years 0.57 at 9 years 
   0.37 at 12 years 
    
 Raised IOP: 0.96 at 1 year 
  Mean Survival 7.97 years 0.81 at 3 years 
  (SE= 0.21, 95% CI: 7.56, 8.38) 0.63 at 6 years 
  Median Survival 8.29 years 0.46 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.6.7 Penetrating graft survival: influence of graft rejection episodes 
 
Figure 2.6.7 shows the survival for grafts where the eye underwent at least one episode 
of post-graft immunological rejection, compared to those that did not. A significant 
difference was found between groups (Log Rank Statistic=260.26; df=1; p<0.001). This 
variable was retained in the multivariate analysis (see section 2.7), indicating that this is 
an independent factor significantly affecting graft survival. Those grafts that had post-
graft rejection had poorer survival. 
Figure 2.6.7 Rejection episode(s) 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No rejection episodes 6948 2471 871 221 16 
At least one rejection episode 1353 644 279 93 10 
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Penetrating Corneal Graft Survival 
Rejection 
 
 Probability of Graft Survival 
 No rejection episodes: 0.95 at 1 year 
  Mean Survival 9.31 years 0.86 at 3 years 
  (SE= 0.14, 95% CI: 9.04, 9.59) 0.74 at 6 years 
  Median Survival 10.68 years 0.61 at 9 years 
    
 At least one rejection episode: 0.91 at 1 year 
  Mean Survival 6.66 years 0.68 at 3 years 
  (SE= 0.17, 95% CI: 6.33, 7.00) 0.50 at 6 years 
  Median Survival 6.11 years 0.36 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
In the multivariate analysis, presence of at least one post-graft rejection episode was 
shown to have a significant effect (p<0.001). The final model also accounted for the 
effect of indication for graft, graft size, lens status pre- and post-graft, graft year, donor 
age group, experience of surgeon and percentage of follow-up, presence of raised 
intraocular pressure, pre-graft vascularisation, interstate transportation, pre-graft 
inflammation and/or steroid use, and post-graft microbial keratitis. 
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2.6.8 Penetrating graft survival: influence of time to final removal of sutures 
 
Figure 2.6.8 shows the comparison of graft survival depending on the time from graft to 
final suture removal. A significant difference was found amongst groups (Log Rank 
Statistic=19.04; df=4; p=0.001).This information was only available for 4409 (53%) of 
followed grafts and therefore this variable was not included in the multivariate analyses. 
Figure 2.6.8 Time to final removal of sutures 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 0.5 years 162 52 21 5 n/a 
0.5 to < 1 year 1005 396 157 51 8 
1 to < 1.5 years 1410 659 259 72 6 
1.5 to < 2 years 859 445 157 42 n/a 
2 or more years 973 743 295 71 7 
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Penetrating Corneal Graft Survival 
Time to Final Removal of Sutures 
 
 Probability of Graft Survival 
 Less than 0.5 years: 0.91 at 1 year 
  Mean Survival 8.25 years 0.87 at 3 years 
  (SE= 0.53, 95% CI: 7.22, 9.29) 0.69 at 6 years 
  Median Survival n/a   
    
 0.5 to < 1 year: 0.99 at 1 year 
  Mean Survival 10.44 years 0.91 at 3 years 
  (SE= 0.26, 95% CI: 9.93, 10.95) 0.82 at 6 years 
  Median Survival 12.09 years 0.73 at 9 years 
    
 1 to < 1.5 years: 1.00 at 1 year 
  Mean Survival 10.79 years 0.93 at 3 years 
  (SE= 0.22, 95% CI: 10.36, 11.21) 0.83 at 6 years 
  Median Survival 13.41 years 0.70 at 9 years 
    
 1.5 to < 2 years: 1.00 at 1 year 
  Mean Survival 9.53 years 0.95 at 3 years 
  (SE= 0.22, 95% CI: 9.10, 9.96) 0.83 at 6 years 
  Median Survival 11.82 years 0.70 at 9 years 
    
 2 or more years: 1.00 at 1 year 
  Mean Survival 10.46 years 0.97 at 3 years 
  (SE= 0.24, 95% CI: 9.98, 10.93) 0.87 at 6 years 
  Median Survival 11.49 years 0.71 at 9 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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2.7 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered penetrating graft, together with its 
archival follow-up records, was treated as a separate and independent entity. Some 
recipients had multiple penetrating grafts performed during the census period (1/1/2000 
to 30/6/2014), with some having repeat grafts in a single eye, some grafts in both eyes 
and some a combination of both. To control for potential inter-graft and/or inter-eye 
dependence in the multivariate analyses, the multivariate model was adjusted to allow 
for clustering by individual patient [see reference 6]. 
Variables to be included in the multivariate Cox Proportional Hazards regression model 
were identified based on the results of the univariate Kaplan-Meier analyses, with a cut-
off significance level of p<0.08 used to select variables for inclusion. Some variables 
which were found to be significant in the univariate analyses were omitted due to co-
linearity, or because of large amounts of missing data (>25%). 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in 
a stepwise manner, beginning with the least significant variable. The Kaplan-Meier 
plots, and additional appropriate STATA analyses, were used to assess whether each 
included variable met the assumption of proportional hazards. Where variables were 
found to be time-variant, they were treated as such in the multivariate model.  
Table 2.9 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained 
in the final model. Some variables that were found to be significant in the univariate 
analyses were excluded from the multivariate model as they were found to be co-linear 
with (i.e. were highly correlated to, and produced the same effect on the outcome as) 
another variable in the model.  
  
 Penetrating Keratoplasty 
121 Australian Corneal Graft Registry Report 2015 
Table 2.9 Multivariate model 
 
Penetrating Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Storage medium 
Storage time in organ culture 
Donor sex 
Corneal endothelial cell density 
Recipient sex 
 
Significant in univariate analysis but excluded from multivariate model due 
to co-linearity or missing data 
The centre effect (co-linear) 
Raised intraocular pressure post-graft (co-linear) 
Storage time in Optisol (missing data) 
Time to removal of sutures (missing data) 
 
Significant in univariate analysis but not retained in multivariate model 
Eye Bank 
Time from death to enucleation* 
Recipient State 
Recipient age group 
Cause of donor death 
Peripheral iridectomy at time of graft 
Anterior vitrectomy at time of graft 
Multi-organ donor 
Previous contralateral graft 
Post-graft neovascularisation 
Post-graft herpetic infection 
Post-graft uveitis 
Post-graft synechia 
 
Significant in univariate analysis and retained in multivariate model 
Indication for graft 
Change in lens status pre- to post-graft 
Graft year 
Graft size 
Donor age group 
Surgeon experience and level of follow-up 
History of raised intraocular pressure 
Pre-graft neovascularisation 
Interstate transportation 
Pre-graft inflammation and/or steroid use 
Post-graft microbial keratitis 
Post-graft rejection episode(s) 
 
*p<0.08  
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Table 2.10 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The first level of each categorical variable was taken as the 
referent. The hazard ratios for a given variable are adjusted for all other variables in the 
model. This model included data from the 7,626 penetrating keratoplasties, performed 
in 6,494 recipients, for which there were valid responses (no unknown data) for each of 
the included variables. 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (chi²=1471.11, p<0.0001). The rows highlighted in blue were not significantly 
different to the referent group. 
Table 2.10 Clustered multivariate model 
 
Penetrating Corneal Graft 
Clustered Multivariate Model 
 
 n 
Hazard 
Ratio 
Standard 
error 
p-
value 
Global 
p-value 
95% 
confidence 
interval 
Indication for graft (tvc) 
Keratoconus 2283 1.00   <0.001  
Failed previous graft 1983 2.62 0.33 <0.001  2.05 – 3.36 
Bullous keratopathy 1322 2.94 0.41 <0.001  2.24 – 3.87 
Corneal dystrophy 1028 1.96 0.29 <0.001  1.46 – 2.62 
Scar/opacity 110 2.35 0.65 0.002  1.37 – 4.06 
Ulcer/perforation 146 8.41 1.70 <0.001  5.66 – 12.50 
Herpetic infection 238 3.32 0.66 <0.001  2.24 – 4.90 
Trauma 179 3.45 0.77 <0.001  2.23 – 5.33 
Non herpetic infection 155 4.46 1.09 <0.001  2.76 – 7.18 
Other 182 4.79 1.09 <0.001  3.07 – 7.47 
 
Graft size 
7.75 mm to < 8 mm 588 1.00   <0.001  
Less than 7.75 mm 620 1.45 0.18 0.003  1.13 – 1.86 
8 mm to < 8.25 mm 3206 1.12 0.12 0.302  0.90 – 1.39 
8.25 mm to < 8.5 mm 1537 1.14 0.13 0.283  0.90 – 1.43 
8.5 mm to < 8.75 mm 942 1.34 0.17 0.018  1.05 – 1.72 
8.75 mm or more 733 1.50 0.20 0.002  1.16 – 1.95 
 
Lens status pre- and post-graft 
Phakic/phakic 3565 1.00   <0.001  
Phakic/pseudophakic 880 1.14 0.12 0.227  0.92 – 1.40 
Not phakic/pseudophakic 2842 1.62 0.14 <0.001  1.37 – 1.91 
Any/aphakic 339 2.26 0.26 <0.001  1.79 – 2.84 
 
Graft year (tvc) 
2000 704 1.00   0.001  
2001/2002 1412 0.90 0.10 0.319  0.73 – 1.11 
2003/2004 1392 0.85 0.10 0.178  0.67 – 1.08 
2005/2006 1442 0.68 0.09 0.005  0.52 – 0.89 
2007/2008 1225 0.60 0.09 0.001  0.45 – 0.80 
2009/2010 889 0.67 0.10 0.007  0.49 – 0.90 
2011/2012 562 0.90 0.17 0.552  0.62 – 1.29 
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Donor age group 
0-19 years 264 1.00   <0.001  
20-29 years 345 0.95 0.23 0.821  0.58 – 1.53 
30-39 years 411 1.27 0.26 0.242  0.85 – 1.91 
40-49 years 839 1.04 0.20 0.835  0.72 – 1.50 
50-59 years 1445 1.27 0.22 0.179  0.90 – 1.79 
60-69 years 1785 1.40 0.24 0.052  1.00 – 1.95 
70-79 years 1824 1.45 0.25 0.031  1.04 – 2.03 
80-99 years 713 1.69 0.31 0.004  1.18 – 2.42 
 
Experience of surgeon and percentage of follow-up (tvc) 
100+ followed PK, ≥73% follow-up 3523 1.00   <0.001  
100+ followed PK, <73% follow-up 1741 1.45 0.13 <0.001  1.22 – 1.72 
Fewer than 100 followed PK 2362 1.82 0.14 <0.001  1.57 – 2.11 
 
History of raised intraocular pressure 
IOP never raised 6438 1.00   <0.001  
IOP raised in past but not at graft 1060 1.34 0.09 <0.001  1.17 – 1.54 
IOP raised at graft 128 1.51 0.25 0.012  1.09 – 2.09 
 
Pre-graft neovascularisation 
No 5427 1.00     
Yes 2199 1.21 0.07 0.002  1.08 – 1.37 
 
Pre-graft inflammation or steroid use (tvc) 
No 5720 1.00     
Yes 1906 1.82 0.16 <0.001  1.53 – 2.16 
 
Post-graft rejection episode(s) 
No 6358 1.00     
Yes 1268 2.21 0.13 <0.001  1.98 – 2.48 
 
Interstate transportation of cornea (tvc) 
No 7208 1.00     
Yes 418 1.78 0.25 <0.001  1.35 – 2.34 
 
Post-graft microbial keratitis 
No 7411 1.00     
Yes 215 1.75 0.19 <0.001  1.41 – 2.18 
       
tvc= time varying coefficient.  
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2.8 Reasons for Graft Failure 
 
Of the 8,301 followed grafts, 1,639 (20%) were known to have failed by the census 
date. This equates to 14% of the 11,431 registered grafts. Surgeons were asked to 
indicate the reason for graft failure. This information was also gathered from repeat 
registration forms, where the reason for failure of the previous graft was given.  
Table 2.11 shows the reasons for failure. Please note that for some of the reasons for 
failure given, the sub-categories do not add up to the total number of cases.  
Table 2.11 Reasons for failure 
 
Penetrating Corneal Graft 
Reasons for Graft Failure 
 
 Sub-total Total 
Rejection  482 (29%) 
  Unspecified/endothelial cell failure 431  
  With non-herpetic infection 14  
  With glaucoma 10  
  With scarring 8  
  With herpetic infection 5  
  With other 14  
   
Endothelial cell failure  285 (17%) 
  Pseudophakic 227  
  Phakic 38  
  Aphakic 20  
   
Non herpetic infection  167 (10%) 
  Microbial/Pseudomonas keratitis 114  
  Endophthalmitis 24  
  Fungal keratitis 20  
  Crystalline keratopathy 5  
  Other 4  
   
Glaucoma  67 (4%) 
  With endothelial cell failure  7  
  With other* 10  
   
Primary graft failure  54 (3%) 
   
Corneal ulcer  52 (3%) 
  Perforated 40  
   
Trauma  41 (3%) 
  Rupture 18  
  Penetrating eye injury 10  
  Other specified 6  
  Unspecified 7  
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Herpetic infection  33 (2%) 
   
Corneal melt  22 (1%) 
   
Scarring  21 (1%) 
   
Stem cell/epithelial failure  19 (1%) 
   
Other specified**  110 (4%) 
   
Unspecified  286 (17%) 
   
Total  1639 (100%) 
   
 
* Other included: anterior chamber haemorrhage (3), neovascularisation (2), epithelial 
defect (1), cataract (1), central retinal vein occlusion (1), ICE syndrome (1), Peters’ 
anomaly (1).  
** Other included: astigmatism (16), neovascularisation (15), phthisis (12), wound 
dehiscence (9), retrocorneal membrane (7), recurrent dystrophy (7), band keratopathy 
(5), ICE syndrome (4), unspecified ectasia (4), small cell carcinoma (4), 
descemetocoele (4), epithelial downgrowth (3), recurrent keratoconus (2), synechia (2), 
hypotony (2), retinal detachment (2), uveitis (2), choroidal haemorrhage (2), retinal 
occlusion (1), anterior chamber haemorrhage (1), pupillary membrane (1), anterior 
segment ischaemia (1), protein deposits (1), dry eye (1), unspecified inflammation (1), 
Stevens-Johnson syndrome (1). 
 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For penetrating grafts, the time from graft to failure is as reported by 
the surgeon. It is usually 1-2 days but no more than 7 days. 
Of the 54 grafts reported by surgeons to have been primary graft failures, the majority 
(42) had no further information provided, and for a further three the surgeon specified 
that the graft never cleared but provided no further information. Other specific reasons 
given were: undersized graft (3), expulsive haemorrhage (2), allergic conjunctivitis (1), 
enucleation due to fungal keratitis (1), epithelium not intact (1), and persistent wound 
leakage (1). 
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2.8.1 Failure from rejection 
 
The leading cause of graft failure was rejection. Post-graft factors that may be related to 
an increase in the incidence of rejection were examined using Chi-square tests of 
independence.  
There was a significant difference in the occurrence of post-graft rejection between 
grafts that had pre-graft neovascularisation and those that did not (p<0.001); however, 
there was no significant difference across groups depending on how many quadrants 
had vessels (p=0.902). There was also a significant difference in the occurrence of 
post-graft rejection between grafts that had post-graft neovascularisation and those that 
did not (p<0.001). Not all cases of rejection result in failure. Failure from rejection was 
also significantly more likely when the eye had pre-graft neovascularisation than when it 
did not (8.8% vs. 1.6%, Chi²=52.93, df=1, p<0.001), and when the eye had post-graft 
neovascularisation, than when it did not (13.1% vs. 5.5%, Chi²=37.19, df=1, p<0.001). 
This difference remained significant when only grafts that had pre-graft 
neovascularisation were examined (14.0% vs. 8.4%, Chi²=5.55, df=1, p=0.019). 
Figure 2.8.1 shows time to failure due to rejection, for each of the four combinations of 
pre- and post-graft neovascularisation. For the purpose of this analysis, the event was 
“failure due to rejection”. Grafts that failed from something other than rejection were 
treated as surviving up to the date of their failure and were then censored. A significant 
difference in survival was found (Log Rank Statistic=121.31; df=3; p<0.001). A 
comparison of the survival of grafts with pre-graft neovascularisation, depending on 
whether they had post-graft vascularisation, was also significant (Log Rank 
Statistic=4.72; df=1; p=0.030). 
Figure 2.8.1 Time to failure from rejection 
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Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No neovascularisation 5707 2292 876 234 19 
Post- but no pre-graft neovascularisation  211 80 22 2 n/a 
Pre- but no post-graft neovascularisation 2211 684 238 73 6 
Both pre- and post-graft neovascularisation 172 59 14 5 1 
 
Rejection episodes were also found to occur significantly more frequently (all p<0.001) 
in grafts with post-graft herpetic infection, post-graft microbial keratitis and/or stitch 
abscess, post-graft synechia, post-graft uveitis, and post-graft rise in intraocular 
pressure. Pre-graft factors that are closely related to these variables were also 
examined in the same way. Rejection episodes were also found to be significantly more 
common in eyes with a history of raised intraocular pressure (p<0.001), though 
presence of raised intraocular pressure at time of graft did not have a significant impact 
(p=0.628). Likewise, there was no significant difference for those grafts that had an 
active herpetic infection at the time of graft (p=1.00).  
Table 2.12 shows the percentages of each group that also had post-graft rejection and 
the Chi² values for each analysis. 
Table 2.12 Post-graft rejection episodes 
 
Penetrating Keratoplasty 
Post Graft Rejection Episodes 
 
 % Rejection 
Chi² p-value 
 With factor Without factor 
Synechia 29% 16% 10.85 <0.001 
Herpetic infection 29% 16% 12.44 <0.001 
Microbial keratitis 29% 16% 28.64 <0.001 
Uveitis 53% 16% 54.57 <0.001 
Raised intraocular pressure 25% 15% 92.96 <0.001 
Neovascularisation 42% 15% 192.99 <0.001 
     
Pre-graft neovascularisation 19% 15% 15.50 <0.001 
History of raised IOP 21% 16% 20.24 <0.001 
Raised IOP at graft 18% 16% 0.24 0.628 
Active HSV at graft 17% 16% 0.00 1.000 
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2.9 Post-graft Changes in Visual Acuity 
 
2.9.1 All indications for graft 
 
Post-graft visual acuity is an important outcome for corneal graft recipients. A desire for 
improved visual acuity was specified as a reason for graft in 10,257 (90%) of registered 
penetrating keratoplasties. In 70% of cases (8,058), this was the sole desired outcome 
indicated. It is likely that this was also at least part of the reason for graft in some of the 
further 447 (4%) grafts where no reason was specified. We analysed post-graft visual 
acuity in two ways, firstly in terms of the Snellen acuity post-graft and secondly, in terms 
of the change in Snellen acuity from pre-to post-graft. 
Table 2.13 shows the reported post-graft visual acuity for all grafts; separated for grafts 
that were surviving and failed at the last follow-up; and also specifically for the 7,418 
followed penetrating grafts for which vision was listed as one of the reasons for graft.  
Table 2.13 Post-graft visual acuity 
 
Penetrating Corneal Graft: Post-graft Visual Acuity 
(as reported at last follow up) 
 
 All grafts Surviving Failed To improve VA 
6/12 or better 3286 (40%) 3264 (49%) 22 (1%) 3090 (42%) 
6/15 - 6/36 1486 (18%) 1364 (20%) 122 (7%) 1366 (18%) 
6/60 or worse 2435 (29%) 1201 (18%) 1234 (75%) 2049 (28%) 
Unknown 1094 (13%) 833 (13%) 261 (16%) 913 (12%) 
Total 8301 (100%) 6662 (100%) 1639 (100%) 7418 (100%) 
     
VA = Visual acuity 
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Figure 2.9.1 shows the best corrected visual acuity in the grafted eye at the time of the 
most recent follow-up. Post-graft visual acuity was provided for 7,207 followed 
penetrating grafts (87%). Of these, 3,286 (46%) had vision of 6/12 or better at their most 
recent follow-up, while 2,435 (34%) reported vision of 6/60 or worse. 
Figure 2.9.1 Best corrected visual acuity at time of last follow-up  
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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Visual acuity data were available both pre- and post-graft for 6,942 (84%) followed 
penetrating grafts. Of these, 1,315 (19%) had failed, while 5,627 (81%) were still 
surviving. Figure 2.9.2 shows the number of lines of improvement or deterioration in 
visual acuity since graft, as measured in terms of Snellen acuity at the latest follow-up. 
Figure 2.9.2 Number of lines of change on a Snellen chart pre- to post-graft 
 
Table 2.14 summarises the change in visual acuity form pre- to post-graft, stratified by 
whether the graft was surviving at last follow-up. 
Table 2.14 Number of lines of change on a Snellen chart pre- to post-graft 
 
Penetrating Corneal Graft 
Change in Visual Acuity from Pre-graft 
(as reported at last follow up) 
 
 Surviving Failed Total 
 n % n % n % 
VA worse by > 4 lines 20 <1% 45 3% 65 <1% 
VA worse by 2 to 4 lines 197 3% 213 13% 410 5% 
VA worse by 1 line 208 3% 282 17% 490 6% 
VA unchanged 527 8% 403 25% 930 11% 
VA better by 1 line 545 8% 230 14% 775 9% 
VA better by 2 to 4 lines 1508 23% 126 8% 1634 20% 
VA better by 5 to 7  lines 1750 26% 13 <1% 1763 21% 
VA better by > 7  lines 872 13% 3 <1% 875 11% 
Unknown 1035 16% 324 20% 1359 16% 
Total 6662 100% 1639 100% 8301 100% 
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The data on pages 132 to 136 show the post-graft visual acuity obtained, and the 
change in visual acuity, for grafts performed for specific indications. Data are 
reported for each of: keratoconus, Fuchs’ dystrophy, and bullous keratopathy.  
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2.9.2 Keratoconus 
 
Figure 2.9.3 Best corrected visual acuity at time of last follow-up 
 
Figure 2.9.4 Number of lines of change on a Snellen chart pre- to post-graft 
 
Post-graft vision of 6/12 or better was reported in 66% of followed penetrating grafts 
performed for keratoconus. Visual acuity was reported both pre- and post-graft for 91% 
of grafts for keratoconus and at least one line of improvement on the Snellen chart was 
achieved after graft in 88% of these. 
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2.9.3 Fuchs’ dystrophy 
 
Figure 2.9.5 Best corrected visual acuity at time of last follow-up 
 
Figure 2.9.6 Number of lines of change on a Snellen chart pre- to post-graft 
 
Post-graft vision of 6/12 or better was reported in 46% of followed penetrating grafts 
performed for Fuchs’ dystrophy. Visual acuity was reported both pre- and post-graft for 
86% of grafts for Fuchs’ dystrophy and at least one line of improvement on the Snellen 
chart was achieved after graft in 71% of these. 
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2.9.4 Bullous keratopathy 
 
Figure 2.9.7 Best corrected visual acuity at time of last follow-up 
 
Figure 2.9.8 Number of lines of change on a Snellen chart pre- to post-graft 
 
Post-graft vision of 6/12 or better was reported in 15% of followed penetrating grafts 
performed for bullous keratopathy. Visual acuity was reported both pre- and post-graft 
for 77% of grafts for bullous keratopathy and at least one line of improvement on the 
Snellen chart was achieved after graft in 60% of these. 
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3 Descemet’s Stripping Endothelial Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 1,801 
Descemet’s stripping endothelial keratoplasties for which follow-up information was 
available. The preparation of donor material may have been automated (DSAEK) or 
manual (DSEK). In some cases, this was unspecified by the contributing surgeon. All 
grafts in these three groups were analysed together and are referred to throughout this 
report as DS(A)EKs. Kaplan-Meier survival analyses were conducted using IBM SPSS 
for Windows (Version 21.0), to compare the graft survival across groups for a range of 
variables relating to the corneal donor, graft recipient, surgical procedure, surgeon, and 
follow-up care. 
3.1 Donor and Eye Banking Factors 
 
Table 3.1 shows the number of grafts within each of the variable sub-groups, for the 
donor factors examined in this report. The sum of these numbers for each variable 
equals the total number of grafts (2,701 registered and 1,801 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 3.1 Donor and eye banking factors 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank M 917 (34%) 624 (35%) 
  Eye bank O 435 (16%) 229 (13%) 
  Eye bank P 855 (32%) 655 (36%) 
  Eye bank R 283 (11%) 158 (9%) 
  Eye bank U 211 (8%) 135 (8%) 
   
Storage medium   
  Optisol 1698 (63%) 1304 (72%) 
  Organ culture 1002 (37%) 496 (28%) 
  Moist pot 1 (<1%) 1 (<1%) 
   
Death-to-enucleation time   
  ≤ 3 hours 273 (10%) 168 (9%) 
  4 to 6 hours 444 (16%) 305 (17%) 
  7 to 9 hours 537 (20%) 381 (21%) 
  10 to 12 hours 582 (22%) 438 (24%) 
  ≥ 13 hours 857 (32%) 506 (28%) 
  Not advised 8 (<1%) 3 (<1%) 
   
Interstate transportation   
  No 2558 (95%) 1682 (93%) 
  Yes 143 (5%) 119 (7%) 
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Sex of donor   
  Female 1004 (37%) 662 (37%) 
  Male 1697 (63%) 1139 (63%) 
   
Age group   
  <10 years 5 (<1%) 5 (<1%) 
  10 to 19 years 25 (<1%) 17 (<1%) 
  20 to 29 years 52 (2%) 40 (2%) 
  30 to 39 years 118 (4%) 78 (4%) 
  40 to 49 years 222 (8%) 148 (8%) 
  50 to 59 years 471 (17%) 297 (17%) 
  60 to 69 years 889 (33%) 582 (32%) 
  70 to 79 years 691 (26%) 455 (25%) 
  80 to 89 years 225 (8%) 178 (10%) 
  90 to 99 years 3 (<1%) 1 (<1%) 
   
Cause of death   
  Cardiac event 642 (24%) 453 (25%) 
  Malignancy 1002 (37%) 675 (38%) 
  Trauma 202 (8%) 130 (7%) 
  Respiratory event 219 (8%) 143 (8%) 
  Intracranial/cerebral haemorrhage 449 (17%) 288 (16%) 
  Other specified 164 (6%) 94 (5%) 
  Not advised1 23 (<1%) 18 (1%) 
   
Multi-organ donor status   
  No 2345 (87%) 1577 (88%) 
  Yes 356 (13%) 224 (12%) 
   
Central corneal endothelial cell density  
  <2500 cells/mm² 129 (5%) 75 (4%) 
  2500 to 2999 cells/mm² 677 (25%) 421 (23%) 
  3000 to 3499 cells/mm² 731 (27%) 456 (25%) 
  ≥ 3500 cells/mm² 118 (4%) 87 (5%) 
  Not advised 1046 (39%) 762 (42%) 
   
Total 2701 (100%) 1801(100%) 
   
 
1 
ACGR advised that cause of death was not yet determined but there were no medical contraindications, and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Likelihood of follow-up was significantly more likely (p<0.05) in some groups 
that others. Higher rates of follow-up were received for grafts where donor tissue had 
been transported interstate and for grafts where donors were aged 20-29 or 80-89. 
Rates were lower for grafts performed using donor tissue stored in organ culture, or 
from donors who had died from “other” specified causes. Significant differences in 
follow-up were also found across groups for eye bank and death-to-enucleation times. 
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3.1.1 DS(A)EK survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks 
around Australia. Figure 3.1.1 shows the comparison of graft survival for corneas 
provided by each of these eye banks. A significant difference was found across eye 
banks (Log Rank Statistic=25.50; df=4; p<0.001). This variable was not included in the 
multivariate analysis as it is collinear with the recipient State variable shown in Figure 
3.2.1. 
Figure 3.1.1 Australian eye bank 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Eye bank M 624 307 139 67 29 10 
Eye bank O 229 117 39 11 2 1 
Eye bank P 655 363 182 90 25 7 
Eye bank R 158 95 61 29 4 1 
Eye bank U 135 76 38 18 8 1 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Eye Bank 
 
 Probability of Graft Survival 
 Eye bank M: 0.84 at 1 year 
  Mean Survival 3.76 years 0.75 at 2 years 
  (SE= 0.17, 95% CI: 3.44, 4.09) 0.65 at 3 years 
  Median Survival 4.17 years 0.55 at 4 years 
    
 Eye bank O: 0.80 at 1 year 
  Mean Survival 2.95 years 0.66 at 2 years 
  (SE= 0.25, 95% CI: 2.45, 3.44)   
  Median Survival 2.53 years   
    
 Eye bank P: 0.87 at 1 year 
  Mean Survival 4.24 years 0.81 at 2 years 
  (SE= 0.16, 95% CI: 3.93, 4.54) 0.77 at 3 years 
  Median Survival 4.76 years 0.68 at 4 years 
    
 Eye bank R: 0.81 at 1 year 
  Mean Survival 3.68 years 0.75 at 2 years 
  (SE= 0.29, 95% CI: 3.10, 4.25) 0.70 at 3 years 
  Median Survival 4.03 years   
    
 Eye bank U: 0.86 at 1 year 
  Mean Survival 4.25 years 0.85 at 2 years 
  (SE= 0.18, 95% CI: 3.89, 4.61)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.2 DSAEK survival: influence of interstate transportation 
 
In the majority of transplants, donor corneas are sourced in the same State as the 
surgery occurs, however, in some cases corneas are transported interstate via air 
freight. Figure 3.1.2 shows the comparison of graft survival for grafts where the surgery 
was performed in the same State as the donor cornea was sourced, compared to those 
where the donor cornea was from interstate. No significant difference was found 
between groups (Log Rank Statistic=1.09; df=1; p=0.297).  
Figure 3.1.2 Interstate transportation 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Different State 119 70 44 22 8 2 
Same State 1682 888 415 193 60 18 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Interstate Transportation 
 
 Probability of Graft Survival 
 Different State: 0.77 at 1 year 
  Mean Survival 3.76 years 0.70 at 2 years 
  (SE= 0.25, 95% CI: 3.28, 4.24) 0.65 at 3 years 
  Median Survival n/a   
    
 Same State: 0.85 at 1 year 
  Mean Survival 8.65 years 0.77 at 2 years 
  (SE= 0.11, 95% CI: 3.80, 4.24) 0.70 at 3 years 
  Median Survival 4.67 years 0.61 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.3 DS(A)EK survival: influence of death to enucleation time 
 
Donor corneas are retrieved as soon as possible following donor death. Retrieval is 
recommended within the first 18 hours and 92% of donor eyes were enucleated within 
this time-frame. Times are rounded to the nearest hour and the median time from donor 
death to enucleation was 10 hours (range 0-26 hours). Data were not available for 3 
grafts. Figure 3.1.3 shows a comparison of graft survival depending on time from donor 
death to enucleation, stratified into three-hourly groups. No significant difference was 
found across time groups (Log Rank Statistic=7.80; df=4; p=0.099).  
Figure 3.1.3 Time from donor death to enucleation 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
3 hours or less 168 86 40 16 7 5 
4 to 6 hours 305 182 97 44 14 3 
7 to 9 hours 381 214 93 41 13 2 
10 to 12 hours 438 252 134 67 22 8 
13 hours or more 506 223 94 46 11 2 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Death to Enucleation Time 
 
 Probability of Graft Survival 
 3 hours or less: 0.86 at 1 year 
  Mean Survival 3.85 years 0.77 at 2 years 
  (SE= 0.25, 95% CI: 3.36, 4.35)   
  Median Survival 5.31 years   
    
 4 to 6 hours: 0.86 at 1 year 
  Mean Survival 3.71 years 0.80 at 2 years 
  (SE= 0.18, 95% CI: 3.36, 4.06) 0.69 at 3 years 
  Median Survival 4.28 years   
    
 7 to 9 hours: 0.85 at 1 year 
  Mean Survival 3.92 years 0.75 at 2 years 
  (SE= 0.18, 95% CI: 3.56, 4.28) 0.71 at 3 years 
  Median Survival 5.42 years   
    
 10 to 12 hours: 0.86 at 1 year 
  Mean Survival 4.35 years 0.80 at 2 years 
  (SE= 0.19, 95% CI: 3.98, 4.72) 0.75 at 3 years 
  Median Survival 4.90 years 0.68 at 4 years 
    
 13 hours or more: 0.82 at 1 year 
  Mean Survival 3.57 years 0.74 at 2 years 
  (SE= 0.19, 95% CI: 3.19, 3.94) 0.64 at 3 years 
  Median Survival 4.76 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.4 DS(A)EK survival: influence of corneal storage media 
 
In Australia, two storage media are commonly used to preserve donor corneas prior to 
transplantation. Data were not analysed for 1 graft where the donor eye was stored in a 
moist pot. Figure 3.1.4 shows the comparison of graft survival for corneas stored in 
Optisol medium compared to organ culture medium. A significant difference was found 
across groups (Log Rank Statistic=9.37; df=1; p=0.002). This variable was not retained 
in the multivariate analysis (see section 3.7) indicating that this is not an independent 
factor significantly affecting graft survival. 
Figure 3.1.4 Corneal storage media 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Optisol 1304 743 417 206 67 19 
Organ culture 496 215 42 9 1 1 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Corneal Storage Media 
 
 Probability of Graft Survival 
 Optisol: 0.85 at 1 year 
  Mean Survival 4.16 years 0.79 at 2 years 
  (SE= 0.11, 95% CI: 3.94, 4.39) 0.72 at 3 years 
  Median Survival 4.76 years 0.64 at 4 years 
    
 Organ culture: 0.83 at 1 year 
  Mean Survival 2.94 years 0.69 at 2 years 
  (SE= 0.26, 95% CI: 2.43, 3.44)   
  Median Survival 2.53   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
Further statistical examination of the relationship between storage media and the 
variables retained in multivariate analysis, revealed that three-quarters of grafts 
performed by high volume surgeons used corneas that had been stored in Optisol, while 
only one-third of those performed by low volume surgeons did. The difference in 
survival between corneas stored in these two media therefore reflects the difference in 
survival seen between high and low volume surgeons as examined in section 3.4.5. 
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3.1.5 DS(A)EK survival: influence of storage time to graft – Optisol medium 
 
Corneas stored in Optisol medium are most often used within 5 days of storage and are 
rarely stored for longer than 7 days. Figure 3.1.5 shows the comparison of graft survival 
across storage time for just those corneas stored in Optisol medium. Data were not 
provided for 235 grafts and these were excluded from the analysis. No significant 
difference was found across groups (Log Rank Statistic=4.10; df=2; p=0.129).  
Figure 3.1.5 Time from storage to graft, Optisol medium storage 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
5 days or less 748 417 231 111 33 8 
6 or 7 days 280 161 89 44 14 4 
More than 7 days 41 26 17 10 4 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Storage Time to Graft: Optisol 
 
 Probability of Graft Survival 
 5 days or less: 0.84 at 1 year 
  Mean Survival 3.97 years 0.78 at 2 years 
  (SE= 0.14, 95% CI: 3.70, 4.23) 0.70 at 3 years 
  Median Survival 4.68 years 0.63 at 4 years 
    
 6 or 7 days: 0.86 at 1 year 
  Mean Survival 4.25 years 0.82 at 2 years 
  (SE= 0.21, 95% CI: 3.84, 4.66) 0.81 at 3 years 
  Median Survival 4.76 years   
    
 More than 7 days: 0.88 at 1 year 
  Mean Survival 4.10 years   
  (SE= 0.38, 95% CI: 3.55, 4.65)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.6 DS(A)EK survival: influence of storage time to graft – organ culture 
medium 
 
Organ culture storage can allow preservation times of up to four weeks. Figure 3.1.6 
shows the comparison of graft survival across storage time for those corneas stored in 
organ culture medium. Data were not provided for 178 grafts and these were excluded 
from the analysis. No significant difference was found across groups (Log Rank 
Statistic=4.48; df=2; p=0.107).  
Figure 3.1.6 Time from storage to graft, organ culture medium storage 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 
Less than 2 weeks 113 49 14 3 
2 to 3 weeks 148 66 11 n/a 
More than 3 weeks 57 22 3 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Storage Time to Graft: Organ Culture 
 
 Probability of Graft Survival 
 Less than 2 weeks: 0.88 at 1 year 
  Mean Survival 2.65 years   
  (SE= 0.22, 95% CI: 2.22, 3.07)   
  Median Survival 3.54   
    
 2 to 3 weeks: 0.80 at 1 year 
  Mean Survival 1.88 years   
  (SE= 0.10, 95% CI: 1.69, 2.06)   
  Median Survival 2.43   
    
 More than 3 weeks: 0.73 at 1 year 
  Mean Survival 1.84 years   
  (SE= 0.24, 95% CI: 1.37, 2.31)   
  Median Survival 2.09   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.7 DS(A)EK survival: influence of donor sex 
 
Historically, a higher proportion of corneal donors are male and this was also the case 
in the current cohort. Figure 3.1.7 shows the comparison of graft survival depending on 
donor sex. No significant difference was found between groups (Log Rank 
Statistic=0.39; df=1; p=0.532).  
Figure 3.1.7 Donor sex 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Female 662 354 150 67 18 7 
Male 1139 604 309 148 50 13 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Donor Sex 
 
 Probability of Graft Survival 
 Female: 0.84 at 1 year 
  Mean Survival 4.06 years 0.76 at 2 years 
  (SE= 0.18, 95% CI: 3.71, 4.42) 0.66 at 3 years 
  Median Survival 5.10 years   
    
 Male: 0.85 at 1 year 
  Mean Survival 3.95 years 0.78 at 2 years 
  (SE= 0.11, 95% CI: 3.73, 4.17) 0.70 at 3 years 
  Median Survival 4.67 years 0.62 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.8 DS(A)EK survival: influence of donor age (years) 
 
Figure 3.1.8 shows the comparison of graft survival depending on donor age, stratified 
by 10 year age groups. Due to low numbers, donors aged under 19 years (n=22) were 
combined with those aged 20 to 29, while a single donor aged over 90 years was 
combined with donors aged 80 to 89. No significant difference was found across groups 
(Log Rank Statistic=10.04; df=6; p=0.123).  
Figure 3.1.8 Donor age 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
0 to 29 years 62 34 16 12 4 n/a 
30 to 39 years 78 37 20 9 1 n/a 
40 to 49 years 148 80 37 14 6 n/a 
50 to 59 years 297 160 88 46 14 3 
60 to 69 years 582 313 151 68 20 11 
70 to 79 years 455 243 107 48 14 4 
80 to 99 years 179 91 40 18 8 2 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Donor Age 
 
 Probability of Graft Survival 
 0 to 29 years: 0.91 at 1 year 
  Mean Survival 4.39 years   
  (SE= 0.21, 95% CI: 3.95, 4.78)   
  Median Survival n/a   
    
 30 to 39 years: 0.83 at 1 year 
  Mean Survival 3.13 years 0.81 at 2 years 
  (SE= 0.23, 95% CI: 2.69, 3.58)   
  Median Survival 3.48 years   
    
 40 to 49 years: 0.82 at 1 year 
  Mean Survival 3.49 years 0.78 at 2 years 
  (SE= 0.21, 95% CI: 3.07, 3.91)   
  Median Survival n/a   
    
 50 to 59 years: 0.87 at 1 year 
  Mean Survival 3.81 years 0.80 at 2 years 
  (SE= 0.16, 95% CI: 3.50, 4.12) 0.73 at 3 years 
  Median Survival 4.67 years   
     
 60 to 69 years: 0.85 at 1 year 
  Mean Survival 4.19 years 0.79 at 2 years 
  (SE= 0.18, 95% CI: 3.84, 4.53) 0.70 at 3 years 
  Median Survival 5.10 years 0.64 at 4 years 
     
 70 to 79 years: 0.82 at 1 year 
  Mean Survival 3.84 years 0.71 at 2 years 
  (SE= 0.19, 95% CI: 3.48, 4.21) 0.63 at 3 years 
  Median Survival 4.60 years   
     
 80 to 99 years: 0.84 at 1 year 
  Mean Survival 3.60 years 0.74 at 2 years 
  (SE= 0.26, 95% CI: 3.10, 4.10)   
  Median Survival 4.14 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.9 DS(A)EK survival: influence of cause of donor death 
 
Few causes of death exclude a person from becoming a corneal donor. Figure 3.1.9 
shows the comparison of graft survival depending on cause of donor death. Cause of 
death was unknown for 18 grafts and these were excluded from the analysis. No 
significant difference was found across groups (Log Rank Statistic=4.83; df=5; 
p=0.438).  
Figure 3.1.9 Cause of donor death 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Cardiac event 453 260 143 66 18 5 
Malignancy 675 346 152 77 31 10 
Trauma 130 61 30 14 3 n/a 
Respiratory event 143 78 38 14 2 1 
Intracranial/cerebral haemorrhage 288 161 81 37 13 4 
Other 94 46 13 7 1 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Cause of Donor Death 
 
 Probability of Graft Survival 
 Cardiac event: 0.86 at 1 year 
  Mean Survival 4.07 years 0.79 at 2 years 
  (SE= 0.17, 95% CI: 3.73, 4.41) 0.69 at 3 years 
  Median Survival 4.90 years   
    
 Malignancy: 0.83 at 1 year 
  Mean Survival 4.12 years 0.76 at 2 years 
  (SE= 0.170, 95% CI: 3.79, 4.44) 0.70 at 3 years 
  Median Survival 4.76 years 0.62 at 4 years 
    
 Trauma: 0.83 at 1 year 
  Mean Survival 3.25 years 0.75 at 2 years 
  (SE= 0.24, 95% CI: 2.77, 3.72)   
  Median Survival 3.77 years   
    
 Respiratory event: 0.88 at 1 year 
  Mean Survival 4.56 years 0.84 at 2 years 
  (SE= 0.27, 95% CI: 4.03, 5.10)   
  Median Survival n/a   
    
 Intracranial/cerebral haemorrhage: 0.86 at 1 year 
  Mean Survival 3.66 years 0.75 at 2 years 
  (SE= 0.18, 95% CI: 3.30, 4.02) 0.73 at 3 years 
  Median Survival 4.28 years   
    
 Other: 0.83 at 1 year 
  Mean Survival 2.94 years   
  (SE= 0.28, 95% CI: 2.40, 3.48)   
  Median Survival 3.76 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
“Other” included donors who died from diseases of the liver, kidney, pancreas, gastro-
intestinal tract, encephalopathy, sepsis, and rare diseases. It also includes a large 
number of cases (33), where the donor was listed as dying from brain damage or brain 
death with no specific cause provided.  
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3.1.10 DS(A)EK survival: influence of multi-organ donor status 
 
Figure 3.1.10 shows the comparison of graft survival depending on whether the donor 
cornea was obtained from a multi-organ donor. No significant difference was found 
between groups (Log Rank Statistic=0.45; df=1; p=0.500).  
Figure 3.1.10 Multi-organ donor status 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No 1577 834 402 192 61 19 
Yes 224 124 57 23 7 1 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Multi-organ Donor 
 
 Probability of Graft Survival 
 No: 0.84 at 1 year 
  Mean Survival 4.10 years 0.77 at 2 years 
  (SE= 0.11, 95% CI: 3.89, 4.32) 0.69 at 3 years 
  Median Survival 4.90 years 0.62 at 4 years 
    
 Yes: 0.86 at 1 year 
  Mean Survival 3.37 years 0.75 at 2 years 
  (SE= 0.22, 95% CI: 2.95, 3.79) 0.69 at 3 years 
  Median Survival 4.01 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.1.11 DS(A)EK survival: influence of donor central corneal endothelial cell 
density 
 
Information on donor corneal endothelial cell count (ECC) has been requested by the 
registry in recent years. ECC had been reported for just over one half (58%) of DSAEKs 
for which follow-up had been provided. Reported ECC ranged from 1700 to 4500 
cells/mm². Comparison of graft survival across donor ECC groups is shown in Figure 
3.1.11. A significant difference was found across groups (Log Rank Statistic=13.59; 
df=3; p=0.004). This variable was not included in the multivariate analysis due to the 
high proportion (42%) of missing data. See section 3.7 for discussion of the impact on 
the results when this variable was included in the multivariate analyses in two different 
ways. 
Figure 3.1.11 Endothelial cell density 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Less than 2500 cells/mm² 75 40 13 2 n/a n/a 
2500 – 2999 cells/mm² 421 215 106 43 14 8 
3000 – 3499 cells/mm² 456 234 103 51 18 3 
3500 or more cells/mm² 87 47 25 10 2 1 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Endothelial Cell Density 
 
 Probability of Graft Survival 
 Less than 2500 cells/mm²: 0.74 at 1 year 
  Mean Survival 2.00 years   
  (SE= 0.21, 95% CI: 1.59, 2.42)   
  Median Survival 2.13 years   
    
 2500 – 2999 cells/mm²: 0.80 at 1 year 
  Mean Survival 3.72 years 0.73 at 2 years 
  (SE= 0.21, 95% CI: 3.31, 4.12) 0.61 at 3 years 
  Median Survival 4.03   
    
 3000 – 3499 cells/mm²: 0.85 at 1 year 
  Mean Survival 3.62 years 0.76 at 2 years 
  (SE= 0.15, 95% CI: 3.33, 3.91) 0.66 at 3 years 
  Median Survival 4.28 years   
     
 3500 or more cells/mm²: 0.84 at 1 year 
  Mean Survival 3.28 years 0.80 at 2 years 
  (SE= 0.31, 95% CI: 2.66, 3.89)   
  Median Survival 3.30 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.2 Recipient Factors 
 
Table 3.2 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report. The sum of these numbers for each variable 
equals the total number of grafts (2,701 registered and 1,801 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 3.2 Recipient factors 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Recipient factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Failed previous 506 (19%) 335 (19%) 
  Bullous keratopathy (no Fuchs’ endothelial dystrophy) 825 (31%) 558 (31%) 
  Corneal dystrophy (inc. Fuchs’ endothelial dystrophy) 1316 (49%) 868 (48%) 
  Trauma 33 (1%) 25 (1%) 
  Other* 21 (<1%) 15 (<1%) 
   
Australian State where graft was performed   
  State X 915 (34%) 625 (35%) 
  State Y 398 (15%) 201 (11%) 
  State Z 783 (29%) 590 (33%) 
  State A 375 (14%) 237 (13%) 
  State B 186 (7%) 113 (6%) 
  State C 44 (2%) 35 (2%) 
   
Recipient sex   
  Female 1529 (57%) 1034 (57%) 
  Male 1172 (43%) 767 (43%) 
   
Recipient age group   
  <10 years 3 (<1%) 3 (<1%) 
  10 to 19 years 2 (<1%) 0 (0%) 
  20 to 29 years 11 (<1%) 8 (<1%) 
  30 to 39 years 27 (1%) 16 (<1%) 
  40 to 49 years 88 (3%) 55 (3%) 
  50 to 59 years 287 (11%) 177 (10%) 
  60 to 69 years 698 (26%) 449 (25%) 
  70 to 79 years 825 (31%) 560 (31%) 
  80 to 89 years 675 (25%) 475 (26%) 
  ≥ 90 years 85 (3%) 58 (3%) 
   
Type of graft   
  DSEK 1881 (70%) 1380 (77%) 
  DSAEK 675 (25%) 332 (18%) 
  Not specified 145 (5%) 89 (5%) 
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Pre-graft neovascularisation   
  No 2471 (92%) 1658 (92%) 
  Yes 230 (9%) 143 (8%) 
   
Pre-graft inflammation and/or steroid use   
  No 1945 (72%) 1312 (73%) 
  Yes 728 (27%) 474 (26%) 
  Not advised 28 (1%) 15 (<1%) 
   
History of raised intraocular pressure   
  No 2243 (83%) 1512 (84%) 
  Yes 424 (16%) 273 (15%) 
  Not advised 34 (1%) 16 (<1%) 
   
Prior existing contralateral graft   
  No 2144 (79%) 1427 (79%) 
  Yes 557 (21%) 374 (21%) 
   
Change in lens status   
  Phakic/phakic 106 (4%) 66 (4%) 
  Any/aphakic 41 (2%) 21 (1%) 
  Phakic/pseudophakic 639 (24%) 412 (23%) 
  Not phakic/pseudophakic 1915 (71%) 1302 72(%) 
   
Total 2701 (100%) 1801 (100%) 
   
 
*Other included: ICE syndrome (14), congenital glaucoma (1), Descemet’s membrane 
detachment (1), Descemet’s membrane tear (1), non-herpetic infection (1), primary 
endotheliopathy (1), Riegers’ anomaly (1), and toxic anterior segment syndrome (1). 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Likelihood of follow-up was significantly more likely (p<0.05) in some groups 
that others. Grafts where the eye was aphakic post-graft were less likely to have been 
followed. Significant differences in follow-up were also found across groups for graft 
State.  
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3.2.1 DS(A)EK survival: influence of Australian State where graft was performed 
 
Figure 3.2.1 shows the comparison of graft survival depending on the Australian State 
in which the transplantation occurred. A significant difference was found across groups 
(Log Rank Statistic=46.70; df=5; p<0.001). This variable was not retained in the 
multivariate analysis (see section 3.7) indicating that this is not an independent factor 
significantly affecting graft survival.  
Figure 3.2.1 Australian State where graft was performed 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
State X 625 311 142 68 30 10 
State Y 201 101 33 9 1 n/a 
State Z 590 323 154 75 20 6 
State A 237 145 95 46 10 3 
State B 113 62 28 13 6 1 
State C 35 16 7 4 1 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Australian State Where Graft was Performed 
 
 Probability of Graft Survival 
 State X: 0.84 at 1 year 
  Mean Survival 3.79 years 0.75 at 2 years 
  (SE= 0.17, 95% CI: 3.46, 4.11) 0.66 at 3 years 
  Median Survival 4.17 years 0.55 at 4 years 
    
 State Y: 0.81 at 1 year 
  Mean Survival 2.51 years 0.67 at 2 years 
  (SE= 0.17, 95% CI: 2.19, 2.84)   
  Median Survival 2.54 years   
    
 State Z: 0.88 at 1 year 
  Mean Survival 4.23 years 0.82 at 2 years 
  (SE= 0.17, 95% CI: 3.89, 4.57) 0.78 at 3 years 
  Median Survival 4.76 years 0.70 at 4 years 
    
 State A: 0.82 at 1 year 
  Mean Survival 4.01 years 0.77 at 2 years 
  (SE= 0.20, 95% CI: 3.61, 4.41) 0.71 at 3 years 
  Median Survival n/a   
    
 State B: 0.87 at 1 year 
  Mean Survival 4.25 years 0.85 at 2 years 
  (SE= 0.21, 95% CI: 3.83, 4.67)   
  Median Survival n/a   
     
 State C:   
  Mean Survival 1.97 years  n/a 
  (SE= 0.31, 95% CI: 1.35, 2.58)   
  Median Survival 1.26 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
Examination of the difference across recipient State with regards to the variables 
retained in the multivariate analysis, suggest that the differences seen here may be 
related to differing proportions in the number of grafts performed in certain years, the 
lens status pre- and post-graft, pre-graft neovascularisation, presence of rejection, and 
the level of follow-up received.  
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3.2.2 DS(A)EK survival: influence of recipient sex 
 
Comparison of graft survival between male and female transplant recipients is shown in 
Figure 3.2.2. No significant difference was found between groups (Log Rank 
Statistic=3.14; df=1; p=0.076). While this difference was not significant at the p<0.05 
level, it met the p<0.08 criterion to be included in the multivariate analysis (see section 
3.7). This variable was not retained in the final model, indicating that this is not an 
independent factor significantly affecting graft survival. 
Figure 3.2.2 Recipient sex 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Female 1034 569 282 130 38 11 
Male 767 389 177 85 30 9 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Recipient Sex 
 
 Probability of Graft Survival 
 Female: 0.86 at 1 year 
  Mean Survival 4.15 years 0.79 at 2 years 
  (SE= 0.14, 95% CI: 3.87, 4.43) 0.70 at 3 years 
  Median Survival 5.31 years 0.63 at 4 years 
    
 Male: 0.82 at 1 year 
  Mean Survival 3.81 years 0.74 at 2 years 
  (SE= 0.14, 95% CI: 3.54, 4.08) 0.68 at 3 years 
  Median Survival 4.68 years 0.59 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.2.3 DS(A)EK survival: influence of donor/recipient sex match/mismatch 
 
Further analysis examined whether there was any effect of a cornea being transplanted 
into a recipient of a different sex to the donor. Comparison of graft survival across 
groups based on donor/recipient sex combinations is shown in Figure 3.2.3. No 
significant difference was found across groups (Log Rank Statistic=3.76; df=3; 
p=0.288). 
Figure 3.2.3 Donor/recipient sex match/mismatch 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Female/female 369 205 84 38 10 4 
Female/male 293 149 66 29 8 3 
Male/female 665 364 198 92 28 7 
Male/male 474 240 111 56 22 6 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Donor/Recipient Sex Match/Mismatch 
 
 Probability of Graft Survival 
 Female/female: 0.86 at 1 year 
  Mean Survival 426 years 0.78 at 2 years 
  (SE= 0.23, 95% CI: 3.82, 4.71) 0.71 at 3 years 
  Median Survival 5.31 years   
    
 Female/male: 0.80 at 1 year 
  Mean Survival 3.57 years 0.73 at 2 years 
  (SE= 0.19, 95% CI: 3.19, 3.94) 0.65 at 3 years 
  Median Survival 4.27 years   
    
 Male/female: 0.86 at 1 year 
  Mean Survival 3.96 years 0.79 at 2 years 
  (SE= 0.14, 95% CI: 3.68, 4.24) 0.70 at 3 years 
  Median Survival 4.60 years 0.64 at 4 years 
    
 Male/male: 0.83 at 1 year 
  Mean Survival 3.87 years 0.75 at 2 years 
  (SE= 0.17, 95% CI: 3.54, 4.21) 0.70 at 3 years 
  Median Survival 4.68 years 0.59 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.2.4 DS(A)EK survival: influence of recipient age (years) 
 
Figure 3.2.4 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for recipients aged under 40 were combined due to small 
numbers in these groups (0-9 years: n=3, 10 to 19 years: n=0, 20 to 29 years: n=8 and 
30 to 39 years: n=16). No significant difference was found across groups (Log Rank 
Statistic=12.376; df=6; p=0.054). While this difference was not significant at the p<0.05 
level, it met the p<0.08 criteria to be included in the multivariate analysis (see section 
3.7). This variable was retained in the final model, indicating that this is an independent 
factor significantly affecting graft survival. 
Figure 3.2.4 Recipient age 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
0 to 39 years 27 12 6 5 n/a n/a 
40 to 49 years 55 35 18 8 5 1 
50 to 59 years 177 99 50 19 5 2 
60 to 69 years 449 261 121 58 18 4 
70 to 79 years 560 300 145 73 24 7 
80 to 89 years 475 223 110 49 15 6 
90 to 99 years 58 28 9 3 1 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Recipient Age 
 
 Probability of Graft Survival 
 0 to 39 years:   
  Mean Survival 2.49 years  n/a 
  (SE= 0.38, 95% CI: 1.74, 3.23)   
  Median Survival 3.85 years   
    
 40 to 49 years: 0.86 at 1 year 
  Mean Survival 3.64 years   
  (SE= 0.35, 95% CI: 2.95, 4.33)   
  Median Survival 5.10 years   
    
 50 to 59 years: 0.79 at 1 year 
  Mean Survival 3.52 years 0.68 at 2 years 
  (SE= 0.26, 95% CI: 3.02, 4.03)   
  Median Survival 4.67 years   
     
 60 to 69 years: 0.87 at 1 year 
  Mean Survival 4.04 years 0.80 at 2 years 
  (SE= 0.18, 95% CI: 3.69, 4.40) 0.70 at 3 years 
  Median Survival 4.90 years   
     
 70 to 79 years: 0.83 at 1 year 
  Mean Survival 4.07 years 0.74 at 2 years 
  (SE= 0.18, 95% CI: 3.73, 4.42) 0.68 at 3 years 
  Median Survival 4.28 years 0.62 at 4 years 
     
 80 to 89 years: 0.86 at 1 year 
  Mean Survival 4.08 years 0.83 at 2 years 
  (SE= 0.18, 95% CI: 3.74, 4.43) 0.73 at 3 years 
  Median Survival 5.31 years   
     
 90 to 99 years: 0.85 at 1 year 
  Mean Survival 3.39 years   
  (SE= 0.24, 95% CI: 2.93, 3.85)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
In the multivariate analysis, recipient age was shown to have a significant effect 
(p=0.009) on graft survival. Using the age group “0 to 39 years” as referent, there was 
significantly better survival of grafts performed in recipients aged 40 to 49 (p=0.039), 60 
to 69 (p=0.038), 80 to 89 (p=0.019), and 90 to 99 (p=0.043). Using the age group “50 to 
59 years” as referent, there was significantly better survival of grafts performed in 
recipients aged 40 to 49 (p=0.037), 60 to 69 (p=0.007), 70 to 79 (p=0.033), and 80 to 89 
(p=0.002). No other comparisons were significantly different. The final model also 
accounted for the effect of lens status pre- and post-graft, experience of surgeon and 
percentage of follow-up, graft year, and post-graft rejection episode(s).  
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3.2.5 DS(A)EK survival: influence of indication for graft 
 
Figure 3.2.5 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. Data relating to 
15 grafts that had an indication other than the four included groups, were excluded from 
the analysis. A significant difference was found across groups (Log Rank 
Statistic=13.63; df=3; p=0.003). This variable was not retained in multivariate analysis 
(see section 3.7) indicating that this is not an independent factor significantly affecting 
graft survival.  
Figure 3.2.5 Indication for graft 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Failed previous graft 335 174 74 40 14 3 
Bullous keratopathy 558 288 138 58 19 5 
Corneal dystrophy 868 469 233 111 34 12 
Trauma 25 17 8 5 1 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Indication for Graft 
 
 Probability of Graft Survival 
 Failed previous graft: 0.82 at 1 year 
  Mean Survival 3.43 years 0.68 at 2 years 
  (SE= 0.19, 95% CI: 3.05, 3.80) 0.59 at 3 years 
  Median Survival 4.08 years   
    
 Bullous keratopathy: 0.85 at 1 year 
  Mean Survival 3.74 years 0.78 at 2 years 
  (SE= 0.14, 95% CI: 3.46, 4.03) 0.69 at 3 years 
  Median Survival 4.27 years   
    
 Corneal dystrophy: 0.85 at 1 year 
  Mean Survival 4.28 years 0.80 at 2 years 
  (SE= 0.15, 95% CI: 3.99, 4.57) 0.73 at 3 years 
  Median Survival 5.10 years 0.67 at 4 years 
    
 Trauma:   
  Mean Survival 4.20 years  n/a 
  (SE= 0.25, 95% CI: 3.71, 4.70)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
Bullous keratopathy includes pseudophakic bullous keratopathy and aphakic bullous 
keratopathy, as well as bullous keratopathy in phakic eyes. Eyes with Fuchs’ endothelial 
dystrophy are included in the “corneal dystrophy” group, regardless of whether this had 
progressed to endothelial failure or not. 
The fifteen grafts excluded from the analysis were performed for ICE syndrome (8), 
congenital glaucoma (1), Descemet’s membrane detachment (1), Descemet’s 
membrane tear (1), non-herpetic infection (1), primary endotheliopathy (1), Riegers’ 
anomaly (1), and toxic anterior segment syndrome (1). 
 
The analyses on pages 172 and 173 are of subcategories in an individual 
indication for graft cohort (failed previous graft). This sub-analysis was not 
included in multivariate analyses. 
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3.2.5.1 DS(A)EK survival: influence of the number of previous ipsilateral grafts 
 
For repeat grafts, survival was compared across groups based on the number of 
previous grafts in the same eye (range 1 to 6), as shown in Figure 3.2.6. This difference 
was significant (Log Rank Statistic=9.01, df=2, p=0.011). Data for first grafts were not 
included in this analysis. Second grafts had significantly (p=0.010) better survival than 
third grafts (one previous graft compared to two previous grafts), while there was no 
significant difference (p=0.776) between the survival of third grafts (two previous grafts) 
and subsequent grafts (three or more previous grafts). The Kaplan Meier curve also 
shows the survival of first grafts for any indication, to give context to the other survival 
rates.  
Figure 3.2.6 Number of previous ipsilateral grafts 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
First graft for any indication 1465 783 385 175 54 17 
One previous graft 254 133 61 34 11 3 
Two previous grafts 56 31 8 3 2 n/a 
Three or more previous grafts 26 11 5 3 1 n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Number of Ipsilateral Grafts 
 
 Probability of Graft Survival 
 First graft for any indication: 0.85 at 1 year 
  Mean Survival 4.17 years 0.79 at 2 years 
  (SE= 0.12, 95% CI: 3.94, 4.41) 0.72 at 3 years 
  Median Survival 4.90 years 0.64 at 4 years 
    
 One previous graft: 0.84 at 1 year 
  Mean Survival 3.74 years 0.71 at 2 years 
  (SE= 0.23, 95% CI: 3.29, 4.18) 0.66 at 3 years 
  Median Survival 4.17 years   
    
 Two previous grafts: 0.73 at 1 year 
  Mean Survival 2.41 years   
  (SE= 0.34, 95% CI: 1.74, 3.08)   
  Median Survival 2.81 years   
    
 Three or more previous grafts:  n/a 
  Mean Survival 2.42 years   
  (SE= 0.38, 95% CI: 1.67, 3.17)   
  Median Survival 2.49 years   
     
 
Note: Previous ipsilateral grafts could be of any type, not just DS(A)EK. 
 
This concludes the subcategory analyses. Analyses from page 174 onwards are 
again performed on the full cohort. 
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3.2.6 DS(A)EK survival: influence of pre- and post-graft lens status 
 
Figure 3.2.7 shows the comparison of graft survival stratified by the change of lens 
status from pre- to post-graft. “Phakic/phakic” means the eye was phakic both before 
and after the graft. “Any/aphakic” means the eye was phakic, pseudophakic or aphakic 
before the graft and aphakic afterwards. “Phakic/pseudophakic” means the eye was 
phakic before the graft and pseudophakic afterwards, having undergone a triple 
procedure. “Not phakic/pseudophakic” means the eye was aphakic or pseudophakic 
before the graft and pseudophakic afterwards.  
A significant difference was found across groups (Log Rank Statistic=20.38; df=3; 
p<0.001). This variable was retained in the multivariate analysis (see section 3.7), 
indicating that this is an independent factor significantly affecting graft survival.  
Figure 3.2.7 Change in lens status from pre- to post-graft  
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Phakic/phakic 66 37 23 11 1 1 
Any/aphakic 21 13 4 3 1 n/a 
Phakic/pseudophakic 412 229 114 51 10 6 
Not phakic/pseudophakic 1302 679 318 150 56 13 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Pre- and Post-graft Lens Status 
 
 Probability of Graft Survival 
 Phakic/phakic: 0.71 at 1 year 
  Mean Survival 3.08 years 0.64 at 2 years 
  (SE= 0.33, 95% CI: 2.44, 3.73)   
  Median Survival 3.48 years   
    
 Any/aphakic:   
  Mean Survival 3.05 years  n/a 
  (SE= 0.41, 95% CI: 2.25, 3.86)   
  Median Survival 4.01 years   
    
 Phakic/pseudophakic: 0.88 at 1 year 
  Mean Survival 4.86 years 0.85 at 2 years 
  (SE= 0.21, 95% CI: 4.45, 5.27) 0.81 at 3 years 
  Median Survival n/a   
    
 Not phakic/pseudophakic: 0.84 at 1 year 
  Mean Survival 3.81 years 0.75 at 2 years 
  (SE= 0.11, 95% CI: 3.60, 4.01) 0.66 at 3 years 
  Median Survival 4.60 years 0.58 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, lens status pre- and post-graft was shown to have a 
significant effect (p=0.002) on graft survival. The final model also accounted for the 
effect of graft year, experience of surgeon, percentage of follow-up, recipient age, and 
post-graft rejection episode(s). Grafts that were phakic pre- graft and pseudophakic 
post-graft, exhibit better graft survival than any of the other three combinations 
(p<0.001, p=0.012, and p<0.001, respectively).  
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3.2.7 DS(A)EK survival: influence of pre-graft corneal neovascularisation 
 
Figure 3.2.8 shows the comparison of graft survival between those recipients with 
corneal neovascularisation pre-graft and those without (Log Rank Statistic=5.83; df=1; 
p=0.016). Recipients with pre-graft neovascularisation had poorer graft survival than 
those with avascular corneas. This variable was not retained in the multivariate analysis 
(see section 3.7), indicating that this is not an independent factor significantly affecting 
graft survival.  
Figure 3.2.8 Pre-graft corneal neovascularisation 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No neovascularisation 1658 882 428 201 61 18 
Neovascularisation 143 76 31 14 7 2 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Pre-graft Neovascularisation 
 
 Probability of Graft Survival 
 No neovascularisation: 0.85 at 1 year 
  Mean Survival 4.08 years 0.78 at 2 years 
  (SE= 0.11, 95% CI: 3.87, 4.30) 0.71 at 3 years 
  Median Survival 4.68 years 0.62 at 4 years 
    
 Neovascularisation: 0.80 at 1 year 
  Mean Survival 3.17 years 0.67 at 2 years 
  (SE= 0.24, 95% CI: 2.69, 3.65)   
  Median Survival 3.49 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
 
 
  
 Descemet’s Stripping Endothelial Keratoplasty 
178 Australian Corneal Graft Registry Report 2015 
3.2.8 DS(A)EK survival: influence of inflammation and/or steroid use at time of 
graft 
 
Figure 3.2.9 shows the comparison of graft survival between grafts performed in an eye 
with current inflammation and/or steroid use within the past two weeks, compared to 
those with neither of these factors. This information was not known for 15 grafts and 
these were excluded from the analysis. The difference was not significant (Log Rank 
Statistic=0.222; df=1; p=0.638). 
Figure 3.2.9 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No inflammation/steroid use 1312 686 344 156 46 14 
Inflammation/steroid use 474 265 110 58 21 6 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Inflammation and/or Steroid Use at Time of Graft 
 
 Probability of Graft Survival 
 No inflammation/steroid use: 0.84 at 1 year 
  Mean Survival 4.10 years 0.77 at 2 years 
  (SE= 0.13, 95% CI: 3.86, 4.35) 0.71 at 3 years 
  Median Survival 4.76 years 0.62 at 4 years 
    
 Inflammation/steroid use: 0.86 at 1 year 
  Mean Survival 3.80 years 0.76 at 2 years 
  (SE= 0.17, 95% CI: 3.47, 4.14) 0.65 at 3 years 
  Median Survival 4.28 years 0.58 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.2.9 DS(A)EK survival: influence of history of raised intraocular pressure (IOP)  
 
Figure 3.2.10 shows the comparison of graft survival between groups based on whether 
the recipient had a history of raised intraocular pressure (Log Rank Statistic=10.80; 
df=1; p=0.001). This was irrespective of whether IOP was raised at the time of graft. In 
16 cases the surgeon was unable to state whether IOP had been raised in the past, and 
these grafts were excluded from the analysis. This variable was not retained in the 
multivariate analysis (see section 3.7) indicating that this is not an independent factor 
significantly affecting graft survival. 
Figure 3.2.10 History of raised intraocular pressure 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
IOP never raised 1512 800 392 184 53 18 
History of raised IOP  273 150 60 28 12 1 
 
 
 
 
 Descemet’s Stripping Endothelial Keratoplasty 
181 Australian Corneal Graft Registry Report 2015 
 
 
 
 
 
 
 
 
 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
History of Raised IOP  
 
 Probability of Graft Survival 
 IOP never raised: 0.85 at 1 year 
  Mean Survival 4.20 years 0.79 at 2 years 
  (SE= 0.12, 95% CI: 3.97, 4.43) 0.72 at 3 years 
  Median Survival 5.10 years 0.64 at 4 years 
    
 History of raised IOP: 0.82 at 1 year 
  Mean Survival 3.20 years 0.68 at 2 years 
  (SE= 0.19, 95% CI: 2.84, 3.57) 0.57 at 3 years 
  Median Survival 3.85 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.2.10 DS(A)EK survival: influence of previous contralateral graft 
 
Figure 3.2.11 shows the comparison of graft survival between grafts where the recipient 
had undergone a previous contralateral graft and those where they had not. No 
significant difference was found (Log Rank Statistic=0.66; df=1; p=0.418).  
Figure 3.2.11 Previous contralateral graft 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No contralateral graft 1427 754 371 170 55 17 
Previous contralateral graft 374 204 88 45 13 3 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Previous Contralateral Graft 
 
 Probability of Graft Survival 
 No contralateral graft: 0.84 at 1 year 
  Mean Survival 4.05 years 0.77 at 2 years 
  (SE= 0.12, 95% CI: 3.82, 4.28) 0.68 at 3 years 
  Median Survival 4.68 years 0.59 at 4 years 
    
 Previous contralateral graft: 0.86 at 1 year 
  Mean Survival 3.79 years 0.78 at 2 years 
  (SE= 0.17, 95% CI: 3.45, 4.13) 0.73 at 3 years 
  Median Survival 4.17 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
Note: Previous contralateral grafts could be of any type, not just DS(A)EK. 
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3.3 Graft Era 
 
Table 3.3 shows the number of grafts registered and followed, in blocks of two years. 
The percentages, which should be summed vertically, total 100. 
Table 3.3 Graft era 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  2006/2007 101 (4%) 92 (5%) 
  2008/2009 544 (20%) 520 (29%) 
  2010/2011 850 (32%) 664 (37%) 
  2012/2013 1123 (42%) 523 (29%) 
  2014 83 (3%) 2 (<1%) 
   
Total 2701 (100%) 1801 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses and found to be significant (p<0.001). Level of follow-up reduces as time since 
graft reduces, with 47% of grafts performed in 2012/13 followed, compared with 78% of 
grafts performed in 2010/11 and 96% of grafts performed in 2008/09. 
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3.3.1 DS(A)EK survival: influence of year of graft 
 
Figure 3.3.1 shows the comparison of graft survival between year of graft, stratified into 
two-year groups (Log Rank Statistic=17.56; df=3; p=0.001). Due to the low number of 
followed grafts (2), data for grafts performed in 2014 were not included in the analysis. 
This variable was retained in the multivariate analysis (see section 3.7) indicating that 
this is an independent factor significantly affecting graft survival. 
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a 
replacement graft. A “lag time” operates at the furthest end of each curve in a Kaplan 
Meier plot. This effect is most pronounced in the early years following graft registration, 
when requests have not yet been made for follow-up information, and tends to reduce 
predictably over time. It can be seen that in the analysis below, the survival curve for 
2012/2013 drops off suddenly, illustrating this skewing of the data. In consequence, the 
variable is treated as “time variant” in multivariate analyses, to statistically control for 
this effect. 
Figure 3.3.1 Graft era 
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Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
2006/2007 92 51 43 27 20 9 
2008/2009 520 373 271 162 48 11 
2010/2011 664 369 144 26 n/a n/a 
2012/2013 523 165 1 n/a n/a n/a 
 
 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Era of Graft 
 
 Probability of Graft Survival 
 2006/2007 : 0.67 at 1 year 
  Mean Survival 3.30 years  0.61 at 2 years 
  (SE= 0.30, 95% CI: 2.71, 3.90) 0.55 at 3 years 
  Median Survival 4.08 years  0.53 at 4 years 
    
 2008/2009 : 0.87 at 1 year 
  Mean Survival 4.14 years  0.82 at 2 years 
  (SE= 0.12, 95% CI: 3.91, 4.37) 0.77 at 3 years 
  Median Survival 4.76 years  0.67 at 4 years 
    
 2010/2011 : 0.85 at 1 year 
  Mean Survival 2.82 years  0.76 at 2 years 
  (SE= 0.08, 95% CI: 2.67, 2.98) 0.60 at 3 years 
  Median Survival 3.47 years    
    
 2012/2013 : 0.85 at 1 year 
  Mean Survival 1.64 years    
  (SE= 0.05, 95% CI: 1.55, 1.74)   
  Median Survival 1.96 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
In the multivariate analysis, graft year was shown to have a significant effect (p<0.001) 
on graft survival. This effect varied over time. Using the years 2006/2007 as referent, 
there was a significant improvement in survival for grafts performed in all other years (all 
p<0.001). There were no significant differences in survival for grafts performed in 
2008/2009, 2010/2011 or 2012/2013 when compared to each other (p=0.235, p=0.946 
and p=0.222). 
The final model also accounted for the effect of lens status pre- and post-graft, 
experience of surgeon and percentage of follow-up, recipient age, and post-graft 
rejection episode(s). 
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3.4 Surgery and Surgeon Factors 
 
Table 3.4 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report. The sum of these numbers for 
each variable equals the total number of grafts (2,701 registered and 1,801 followed) 
and the percentages, which should be summed vertically for each variable, total 100. 
Table 3.4 Surgery and surgeon factors 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  Less than 8.0 mm 154 (6%) 95 (5%) 
  8.0 mm to <8.25 mm 516 (19%) 320 (18%) 
  8.25 mm to <8.5 mm 239 (9%) 141 (8%) 
  8.5 mm to <8.75 mm 952 (35%) 654 (36%) 
  8.75 mm or more 604 (33%) 426 (24%) 
  Not advised 236 (9%) 165 (9%) 
   
Use of glide and/or forceps   
  Neither 1637 (61%) 1300 (72%) 
  Glide only 892 (33%) 412 (23%) 
  Forceps only 126 (5%) 71 (4%) 
  Both glide and forceps 46 (2%) 18 (1%) 
   
Type of graft   
  DSEK 1881(70%) 1380 (77%) 
  DSAEK 675 (25%) 332 (18%) 
  Unspecified 145 (5%) 89 (5%) 
   
Surgeon volume   
  Fewer than 25 followed grafts 854 (32%) 354 (20%) 
  25+ followed grafts, ≥67% follow-up 1616 (60%) 1309 (73%) 
  25+ followed grafts, <67% follow-up 231 (9%) 138 (8%) 
   
Total 2701 (100%) 1801 (100%) 
   
 
67% was selected as the cut-off point for the follow-up categories as this (66.7%) was 
the average percentage of follow-up for all DS(A)EK, regardless of surgeon experience. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Likelihood of follow-up was significantly more likely (p<0.05) in some groups 
that others. Lower rates of follow-up had been received for grafts performed using 
forceps or a glide. DSAEK grafts were significantly less likely to have been followed, 
possibly due to the more recent introduction of this technique. Significant differences in 
follow-up were also found across groups for graft size. Due to the nature of the variable, 
follow-up was, logically, significantly higher (p<0.001) for grafts performed by surgeons 
with 25+ followed grafts and ≥67% follow-up.   
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3.4.1 DS(A)EK survival: influence of graft size 
 
Figure 3.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. This information was not 
reported for 165 of the followed grafts. A significant difference was found across groups 
(Log Rank Statistic=41.62; df=4; p<0.001). This variable was not retained in the final 
model, indicating that this is not an independent factor significantly affecting graft 
survival. 
Figure 3.4.1 Graft size 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Less than 8 mm 95 50 22 8 1 n/a 
8 mm to < 8.25 mm 320 162 75 40 14 4 
8.25 mm to < 8.5 mm 141 76 42 23 11 5 
8.5 mm to < 8.75 mm 654 322 141 71 27 6 
8.75 mm or more 426 251 129 55 8 1 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Graft Size 
 
 Probability of Graft Survival 
 Less than 8 mm: 0.78 at 1 year 
  Mean Survival 2.59 years 0.66 at 2 years 
  (SE= 0.26, 95% CI: 2.07, 3.10)   
  Median Survival 2.53 years   
    
 8 mm to < 8.25 mm: 0.77 at 1 year 
  Mean Survival 3.66 years 0.67 at 2 years 
  (SE= 0.22, 95% CI: 3.23, 4.09) 0.60 at 3 years 
  Median Survival 3.77 years   
    
 8.25 mm to < 8.5 mm: 0.80 at 1 year 
  Mean Survival 4.02 years 0.72 at 2 years 
  (SE= 0.26, 95% CI: 3.51, 4.53) 0.67 at 3 years 
  Median Survival 5.42 years   
    
 8.5 mm to < 8.75 mm: 0.89 at 1 year 
  Mean Survival 4.23 years 0.83 at 2 years 
  (SE= 0.16, 95% CI: 3.92, 4.54) 0.76 at 3 years 
  Median Survival 5.10 years 0.70 at 4 years 
    
 8.75 mm or more: 0.88 at 1 year 
  Mean Survival 4.06 years 0.84 at 2 years 
  (SE= 0.18, 95% CI: 3.70, 4.42) 0.77 at 3 years 
  Median Survival 4.67 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.4.2 DS(A)EK survival: influence of use of glide or forceps 
 
Figure 3.4.2 shows a comparison of graft survival depending on whether a glide, 
forceps or neither were used to perform the graft, as reported by surgeons. There were 
18 grafts followed for which both were reportedly used and these were excluded from 
the analysis. No significant difference was found across groups (Log Rank 
Statistic=685; df=2; p=0.710).  
Figure 3.4.2 Use of glide or forceps 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Neither glide nor forceps 1300 766 433 211 68 20 
Glide only 412 159 21 4 n/a n/a 
Forceps only 71 28 4 n/a n/a n/a 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Use of Glide or Forceps 
 
 Probability of Graft Survival 
 Neither glide nor forceps: 0.84 at 1 year 
  Mean Survival 4.08 years 0.78 at 2 years 
  (SE= 0.11, 95% CI: 3.86, 4.30) 0.70 at 3 year 
  Median Survival 4.68 years 0.62 at 4 years 
   0.46 at 5 years 
    
 Glide only: 0.85 at 1 year 
  Mean Survival 2.67 years 0.69 at 2 years 
  (SE= 0.17, 95% CI: 2.35, 3.00)   
  Median Survival n/a   
    
 Forceps only: 0.85 at 1 year 
  Mean Survival 2.05 years   
  (SE= 0.13, 95% CI: 1.79, 2.31)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.4.3 DS(A)EK survival: influence of graft type 
 
Figure 3.4.3 shows a comparison of graft survival depending on the type of graft, as 
reported by surgeons. This information was not reported for 89 of the followed grafts 
and these were labelled “unspecified”. A significant difference was found across groups 
(Log Rank Statistic=6.64; df=1; p=0.010). This variable was not retained in the 
multivariate model, indicating that this is not an independent factor significantly affecting 
graft survival. 
Figure 3.4.3 Graft type 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
DSEK 1380 773 390 181 59 19 
DSAEK 332 139 39 15 4 1 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Graft Type 
 
 Probability of Graft Survival 
 DSEK: 0.85 at 1 year 
  Mean Survival 4.25 years 0.79 at 2 years 
  (SE= 0.12, 95% CI: 4.02, 4.48) 0.73 at 3 years 
  Median Survival 5.10 years 0.66 at 4 years 
    
 DSAEK: 0.84 at 1 year 
  Mean Survival 3.18 years 0.71 at 2 years 
  (SE= 0.25, 95% CI: 2.69, 3.68)   
  Median Survival 2.72 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
This variable is not retained in the multivariate analysis. Further statistical exploration 
indicates that this is due the inclusion of the variable relating to surgeon experience and 
follow-up - high volume surgeons with high follow-up were more likely to have 
performed DSEK rather than DSAEK.  
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3.4.4 DS(A)EK survival: influence of the centre effect  
 
Figure 3.4.4 shows the comparison of graft survival for individual surgeons (shown in 
random order) for which there was follow-up information provided for 25 or more 
DS(A)EKs, and all other grafts (performed by 52 surgeons) combined (Log Rank 
Statistic=162.03; df=16; p<0.001). This analysis indicates that there is a significant 
centre effect. This variable was not included in the multivariate analysis as it is collinear 
with the surgeon volume and follow-up variable shown in Figure 3.4.5. 
Figure 3.4.4 The centre effect 
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Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Fewer than 25 followed grafts 354 146 57 25 13 5 
Surgeon 1 116 66 38 18 4 2 
Surgeon 2 258 140 67 35 12 4 
Surgeon 3 63 38 14 8 1 n/a 
Surgeon 4 74 43 19 11 3 n/a 
Surgeon 5 37 19 6 3 1 n/a 
Surgeon 6 37 20 9 4 n/a n/a 
Surgeon 7 207 99 47 20 7 1 
Surgeon 8 27 12 10 2 n/a n/a 
Surgeon 9 97 52 21 7 1 n/a 
Surgeon 10 98 58 26 13 6 1 
Surgeon 11 27 14 2 n/a n/a n/a 
Surgeon 12 75 30 9 2 1 n/a 
Surgeon 13 33 19 9 2 n/a n/a 
Surgeon 14 78 42 20 10 6 2 
Surgeon 15 37 28 21 14 7 4 
Surgeon 16 183 132 84 41 6 1 
 
Note: to preserve anonymity, high volume surgeons are intentionally listed in no 
particular order.  
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
The Centre Effect 
 
 Probability of Graft Survival 
 Fewer than 25 followed grafts: 0.67 at 1 year 
  Mean Survival 2.90 years 0.54 at 2 years 
  (SE= 0.21, 95% CI: 2.49, 3.31) 0.48 at 3 years 
  Median Survival 2.49 years   
    
 Surgeon 1: 0.80 at 1 year 
  Mean Survival 3.50 years 0.67 at 2 years 
  (SE= 0.28, 95% CI: 2.94, 4.05)   
  Median Survival 4.76 years   
    
 Surgeon 2: 0.97 at 1 year 
  Mean Survival 5.17 years 0.94 at 2 years 
  (SE= 0.21, 95% CI: 4.76, 5.57) 0.92 at 3 years 
  Median Survival n/a   
    
 Surgeon 3: 0.89 at 1 year 
  Mean Survival 3.36 years   
  (SE= 0.23, 95% CI: 2.91, 3.82)   
  Median Survival n/a   
    
 Surgeon 4: 0.78 at 1 year 
  Mean Survival 3.20 years   
  (SE= 0.26, 95% CI: 2.69, 3.71)   
  Median Survival 4.60 years   
     
 Surgeon 5:   
  Mean Survival 3.07 years  n/a 
  (SE= 0.38, 95% CI: 2.32, 3.82)   
  Median Survival n/a   
     
 Surgeon 6: 0.91 at 1 year 
  Mean Survival 3.53 years   
  (SE= 0.18, 95% CI: 3.19, 3.88)   
  Median Survival n/a   
     
 Surgeon 7: 0.93 at 1 year 
  Mean Survival 3.65 years 0.83 at 2 years 
  (SE= 0.23, 95% CI: 3.19, 4.11) 0.66 at 3 years 
  Median Survival 3.76 years   
     
 Surgeon 8:   
  Mean Survival 1.85 years  n/a 
  (SE= 0.33, 95% CI: 1.20, 2.50)   
  Median Survival 2.02 years   
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 Surgeon 9: 0.89 at 1 year 
  Mean Survival 3.45 years 0.87 at 2 years 
  (SE= 0.18, 95% CI: 3.10, 3.80)   
  Median Survival n/a   
     
 Surgeon 10: 0.89 at 1 year 
  Mean Survival 4.34 years 0.87 at 2 years 
  (SE= 0.22, 95% CI: 3.92, 4.77)   
  Median Survival n/a   
     
 Surgeon 11:   
  Mean Survival 1.71 years  n/a 
  (SE= 0.16, 95% CI: 1.39, 2.04)   
  Median Survival 2.09 years   
     
 Surgeon 12: 0.79 at 1 year 
  Mean Survival 2.75 years   
  (SE= 0.35, 95% CI: 2.07, 3.43)   
  Median Survival 3.10 years   
     
 Surgeon 13:   
  Mean Survival 2.40 years  n/a 
  (SE= 0.21, 95% CI: 2.00, 2.81)   
  Median Survival 2.53 years   
     
 Surgeon 14: 0.86 at 1 year 
  Mean Survival 3.89 years 0.75 at 2 years 
  (SE= 0.34, 95% CI: 3.23, 4.55)   
  Median Survival n/a   
     
 Surgeon 15: 0.91 at 1 year 
  Mean Survival 4.61 years 0.88 at 2 years 
  (SE= 0.33, 95% CI: 3.97, 5.26)   
  Median Survival 5.31 years   
     
 Surgeon 16: 0.91 at 1 year 
  Mean Survival 4.44 years 0.85 at 2 years 
  (SE= 0.23, 95% CI: 3.99, 4.89) 0.79 at 3 years 
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
  
 Descemet’s Stripping Endothelial Keratoplasty 
200 Australian Corneal Graft Registry Report 2015 
3.4.5 DS(A)EK survival: influence of surgeon volume (25+ followed DS(A)EKs) 
grouped by level of follow-up  
 
Figure 3.4.5 shows the comparison of graft survival between grafts performed by 
surgeons with 25+ followed DS(A)EKs with average or better (≥67%) follow-up, to those 
with lower than average follow-up (<67%), and to low volume surgeons (Log Rank 
Statistic=105.83; df=2; p<0.001). This variable was retained in the multivariate analysis 
(see section 3.7) indicating that this is an independent factor significantly affecting graft 
survival. 
Figure 3.4.5 Surgeon volume and level of follow-up 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Fewer than 25 followed grafts 354 146 57 25 13 5 
25+ followed DS(A)EK, low follow-up 138 76 27 14 4 n/a 
25+ followed DS(A)EK, high follow-up 1309 736 375 176 51 15 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Surgeon Volume and Level of Follow-up  
 
 Probability of Graft Survival 
 Fewer than 25 followed grafts: 0.67 at 1 year 
  Mean Survival 2.90 years 0.54 at 2 years 
  (SE= 0.21, 95% CI: 2.49, 3.31) 0.48 at 3 years 
  Median Survival 2.49 years   
    
 25+ followed PK, low follow-up: 0.81 at 1 year 
  Mean Survival 3.21 years 0.73 at 2 years 
  (SE= 0.22, 95% CI: 2.79, 3.63)   
  Median Survival 4.60 years   
    
 25+ followed PK, high follow-up: 0.89 at 1 year 
  Mean Survival 4.29 years 0.83 at 2 years 
  (SE= 0.11, 95% CI: 4.08, 4.50) 0.76 at 3 years 
  Median Survival 5.31 years 0.67 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, experience of surgeon and percentage of follow-up was 
shown to have a significant effect (p<0.001) on graft survival. Grafts performed by 
surgeons with fewer than 25 followed DS(A)EK had significantly worse survival than 
those performed by high volume surgeons with average or better follow-up or high 
volume surgeons with low follow-up (p<0.001 in both cases). The difference between 
high volume surgeons with lower than average follow-up and high volume surgeons with 
average or better follow-up, was not significant (p=0.147).  
The final model also accounted for the effect of lens status pre- and post-graft, graft 
year, recipient age, and post-graft rejection episode(s). 
 
 
Further subgroup analyses were conducted on these data, individually examining 
the effect of this variable on grafts performed for pseudophakic bullous 
keratopathy and on those performed for Fuchs’ dystrophy. These analyses are 
shown on pages 202 to 205.  
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3.4.5.1 DS(A)EK graft survival: influence of surgeon volume (25+ followed 
DS(A)EK grafts) grouped by level of follow-up, first grafts for 
pseudophakic bullous keratopathy only 
 
Figure 3.4.6 shows the comparison of graft survival between grafts performed by 
surgeons with 25+ followed DS(A)EKs with average or better (≥67%) follow-up, to those 
with lower than average follow-up (<67%) and to low volume surgeons, for first grafts for 
pseudophakic bullous keratopathy (Log Rank Statistic=26.92; df=2; p<0.001).  
Figure 3.4.6 Surgeon volume and rate of follow-up, pseudophakic bullous 
keratopathy only 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Fewer than 25 followed grafts 109 45 16 4 1 n/a 
25+ followed DS(A)EK, low follow-up 25 12 6 2 n/a n/a 
25+ followed DS(A)EK, high follow-up 393 218 112 49 18 5 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Surgeon Volume and Follow-up Rate, for Pseudophakic Bullous 
Keratopathy Only 
 
 Probability of Graft Survival 
 Fewer than 25 followed grafts: 0.73 at 1 year 
  Mean Survival 2.45 years   
  (SE= 0.21, 95% CI: 2.03, 2.87)   
  Median Survival 4.03 years   
    
 25+ followed grafts, low follow-up: 0.90 at 1 year 
  Mean Survival 2.60 years 0.85 at 2 years 
  (SE= 0.33, 95% CI: 1.95, 3.26) 0.75 at 3 years 
  Median Survival n/a   
    
 25+ followed grafts, high follow-up:   
  Mean Survival 4.05 years  n/a 
  (SE= 0.16, 95% CI: 3.74, 4.36)   
  Median Survival 5.42 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
The significant difference shown for all data was also found when analysing data 
relating solely to first grafts for bullous keratopathy. Grafts performed by high volume 
surgeons with average or better follow-up had significantly better survival than those 
performed by surgeons with fewer than 25 followed DS(A)EKs (p<0.001). The 
difference between high volume surgeons with low follow-up was not significantly 
different to either high volume surgeons with higher than average follow-up (p=0.311) or 
low volume surgeons (p=0.197).  
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3.4.5.2 DS(A)EK survival: influence of surgeon volume (25+ followed DS(A)EK 
grafts) grouped by level of follow-up, first grafts for Fuchs’ dystrophy only 
 
Figure 3.4.7 shows the comparison of graft survival between grafts performed by 
surgeons with 25+ followed DS(A)EKs with average or better (≥67%) follow-up, to those 
with lower than average follow-up (<67%) and to low volume surgeons, for first grafts for 
Fuchs’ dystrophy (Log Rank Statistic=78.97; df=2; p<0.001).  
Figure 3.4.7 Surgeon volume and rate of follow-up, Fuchs' dystrophy only 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Less than 25 followed grafts 156 63 30 18 10 4 
25+ followed DS(A)EK, low follow-up 87 52 17 8 3 n/a 
25+ followed DS(A)EK, high follow-up 624 352 186 85 21 8 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Surgeon Volume and Follow-up Rate, for Fuchs’ Dystrophy Only 
 
 Probability of Graft Survival 
 Less than 25 followed grafts: 0.61 at 1 year 
  Mean Survival 2.81 years 0.52 at 2 years 
  (SE= 0.27, 95% CI: 2.28, 3.34)   
  Median Survival 2.43 years   
    
 25+ followed grafts, low follow-up: 0.88 at 1 year 
  Mean Survival 3.41 years   
  (SE= 0.27, 95% CI: 2.88, 3.94)   
  Median Survival 4.60 years   
    
 25+ followed grafts, high follow-up: 0.90 at 1 year 
  Mean Survival 4.59 years 0.87 at 2 years 
  (SE= 0.15, 95% CI: 4.29, 4.89) 0.82 at 3 years 
  Median Survival 5.31 years 0.77 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
The significant difference shown for all data was also found when analysing data 
relating solely to grafts that were for Fuchs’ dystrophy. As was seen in the overall 
analysis, grafts performed by surgeons with fewer than 25 followed DS(A)EK had 
significantly worse survival than those performed by high volume surgeons with average 
or better follow-up or high volume surgeons with low follow-up (p<0.001 in both cases). 
The difference between high volume surgeons with lower than average follow-up and 
high volume surgeons with higher than average follow-up was not significantly different 
(p=0.068).  
This indicates that, it is the volume of grafts performed by the surgeon (which could be 
seen to reflect experience) rather than the level of follow-up, that affects survival of 
DS(A)EKs performed for Fuchs’ dystrophy.  
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3.5 Operative Procedures at the Time of Graft 
 
Table 3.5 shows the number of grafts for which certain operative procedures were 
performed at the time of graft. The sum of these numbers for each variable equals the 
total number of grafts (2,701 registered and 1,801 followed) and the percentages, which 
should be summed vertically for each variable, total 100. 
Table 3.5 Operative procedures at graft 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Operative Procedures at Graft 
 
 Registered (%) Followed (%) 
   
Peripheral iridectomy at graft   
  No 2534 (94%) 1666 (93%) 
  Yes 167 (6%) 135 (8%) 
   
Total 2701 (100%) 1801 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly higher for grafts that had undergone peripheral 
iridectomy at time of graft (p<0.001). 
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3.5.1 DS(A)EK survival: influence of peripheral iridectomy at time of graft 
 
Figure 3.5.1 shows the comparison of survival for grafts where a peripheral iridectomy 
was performed at the time of graft, to those where one was not. No significant difference 
was found between groups (Log Rank Statistic=1.06; df=1; p=0.302).  
Figure 3.5.1 Peripheral iridectomy at time of graft 
 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No peripheral iridectomy 1666 861 395 176 59 17 
Peripheral iridectomy 135 97 64 39 9 3 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Peripheral Iridectomy 
 
 Probability of Graft Survival 
 No peripheral iridectomy: 0.84 at 1 year 
  Mean Survival 4.10 years 0.76 at 2 years 
  (SE= 0.11, 95% CI: 3.88, 4.32) 0.68 at 3 years 
  Median Survival 4.76 years 0.60 at 4 years 
    
 Peripheral iridectomy: 0.86 at 1 year 
  Mean Survival 3.97 years 0.82 at 2 years 
  (SE= 0.22, 95% CI: 3.55, 4.40) 0.78 at 3 years 
  Median Survival 4.67 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.6 Post-graft Events 
 
Table 3.6 shows the occurrence of post graft events, and Table 3.7 shows post-graft 
surgical procedures, as reported by follow-up practitioners. Please note: post-graft data 
may be incomplete when follow-up is based on a registration for a replacement graft. 
Table 3.6 Post-graft factors 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Post-graft Events 
 
 Followed (%) 
Post-graft rise in IOP  
  No 1590 (88%) 
  Yes 211 (12%) 
  
At least one rejection episode  
  No 1684 (94%) 
  Yes 117 (7%) 
  
Total 1801 (100%) 
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Table 3.7 Post-graft surgical procedures 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Post-graft Surgical Procedures 
 
Type of procedure Number 
Regrafted 322 
YAG laser 59 
Cataract removal/IOL insertion  (17 both, 2 cataract only, 1 IOL only) 20 
IOL exchange/removal/reposition/piggyback lens 10 
Re-bubble 11 
Trabeculectomy 9 
Graft revision/wound repair 8 
Vitrectomy 7 
Other* 33 
  
Total number of surgical procedures (number of grafts) 496 (451) 
  
 
* Other included: PRK laser (3), bevacizumab injection (2), corneal scrape/peel (2), 
macular hole repair (2), peripheral iridectomy (2), capsulotomy (1), cryotherapy (1), 
epithelial debridement (1), eyelid repair (1), filter surgery (1), keratectomy (1), molteno 
valve inserted (1), molteno valve repositioned (1), ptosis repair (1), ranibizumab 
injection (1), reformation of anterior chamber (1), removal of basal cell carcinoma (1), 
removal of conjunctival melanoma (1), removal of epithelial cyst (1), removal of folds in 
Descemet’s membrane (1), removal of iris prosthesis (1), removal of remnant lens 
material (1), removal of upper tarsal concretions (1), retinal laser surgery (1), 
unspecified laser for glaucoma (1), trabeculoplasty (1) vitreous tap (1).  
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3.6.1 DS(A)EK survival: influence of post-graft raised IOP  
 
Figure 3.6.1 shows the comparison of graft survival for grafts where the eye was 
reported to have had raised intraocular pressure post-graft to those where the IOP 
remained in the normal range. A significant difference was found between groups (Log 
Rank Statistic=12.83; df=1; p<0.001). This variable was not included in multivariate 
analysis as it is collinear with presence of graft rejection episodes, shown in Figure 
3.6.2. 
Figure 3.6.1 Post-graft raised intraocular pressure 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No raised IOP 1590 814 389 179 53 16 
Raised IOP 211 144 70 36 15 4 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Post-graft Raised IOP 
 
 Probability of Graft Survival 
 No raised IOP: 0.83 at 1 year 
  Mean Survival 3.90 years 0.75 at 2 years 
  (SE= 0.10, 95% CI: 3.70, 4.09) 0.68 at 3 years 
  Median Survival 4.90 years 0.53 at 4 years 
    
 Raised IOP: 0.95 at 1 year 
  Mean Survival 4.35 years 0.90 at 2 years 
  (SE= 0.25, 95% CI: 3.85, 4.85) 0.82 at 3 years 
  Median Survival 4.67 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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3.6.2 DS(A)EK survival: influence of graft rejection episodes 
 
Figure 3.6.2 shows the survival for grafts where the eye underwent at least one 
incidence of post-graft immunological rejection, compared to those that did not have any 
rejection episodes. A significant difference was found between groups (Log Rank 
Statistic=20.49; df=1; p<0.001). This variable was retained in the multivariate analysis 
(see section 3.7), indicating that this is an independent factor significantly affecting graft 
survival.  
Figure 3.6.2 Rejection episode(s) 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
No rejection episodes 1684 871 417 194 57 15 
At least one rejection episode 117 87 42 21 11 5 
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Descemet’s Stripping (Automated) Endothelial Corneal Graft Survival 
Rejection 
 
 Probability of Graft Survival 
 No rejection episodes: 0.85 at 1 year 
  Mean Survival 4.05 years 0.79 at 2 years 
  (SE= 0.10, 95% CI: 3.85, 4.25) 0.73 at 3 years 
  Median Survival 4.76 years 0.65 at 4 years 
    
 At least one rejection episode: 0.81 at 1 year 
  Mean Survival 3.08 years 0.58 at 2 years 
  (SE= 0.25, 95% CI: 2.58, 3.58) 0.43 at 3 years 
  Median Survival 2.42 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
 
In the multivariate analysis, presence of at least one post-graft rejection episode was 
shown to have a significant negative effect on graft survival (p<0.001). The final model 
also accounted for the effect of lens status pre- and post-graft, graft year, experience of 
surgeon and percentage of follow-up, and recipient age. 
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3.7 Multivariate Analysis 
 
3.7.1 Initial model 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered DS(A)EK, together with its 
archival follow-up records, was treated as a separate and independent entity. Some 
recipients had multiple DS(A)EK performed during the census period (1/1/2000 to 
30/6/2014), with some having repeat grafts in a single eye, some grafts in both eyes 
and some a combination of both. To control for potential inter-graft and/or inter-eye 
dependence in the multivariate analyses, the multivariate model was adjusted to allow 
for clustering by individual patient [see reference 6]. 
Variables to be included in the multivariate Cox Proportional Hazards regression model 
were identified based on the results of the univariate Kaplan-Meier analyses, with a cut-
off significance level of p<0.08 used to select variables for inclusion. Some variables 
that were found to be significant in the univariate analyses were omitted due to co-
linearity, or because of large amounts of missing data (>25%). 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in 
a stepwise manner, beginning with the least significant variable. The Kaplan-Meier 
plots, and additional appropriate STATA analyses, were used to assess whether each 
included variable met the assumption of proportional hazards. Where variables were 
found to be time-variant, they were treated as such in the multivariate model.  
Table 3.8 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained 
in the final model.  
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Table 3.8 Multivariate model 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Donor sex 
Donor age group 
Cause of donor death 
Multi-organ donor 
Time from death to enucleation 
Storage time in Optisol 
Storage time in organ culture 
Interstate transportation 
Pre-graft inflammation and/or steroid use 
Previous contralateral graft 
Peripheral iridectomy at time of graft 
Use of glide or forceps during surgery 
 
Significant in univariate analysis but excluded from multivariate model due 
to collinearity or missing data 
The centre effect (collinear) 
Eye bank (collinear) 
Endothelial cell density (missing data) 
Raised intraocular pressure post-graft (collinear) 
 
Significant in univariate analysis but not retained in multivariate model 
Storage medium 
Recipient State 
Recipient sex* 
Indication for graft 
Graft type 
Graft size 
Pre-graft neovascularisation 
History of raised intraocular pressure 
 
Significant in univariate analysis and retained in multivariate model 
Recipient age group* 
Change in lens status pre- to post-graft 
Graft year 
Surgeon experience and level of follow-up 
Post-graft rejection episode(s) 
 
*p<0.08  
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Table 3.9 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The first level of each categorical variable was taken as the 
referent. The hazard ratios for a given variable are adjusted for all other variables in the 
model. This model included data from the 1,799 Descemet’s stripping (automated) 
endothelial keratoplasties, performed in 1,504 recipients, for which there were valid 
responses (no unknown data) for each of the included variables. 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (chi²=238.45, p<0.0001). 
Table 3.9 Clustered multivariate model 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Clustered Multivariate Model 
 
 n 
Hazard 
Ratio 
Standard 
error 
p-
value 
Global 
p-
value 
95% 
confidence 
interval 
Change in lens status pre- to post-graft   
Phakic/pseudophakic 411 1.00   <0.001  
Not phakic/pseudophakic 1301 1.75 0.27 <0.001  1.29 – 2.37 
Phakic/phakic 66 2.71 0.71 <0.001  1.62 – 4.53 
Any/aphakic 21 2.72 1.07 0.012  1.25 – 5.90 
 
Graft year (tvc) 
2006/2007 92 1.00   <0.001  
2008/2009 520 0.31 0.06 <0.001  0.21 – 0.44 
2010/2011 664 0.36 0.08 <0.001  0.24 – 0.55 
2012/2013 523 0.30 0.07 <0.001  0.19 – 0.47 
       
Recipient age group 
0 to 39 years 27 1.00   0.009  
40 to 49 years 55 0.42 0.18 0.039  0.18 – 0.96 
50 to 59 years 177 0.82 0.28 0.552  0.42 – 1.59 
60 to 69 years 448 0.51 0.17 0.038  0.27 – 0.96 
70 to 79 years 560 0.57 0.18 0.082  0.30 – 1.07 
80 to 89 years 474 0.46 0.15 0.019  0.24 – 0.88 
90 to 99 years 58 0.37 0.18 0.043  0.14 – 0.97 
 
Experience of surgeon and percentage of follow-up (tvc) 
Fewer than 25 followed DS(A)EK 353 1.00   <0.001  
25+ followed DS(A)EK, <67% follow-up 138 0.41 0.10 <0.001  0.25 – 0.68 
25+ followed DS(A)EK, ≥67% follow-up 1308 0.30 0.04 <0.001  0.24 – 0.38 
 
Post-graft rejection episode(s) 
No 1682 1.00     
Yes 117 1.91 0.27 <0.001  1.44 – 2.54 
 
tvc = time variant coefficient 
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3.7.2 Alternative model: Impact of the inclusion of donor endothelial cell density 
on multivariate results 
 
Endothelial cell density was not included in the multivariate analysis due to a high 
proportion of missing data (42% of grafts) for this variable. In order to examine the 
potential impact of endothelial cell density on the multivariate analysis, two alternative 
models were created, by including data relating to this variable in the determination 
process.  
In the first alternative model endothelial cell density data were included in the model 
from the beginning and the usual stepwise backwards elimination process was then 
used. The second alternative model involved the variable relating to donor endothelial 
cell density being added to the original model shown in Table 3.9. The stepwise removal 
of variables that were not contributing significantly to the model (p≥0.05) then continued. 
Both approaches resulted in the same final model.  
The resulting model is shown in Table 3.10. This model retained the endothelial cell 
density variable, while removing the variables relating to change in lens status and 
recipient age. This model included data from 1,038 grafts, performed in 874 patients 
and was highly significant: (chi²=125.88, p<0.0001). The rows highlighted in blue were 
not significantly different to the referent group. 
Table 3.10 Alternative clustered multivariate model 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Alternative Clustered Multivariate Model 
 
 n 
Hazard 
Ratio 
Standard 
error 
p-
value 
Global 
p-
value 
95% 
confidence 
interval 
Endothelial cell density 
< 2500 cells/mm² 75 1.00   0.021  
2500 – 2999 cells/mm² 421 0.58 0.11 0.005  0.40 – 0.85 
3000 – 3499 cells/mm² 455 0.56 0.11 0.003  0.38 – 0.82 
3500 + cells/mm² 87 0.64 0.18 0.122  0.37 – 1.13 
 
Graft year (tvc) 
2006/2007 65 1.00   <0.001  
2008/2009 243 0.29 0.06 <0.001  0.19 – 0.45 
2010/2011 365 0.27 0.07 <0.001  0.17 – 0.44 
2012/2013 365 0.25 0.06 <0.001  0.16 – 0.40 
 
Experience of surgeon and percentage of follow-up (tvc) 
Fewer than 25 followed DS(A)EK 302 1.00   <0.001  
25+ followed DS(A)EK, <67% follow-up 62 0.33 0.12 0.003  0.16 – 0.69 
25+ followed DS(A)EK, ≥67% follow-up 674 0.36 0.06 <0.001  0.26 – 0.49 
 
Post-graft rejection episode(s) 
No 975 1.00     
Yes 63 1.55 0.31 0.028  1.05 – 2.30 
 
tvc = time variant coefficient 
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3.8 Reasons for Graft Failure 
 
Of the 1,801 followed grafts, 383 (21%) were known to have failed by the census date. 
This equates to 14% of the 2,701 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration 
forms, where the reason for failure of the previous graft was given. Table 3.11 shows 
the reasons for failure given.  
Table 3.11 Reasons for graft failure 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Reasons for Graft Failure 
 
  Primary graft failure 143 
  Endothelial cell failure 90 
  Rejection 51 
  Scarring  10 
  Infection: non-herpetic (7), HSV (1) 8 
  Glaucoma 6 
  Other specified* 8 
  Unspecified 67 
  
  Total 383 
  
 
* Other included: ICE syndrome (3), corneal perforation (2), astigmatism (1), choroidal 
haemorrhage (1), synechia (1). 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For lamellar procedures, primary graft failure is recorded as reported 
by surgeons. Additional information is collected to ascertain whether this occurred within 
28 days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Of the 143 grafts reported by surgeons to have been primary graft failures, the majority 
(123) had no further information provided. Specific reasons given were: endothelial 
failure (6), surgical trauma (5), folds in Descemet’s membrane (3), oedema (2), 
detachment (1), endothelial defect (1), epithelial defect (1), and presence of Fuchs’ 
dystrophy in the donor tissue (1). 
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3.9 Post-graft Changes in Visual Acuity 
 
3.9.1 All indications for graft 
 
Post-graft visual acuity is an important outcome for corneal graft recipients. A desire for 
improved visual acuity was specified as a reason for graft in 2,510 (93%) of registered 
DS(A)EKs. In 74% of cases (2,001), this was the sole desired outcome indicated. It is 
likely that this was also at least part of the reason for graft in some of the further 125 
(5%) grafts where no reason was specified. We analysed post-graft visual acuity in two 
ways, firstly in terms of the Snellen acuity post-graft and secondly, in terms of the 
change in Snellen acuity from pre-to post-graft. 
 
Table 3.12 shows the reported post-graft visual acuity for all grafts, and also specifically 
for the 1,692 followed DS(A)EKs which listed vision as one of the reasons for graft.  
Table 3.12 Post-graft visual acuity 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Post Graft Visual Acuity 
(as reported at last follow up) 
 
 All grafts Surviving Failed To improve VA 
6/12 or better 557 (31%) 541 (38%) 16 (4%) 532 (31%) 
6/15 - 6/36 469 (26%) 407 (29%) 62 (16%) 450 (27%) 
6/60 or worse 427 (24%) 165 (12%) 262 (68%) 394 (23%) 
Unknown 348 (19%) 305 (22%) 43 (11%) 316 (19%) 
Total 1801 (100%) 1418 (100%) 383 (100%) 1692 (100%) 
     
VA = Visual acuity 
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Figure 3.9.1 shows the best corrected visual acuity in the grafted eye at the time of the 
most recent follow-up. Post-graft visual acuity was provided for 1,453 followed 
DS(A)EKs (81%). Of these, 557 (38%) had vision of 6/12 or better at their most recent 
follow-up, while 427 (29%) reported vision of 6/60 or worse.  
 
Figure 3.9.1 Best corrected visual acuity at time of last follow-up 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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Visual acuity data were available both pre- and post-graft for 1,420 (79%) followed 
DS(A)EKs. Of these, 325 (23%) had failed, while 1,095 (77%) were still surviving. 
Figure 3.9.2 shows the number of lines of improvement or deterioration in visual acuity 
since graft, as measured in terms of Snellen acuity at the latest follow-up. 
Figure 3.9.2 Number of lines of change on a Snellen chart pre- to post-graft 
 
Table 3.13 summarises the change in visual acuity form pre- to post-graft, stratified by 
whether the graft was surviving at last follow-up. 
Table 3.13 Number of lines of change on a Snellen chart pre- to post-graft 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Change in Visual Acuity from Pre-graft 
(as reported at last follow up) 
 
 Surviving Failed Total 
 n % n % n % 
VA worse by > 4 lines 7 <1% 25 7% 32 2% 
VA worse by 2 to 4 lines 48 3% 89 23% 137 8% 
VA worse by 1 line 56 4% 52 14% 108 6% 
VA unchanged 140 10% 87 23% 227 13% 
VA better by 1 line 123 9% 34 9% 157 9% 
VA better by 2 to 4 lines 480 34% 31 8% 511 28% 
VA better by 5 to 7  lines 213 15% 7 2% 220 12% 
VA better by > 7  lines 28 2% 0 0% 28 2% 
Unknown 323 23% 58 15% 381 21% 
Total 1418 100% 383 100% 1801 100% 
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The data on pages 226 and 227 show the post-graft visual acuity obtained, and 
the change in visual acuity, for grafts performed for specific indications. Data are 
reported for each of: Fuchs’ dystrophy, and bullous keratopathy.  
 Descemet’s Stripping Endothelial Keratoplasty 
226 Australian Corneal Graft Registry Report 2015 
3.9.2 Fuchs’ dystrophy 
 
Figure 3.9.3 Best corrected visual acuity at time of last follow-up 
 
Figure 3.9.4 Number of lines of change on a Snellen chart pre- to post-graft 
 
Post-graft vision of 6/12 or better was reported in 41% of followed DS(A)EKs performed 
for Fuchs’ dystrophy. Visual acuity was reported both pre- and post-graft for 81% of 
grafts for Fuchs’ dystrophy and at least one line of improvement on the Snellen chart 
was achieved after graft in 65% of these. 
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3.9.3 Bullous keratopathy 
 
Figure 3.9.5 Best corrected visual acuity at time of last follow-up 
 
Figure 3.9.6 Number of lines of change on a Snellen chart pre- to post-graft 
 
Post-graft vision of 6/12 or better was reported in 20% of followed DS(A)EKs performed 
for bullous keratopathy. Visual acuity was reported both pre- and post-graft for 75% of 
grafts for bullous keratopathy and at least one line of improvement on the Snellen chart 
was achieved after graft in 66% of these. 
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4 Deep Anterior Lamellar Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 574 
deep anterior lamellar keratoplasties for which follow-up information was available. 
Kaplan-Meier survival analyses were conducted using IBM SPSS for Windows (Version 
21.0), to compare the graft survival across groups for a range of variables relating to the 
corneal donor, graft recipient, surgical procedure, surgeon, and follow-up care. 
 
4.1 Donor and Eye Banking Factors 
 
Table 4.1 shows the number of grafts within each of the variable sub-groups, for the 
donor factors examined in this report. The sum of these numbers for each variable 
equals the total number of grafts (1,039 registered and 574 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 4.1 Donor and eye banking factors 
 
Deep Anterior Lamellar Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank D 497 (48%) 218 (38%) 
  Eye bank E 184 (18%) 118 (21%) 
  Eye bank F 255 (25%) 184 (32%) 
  Eye bank G 34 (3%) 13 (2%) 
  Eye bank H 68 (7%) 40 (7%) 
  Not advised1 1 (<1%) 1 (<1%) 
   
Storage medium   
  Optisol 668 (64%) 412 (72%) 
  Organ culture 371 (36%) 162 (28%) 
   
Death-to-enucleation time   
  ≤ 3 hours 114 (11%) 76 (13%) 
  4 to 6 hours 189 (18%) 92 (16%) 
  7 to 9 hours 184 (18%) 99 (17%) 
  10 to 12 hours 220 (21%) 138 (24%) 
  ≥ 13 hours 327 (32%) 168 (29%) 
  Not advised 5 (<1%) 1 (<1%) 
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Interstate transportation   
  No 1002 (96%) 551 (96%) 
  Yes 36 (4%) 22 (4%) 
  Not advised1 1 (<1%) 1 (<1%) 
   
Sex of donor   
  Female 451 (43%) 240 (42%) 
  Male 588 (57%) 334 (58%) 
   
Age group   
  <10 years 3 (<1%) 1 (<1%) 
  10 to 19 years 26 (3%) 13 (2%) 
  20 to 29 years 33 (3%) 19 (3%) 
  30 to 39 years 53 (5%) 25 (4%) 
  40 to 49 years 91 (9%) 44 (8%) 
  50 to 59 years 192 (19%) 101 (18%) 
  60 to 69 years 308 (30%) 158 (28%) 
  70 to 79 years 236 (23%) 144 (25%) 
  80 to 89 years 97 (9%) 69 (12%) 
   
Cause of death   
  Cardiac event 255 (25%) 153 (27%) 
  Malignancy 364 (35%) 188 (33%) 
  Trauma 79 (8%) 42 (7%) 
  Respiratory event 80 (8%) 47 (8%) 
  Intracranial/cerebral haemorrhage 192 (19%) 110 (19%) 
  Other specified 51 (5%) 25 (4%) 
  Not advised2 18 (2%) 9 (2%) 
   
Multi-organ donor status   
  No 911 (88%) 497 (87%) 
  Yes 128 (12%) 77 (13%) 
   
Total 1039 (100%) 574 (100%) 
 
1 
One autograft with no eye bank given 
2 
ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly lower (p<0.05) for grafts performed using donor 
tissue from older donors, and for donor tissue stored in organ culture. Significant 
differences in follow-up were also found across groups for eye bank and death-to-
enucleation times.  
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4.1.1 Deep anterior lamellar graft survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks 
around Australia. Figure 4.1.1 shows the comparison of graft survival for corneas 
provided by each of these eye banks. For one eye bank, only 13 grafts using tissue 
processed by that eye bank had follow-up data available and so these data were 
excluded from the analysis.  
No significant difference was found across eye banks (Log Rank Statistic=6.97; df=3; 
p=0.073). While this difference was not significant at the p<0.05 level, it met the p<0.08 
criterion to be included in the multivariate analysis (see section 4.6). However, this 
variable was found to be co-linear with the centre effect variable (see section 4.4.2) and 
was excluded from the multivariate analysis on this basis. 
Figure 4.1.1 Australian eye bank 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Eye bank D 218 19 1 n/a n/a 
Eye bank E 118 28 5 3 2 
Eye bank F 184 36 1 n/a n/a 
Eye bank H 40 11 4 3 n/a 
 
 
 Deep Anterior Lamellar Keratoplasty 
231 Australian Corneal Graft Registry Report 2015 
 
 
 
 
 
 
 
 
 
Deep Anterior Lamellar Graft Survival 
Eye Bank 
 
 Probability of Graft Survival 
 Eye bank D: 0.93 at 1 year 
  Mean Survival 7.08 years   
  (SE= 0.66, 95% CI: 5.79, 8.36)   
  Median Survival n/a   
    
 Eye bank E: 0.96 at 1 year 
  Mean Survival 10.83 years 0.96 at 3 years 
  (SE= 1.18, 95% CI: 8.51, 13.14)   
  Median Survival n/a   
    
 Eye bank F: 0.91 at 1 year 
  Mean Survival 5.30 years 0.85 at 3 years 
  (SE= 0.60, 95% CI: 4.00, 6.59)   
  Median Survival 4.73 years   
    
 Eye bank H: 0.95 at 1 year 
  Mean Survival 7.88 years   
  (SE= 0.95, 95% CI: 6.01, 9.74)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.2 Deep anterior lamellar graft survival: influence of interstate transportation 
 
For the majority of transplants, donor corneas are sourced in the same State as the 
surgery occurs, however, in some cases corneas are transported interstate for 
transplantation, most often via air freight. Figure 4.1.2 shows the comparison of graft 
survival for grafts where the surgery was performed in the same State as the donor 
cornea was sourced, compared to those where the donor cornea was from interstate. 
No significant difference was found between groups (Log Rank Statistic=0.07; df=1; 
p=0.789).  
Figure 4.1.2 Interstate transportation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Different State 22 2 1 1 1 
Same State 551 99 13 7 1 
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Deep Anterior Lamellar Graft Survival 
Interstate Transportation 
 
 Probability of Graft Survival 
 Different State: 0.94 at 1 year 
  Mean Survival 7.01 years   
  (SE= 2.98, 95% CI: 1.17, 12.85)   
  Median Survival 3.27 years   
    
 Same State: 0.93 at 1 year 
  Mean Survival 8.60 years 0.85 at 3 years 
  (SE= 0.58, 95% CI: 7.46, 9.74)   
  Median Survival 9.07 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.3 Deep anterior lamellar graft survival: influence of death to enucleation time 
 
Donor corneas are retrieved as soon as possible following donor death. Retrieval is 
recommended within the first 18 hours and 90% of donor eyes were enucleated within 
this time-frame. Times are rounded to the nearest hour and the median time from donor 
death to enucleation was 10 hours (range 0-31 hours). Data were not available for one 
graft.  
Figure 4.1.3 shows a comparison of graft survival depending on time from donor death 
to enucleation, stratified into three-hourly groups. No significant difference was found 
across time groups (Log Rank Statistic=7.05; df=4; p=0.133).  
Figure 4.1.3 Time from donor death to enucleation 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
3 hours or less 76 13 2 2 1 
4 to 6 hours 92 16 5 3 n/a 
7 to 9 hours 99 24 4 2 1 
10 to 12 hours 138 24 2 1 n/a 
13 hours or more 168 22 1 n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Death to Enucleation Time 
 
 Probability of Graft Survival 
 3 hours or less: 0.95 at 1 year 
  Mean Survival 9.13 years   
  (SE= 1.48, 95% CI: 6.23, 12.03)   
  Median Survival n/a   
    
 4 to 6 hours: 0.95 at 1 year 
  Mean Survival 8.27 years  at 3 years 
  (SE= 0.53, 95% CI: 7.24, 9.31)   
  Median Survival 9.07 years   
    
 7 to 9 hours: 0.97 at 1 year 
  Mean Survival 7.89 years 0.88 at 3 years 
  (SE= 1.12, 95% CI: 5.70, 10.08)   
  Median Survival 7.63 years   
    
 10 to 12 hours: 0.86 at 1 year 
  Mean Survival 7.00 years 0.81 at 3 years 
  (SE= 0.80, 95% CI: 5.43, 8.56)   
  Median Survival n/a   
    
 13 hours or more: 0.95 at 1 year 
  Mean Survival 6.71 years 0.92 at 3 years 
  (SE= 0.54, 95% CI: 5.65, 7.76)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.4 Deep anterior lamellar graft survival: influence of corneal storage media 
 
In Australia, two storage media are commonly used to preserve donor corneas prior to 
transplantation. Figure 4.1.4 shows the comparison of graft survival for corneas stored 
in Optisol medium compared to organ culture medium. No significant difference was 
found between media (Log Rank Statistic=0.00; df=1; p=0.985). 
Figure 4.1.4 Corneal storage media 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Optisol 412 82 14 8 2 
Organ culture 162 17 n/a n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Corneal Storage Media 
 
 Probability of Graft Survival 
 Optisol: 0.94 at 1 year 
  Mean Survival 9.06 years 0.86 at 3 years 
  (SE= 0.69, 95% CI: 7.69, 10.42)   
  Median Survival 9.07 years   
    
 Organ culture: 0.91 at 1 year 
  Mean Survival 5.12 years   
  (SE= 0.22, 95% CI: 4.69, 5.55)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.5 Deep anterior lamellar graft survival: influence of storage time to graft – 
Optisol medium 
 
Corneas stored in Optisol medium are most often used within 5 days of storage and are 
rarely stored for longer than 7 days. Figure 4.1.5 shows the comparison of graft survival 
across storage time for just those corneas stored in Optisol medium. Data were not 
provided for 76 grafts and these were excluded from the analysis. No significant 
difference was found across groups (Log Rank Statistic=1.46; df=2; p=0.482).  
Figure 4.1.5 Time from storage to graft, Optisol storage medium 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
5 days or less 214 34 5 4 n/a 
6 or 7 days 69 13 2 1 1 
More than 7 days 53 16 2 n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Storage Time to Graft: Optisol 
 
 Probability of Graft Survival 
 5 days or less: 0.94 at 1 year 
  Mean Survival 6.89 years 0.82 at 3 years 
  (SE= 0.70, 95% CI: 5.51, 8.27)   
  Median Survival 8.34 years   
    
 6 or 7 days: 0.88 at 1 year 
  Mean Survival 8.43 years   
  (SE= 1.73, 95% CI: 5.04, 11.82)   
  Median Survival 7.63 years   
    
 More than 7 days: 0.94 at 1 year 
  Mean Survival 7.08 years   
  (SE= 0.40, 95% CI: 6.30, 7.86)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.6 Deep anterior lamellar graft survival: influence of storage time to graft – 
organ culture medium 
 
Organ culture storage can allow preservation times of up to four weeks. Figure 4.1.6 
shows the comparison of graft survival across storage time for those corneas stored in 
organ culture medium. Data were not provided for 74 grafts and there were only 13 
grafts stored for > 3 weeks. These two groups were excluded from the analysis. No 
significant difference was found across groups (Log Rank Statistic=0.04; df=1; 
p=0.845).  
Figure 4.1.6 Time from storage to graft, organ culture medium storage 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 2 weeks 34 2 n/a n/a n/a 
2 to 3 weeks 41 3 n/a n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Storage Time to Graft: Organ Culture 
 
 Probability of Graft Survival 
 Less than 2 weeks: 0.94 at 1 year 
  Mean Survival 3.23 years   
  (SE= 0.13, 95% CI: 2.97, 3.49)   
  Median Survival n/a   
    
 2 to 3 weeks: 0.95 at 1 year 
  Mean Survival 4.40 years   
  (SE= 0.15, 95% CI: 4.10, 4.69)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.7 Deep anterior lamellar graft survival: influence of donor sex 
 
Historically, a higher proportion of corneal donors are male and this was also the case 
in the current cohort. Figure 4.1.7 shows the comparison of graft survival depending on 
donor sex. No significant difference was found between groups (Log Rank 
Statistic=0.01; df=1; p=0.940).  
Figure 4.1.7 Donor sex 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female 240 35 6 3 1 
Male 334 64 8 5 1 
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Deep Anterior Lamellar Graft Survival 
Donor Sex 
 
 Probability of Graft Survival 
 Female: 0.94 at 1 year 
  Mean Survival 8.68 years 0.85 at 3 years 
  (SE= 1.03, 95% CI: 6.65, 10.70)   
  Median Survival 8.34 years   
    
 Male: 0.93 at 1 year 
  Mean Survival 8.98 years 0.87 at 3 years 
  (SE= 0.7, 95% CI: 7.62, 10.34)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.8 Deep anterior lamellar graft survival: influence of donor age (years) 
 
Figure 4.1.8 shows the comparison of graft survival depending on donor age, stratified 
by 10 year age groups. Donors aged under 30 years are rare, so data for this group 
were combined for analysis, due to the low numbers (total n=33). No significant 
difference was found across groups (Log Rank Statistic=5.11; df=6; p=0.530).  
Figure 4.1.8 Donor age 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
0 to 29 years 33 4 n/a n/a n/a 
30 to 39 years 25 3 1 1 n/a 
40 to 49 years 44 7 1 1 n/a 
50 to 59 years 101 19 2 n/a n/a 
60 to 69 years 158 25 5 4 1 
70 to 79 years 144 24 2 1 n/a 
80 to 89 years 69 17 3 1 1 
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Deep Anterior Lamellar Graft Survival 
Donor Age 
 
 Probability of Graft Survival 
 0 to 29 years: 0.96 at 1 year 
  Mean Survival 4.47 years   
  (SE= 0.14, 95% CI: 4.20, 4.75)   
  Median Survival n/a   
    
 30 to 39 years: 0.92 at 1 year 
  Mean Survival 9.79 years   
  (SE= 0.57, 95% CI: 8.68, 10.90)   
  Median Survival n/a   
    
 40 to 49 years: 0.87 at 1 year 
  Mean Survival 7.72 years   
  (SE= 0.62, 95% CI: 6.50, 8.93)   
  Median Survival n/a   
    
 50 to 59 years: 0.96 at 1 year 
  Mean Survival 5.46 years   
  (SE= 0.62, 95% CI: 4.24, 6.68)   
  Median Survival 4.73 years   
    
 60 to 69 years: 0.93 at 1 year 
  Mean Survival 10.24 years 0.89 at 3 years 
  (SE= 0.84, 95% CI: 8.60, 11.88)   
  Median Survival n/a   
    
 70 to 79 years: 0.95 at 1 year 
  Mean Survival 7.37 years 0.87 at 3 years 
  (SE= 0.54, 95% CI: 6.32, 8.42)   
  Median Survival 9.07 years   
    
 80 to 89 years: 0.90 at 1 year 
  Mean Survival 8.90 years   
  (SE= 1.48, 95% CI: 6.01, 11.80)   
  Median Survival 7.63 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.9 Deep anterior lamellar graft survival: influence of cause of donor death 
 
Figure 4.1.9 shows the comparison of graft survival depending on cause of donor death. 
Cause of death was unknown for 9 grafts and these were excluded from the analysis. A 
significant difference was found across groups (Log Rank Statistic=12.95; df=5; 
p=0.024). This variable was not retained in the multivariate analysis (see section 4.6) 
indicating that this is not an independent factor significantly affecting graft survival. 
Figure 4.1.9 Cause of donor death 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Cardiac event 153 37 5 3 2 
Malignancy 188 28 3 2 n/a 
Trauma 42 5 n/a n/a n/a 
Respiratory event 47 8 2 1 n/a 
Intracranial/cerebral haemorrhage 110 18 4 2 n/a 
Other 25 2 n/a n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Cause of Donor Death 
 
 Probability of Graft Survival 
 Cardiac event: 0.92 at 1 year 
  Mean Survival 10.50 years 0.89 at 3 years 
  (SE= 1.07, 95% CI: 8.40, 12.61)   
  Median Survival n/a   
    
 Malignancy: 0.92 at 1 year 
  Mean Survival 6.69 years 0.83 at 3 years 
  (SE= 0.61, 95% CI: 5.49, 7.89)   
  Median Survival n/a   
    
 Trauma: 1.00 at 1 year 
  Mean Survival 4.43 years   
  (SE= 0.18, 95% CI: 4.08, 4.78)   
  Median Survival n/a   
    
 Respiratory event:   
  Mean Survival 9.38 years  n/a 
  (SE= 0.59, 95% CI: 8.22, 10.54)   
  Median Survival n/a   
    
 Intracranial/cerebral haemorrhage: 0.97 at 1 year 
  Mean Survival 7.24 years   
  (SE= 0.71, 95% CI: 5.85, 8.63)   
  Median Survival 8.34 years   
    
 Other:   
  Mean Survival 3.43 years  n/a 
  (SE= 0.37, 95% CI: 2.71, 4.16)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.1.10 Deep anterior lamellar graft survival: influence of multi-organ donor status 
 
Figure 4.1.10 shows the comparison of graft survival depending on whether the donor 
cornea was obtained from a multi-organ donor. No significant difference was found 
between groups (Log Rank Statistic=0.33; df=1; p=0.565).  
Figure 4.1.10 Multi-organ donor status 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No 497 92 13 8 2 
Yes 77 7 1 n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Multi-organ Donor 
 
 Probability of Graft Survival 
 No: 0.93 at 1 year 
  Mean Survival 9.43 years 0.87 at 3 years 
  (SE= 0.67, 95% CI: 8.12, 10.73)   
  Median Survival n/a   
    
 Yes: 0.96 at 1 year 
  Mean Survival 7.34 years   
  (SE= 0.52, 95% CI: 6.31, 8.37)   
  Median Survival 8.34 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.2 Recipient Factors 
 
Table 4.2 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report. The sum of these numbers for each variable 
equals the total number of grafts (1,039 registered and 574 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 4.2 Recipient factors 
 
Deep Anterior Lamellar Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Keratoconus 801 (77%) 431 (75%) 
  Herpetic eye disease 43 (4%) 32 (6%) 
  Corneal degenerations 36 (4%) 22 (4%) 
  Other* 159 (15%) 89 (16%) 
   
Australian State where graft was performed   
  State J 505 (49%) 222 (39%) 
  State K 183 (18%) 117 (20%) 
  State L 238 (23%) 174 (30%) 
  State M 43 (4%) 18(3%) 
  State O 55 (5%) 32(6%) 
  State P 15 (1%) 11(2%) 
   
Recipient sex   
  Female 404 (39%) 230 (40%) 
  Male 635 (61%) 344 (60%) 
   
Recipient age group   
  <10 years 2 (<1%) 2 (<1%) 
  10 to 19 years 74 (7%) 38 (7%) 
  20 to 29 years 340 (33%) 185 (32%) 
  30 to 39 years 289 (28%) 151 (26%) 
  40 to 49 years 134 (13%) 75 (13%) 
  50 to 59 years 96 (9%) 56 (10%) 
  60 to 69 years 53 (5%) 35 (6%) 
  70 to 79 years 32 (3%) 20 (4%) 
  80 to 89 years 17 (2%) 11 (2%) 
  ≥ 90 years 2 (<1%) 1 (<1%) 
   
Pre-graft neovascularisation   
  No 937 (90%) 517 (90%) 
  Yes 102 (10%) 57 (10%) 
   
Pre-graft inflammation and/or steroid use   
  No 941 (91%) 515 (90%) 
  Yes 89 (9%) 55 (10%) 
  Not advised 9 (<1%) 4 (<1%) 
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Prior existing contralateral graft   
  No 896 (86%) 511 (89%) 
  Yes 143 (14%) 63 (11%) 
   
Total 1039 (100%) 574 (100%) 
   
 
* Other included: Failed previous graft (45), non-herpetic infection (28), corneal scars 
and opacities (26), corneal dystrophy (23), trauma (12), corneal ulcer/perforation (7), 
interstitial keratitis (6), congenital abnormality (4), descemetocoele (3), irregular 
astigmatism (1), limbal dermoid (1), metabolic deposits (1), unspecified keratitis (1), 
Wegner’s granulomatosis (1). All categories had < 20 grafts with follow-up. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Significant differences in follow-up (p<0.05) were found across groups for 
graft State. 
Five eyes undergoing deep anterior lamellar keratoplasty had a history of corneal cross-
linking.  
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4.2.1 Deep anterior lamellar graft survival: influence of Australian State where 
graft was performed 
 
Figure 4.2.1 shows the comparison of graft survival depending on the Australian State 
in which transplantation occurred. Data for grafts performed in State M and State P 
were excluded due to the low numbers of followed grafts performed (n=18 and n=11). 
No significant difference was found across groups (Log Rank Statistic=7.81; df=3; 
p=0.050). While this difference met the p<0.08 criterion to be included in the multivariate 
analysis (see section 4.6), it was not included as it is collinear with the significant centre 
effect variable shown in Figure 4.4.2.  
Figure 4.2.1 Australian State where graft was performed 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
State J 222 20 1 1 n/a 
State K 117 27 4 2 1 
State L 174 36 1 n/a n/a 
State O 32 10 4 3 n/a 
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Deep Anterior Lamellar Graft Survival 
Australian State Where Graft was Performed 
 
 Probability of Graft Survival 
 State J: 0.93 at 1 year 
  Mean Survival 6.71 years 0.78 at 3 years 
  (SE= 0.66, 95% CI: 5.40, 8.01)   
  Median Survival n/a   
    
 State K: 0.96 at 1 year 
  Mean Survival 9.62 years 0.96 at 3 years 
  (SE= 1.10, 95% CI: 7.47, 11.77)   
  Median Survival 9.07 years   
    
 State L:   
  Mean Survival 5.29 years 0.92 at 1 year 
  (SE= 0.66, 95% CI: 4.00, 6.59) 0.85 at 3 years 
  Median Survival 4.73 years   
    
 State O: 0.94 at 1 year 
  Mean Survival 8.74 years   
  (SE= 0.86, 95% CI: 7.06, 10.42)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.2.2 Deep anterior lamellar graft survival: influence of recipient sex 
 
Comparison of graft survival between male and female transplant recipients is shown in 
Figure 4.2.2. No significant difference was found between groups (Log Rank 
Statistic=0.10; df=1; p=0.749). 
Figure 4.2.2 Recipient sex 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female 230 46 9 5 1 
Male 344 53 5 3 1 
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Deep Anterior Lamellar Graft Survival 
Recipient Sex 
 
 Probability of Graft Survival 
 Female: 0.94 at 1 year 
  Mean Survival 8.49 years 0.87 at 3 years 
  (SE= 0.73, 95% CI: 7.05, 9.93)   
  Median Survival 9.07 years   
    
 Male: 0.93 at 1 year 
  Mean Survival 9.54 years 0.86 at 3 years 
  (SE= 1.01, 95% CI: 7.55, 11.52)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.2.3 Deep anterior lamellar graft survival: influence of donor/recipient sex 
match/mismatch 
 
Further analysis examined whether there was any effect of a cornea being transplanted 
into a recipient of a different sex to the donor. Comparison of graft survival across 
groups based on donor/recipient sex combinations is shown in Figure 4.2.3. No 
significant difference was found across groups (Log Rank Statistic=0.48; df=3; 
p=0.924). 
Figure 4.2.3 Donor/recipient sex match/mismatch 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female/female 90 15 2 1 n/a 
Female/male 150 20 4 2 1 
Male/female 140 31 7 4 1 
Male/male 194 33 1 1 n/a 
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Deep Anterior Lamellar Graft Survival 
Donor/Recipient Sex Match/Mismatch 
 
 Probability of Graft Survival 
 Female/female: 0.93 at 1 year 
  Mean Survival 6.99 years   
  (SE= 0.70, 95% CI: 5.62, 8.36)   
  Median Survival 8.34 years   
    
 Female/male: 0.94 at 1 year 
  Mean Survival 9.12 years 0.86 at 3 years 
  (SE= 1.27, 95% CI: 6.63, 11.62)   
  Median Survival n/a   
    
 Male/female: 0.94 at 1 year 
  Mean Survival 8.86 years 0.88 at 3 years 
  (SE= 0.85, 95% CI: 7.19, 10.53)   
  Median Survival n/a   
    
 Male/male: 0.92 at 1 year 
  Mean Survival 8.52 years 0.87 at 3 years 
  (SE= 0.38, 95% CI: 7.77, 9.27)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.2.4 Deep anterior lamellar graft survival: influence of recipient age (years) 
 
Figure 4.2.4 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for all recipients under 19 were analysed together due to the 
low number in the “0-9 years” group (n=2). Data for all recipients 70 years old or older 
were analysed together due to the low numbers in the  “80 to 89 years” and “90 to 99 
years” groups (n=11 and n=1, respectively). No significant difference was found across 
groups (Log Rank Statistic=9.66; df=6; p=0.140). 
Figure 4.2.4 Recipient age 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
0 to 19 years 40 5 n/a n/a n/a 
20 to 29 years 185 26 3 1 n/a 
30 to 39 years 151 27 5 4 1 
40 to 49 years 75 10 3 2 n/a 
50 to 59 years 56 13 2 1 1 
60 to 69 years 35 9 1 n/a n/a 
70 to 99 years 32 9 n/a n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Recipient Age 
 
 Probability of Graft Survival 
 0 to 19 years: 0.95 at 1 year 
  Mean Survival 3.51 years   
  (SE= 0.25, 95% CI: 3.02, 4.00)   
  Median Survival n/a   
    
 20 to 29 years: 0.95 at 1 year 
  Mean Survival 7.23 years 0.93 at 3 years 
  (SE= 0.61, 95% CI: 6.03, 8.43)   
  Median Survival 9.07 years   
    
 30 to 39 years: 0.92 at 1 year 
  Mean Survival 8.74 years 0.84 at 3 years 
  (SE= 0.95, 95% CI: 6.88, 10.61)   
  Median Survival n/a   
    
 40 to 49 years: 0.84 at 1 year 
  Mean Survival 9.02 years   
  (SE= 0.31, 95% CI: 8.40, 9.63)   
  Median Survival n/a   
    
 50 to 59 years: 0.96 at 1 year 
  Mean Survival 9.51 years   
  (SE= 1.55, 95% CI: 6.48, 12.54)   
  Median Survival n/a   
    
 60 to 69 years: 0.91 at 1 year 
  Mean Survival 5.66 years   
  (SE= 0.69, 95% CI: 4.31, 7.01)   
  Median Survival 7.63 years   
    
 70 to 79 years:   
  Mean Survival 3.76 years  n/a 
  (SE= 0.36, 95% CI: 3.04, 4.47)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
  
 Deep Anterior Lamellar Keratoplasty 
260 Australian Corneal Graft Registry Report 2015 
4.2.5 Deep anterior lamellar graft survival: influence of indication for graft 
 
Figure 4.2.5 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. A significant 
difference was found across groups (Log Rank Statistic=8.84; df=3; p=0.032). This 
variable was not retained in multivariate analysis (see section 4.6). 
Figure 4.2.5 Indication for graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Keratoconus 431 61 9 5 1 
Herpetic eye disease 32 13 n/a n/a n/a 
Corneal degeneration 22 8 n/a n/a n/a 
Other 89 17 5 3 1 
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Deep Anterior Lamellar Graft Survival 
Indication for Graft 
 
 Probability of Graft Survival 
 Keratoconus: 0.95 at 1 year 
  Mean Survival 9.55 years 0.89 at 3 years 
  (SE= 0.65, 95% CI: 8.28, 10.82)   
  Median Survival n/a   
    
 Herpetic eye disease: 0.91 at 1 year 
  Mean Survival 4.29 years   
  (SE= 0.36, 95% CI: 3.59, 4.99)   
  Median Survival n/a   
    
 Corneal degeneration:   
  Mean Survival 4.26 years  n/a 
  (SE= 0.30, 95% CI: 3.68, 4.84)   
  Median Survival n/a   
    
 Other: 0.87 at 1 year 
  Mean Survival 7.31 years   
  (SE= 1.06, 95% CI: 5.23, 9.39)   
  Median Survival 7.63 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
Other included: failed previous graft (19), non-herpetic infection (18), corneal scars and 
opacities (16), corneal dystrophy (14), trauma (8), corneal ulcer/perforation (6), 
interstitial keratitis (2), congenital abnormality (2), descemetocoele (2), limbal dermoid 
(1), metabolic deposits (1).  
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4.2.6 Deep anterior lamellar graft survival: influence of pre-graft 
neovascularisation 
 
Figure 4.2.6 shows the comparison of graft survival between those recipients with 
corneal neovascularisation pre-graft and those without (Log Rank Statistic=7.50; df=1; 
p=0.006). Recipients with pre-graft neovascularisation had poorer graft survival than 
those with avascular corneas. This variable was not retained in the multivariate analysis 
(see section 4.6), indicating that this is not an independent factor significantly affecting 
graft survival.  
Figure 4.2.6 Pre-graft corneal neovascularisation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No neovascularisation 517 85 14 8 2 
Neovascularisation 57 14 n/a n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Pre-graft Neovascularisation 
 
 Probability of Graft Survival 
 No neovascularisation: 0.94 at 1 year 
  Mean Survival 9.46 years 0.88 at 3 years 
  (SE= 0.70, 95% CI: 8.10, 10.83)   
  Median Survival n/a   
    
 Neovascularisation: 0.86 at 1 year 
  Mean Survival 3.95 years   
  (SE= 0.131, 95% CI: 3.33, 4.56)   
  Median Survival 4.60 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.2.7 Deep anterior lamellar graft survival: influence of inflammation and/or 
steroid use at time of graft 
 
Figure 4.2.7 shows the comparison of graft survival between grafts performed in an eye 
with current inflammation and/or steroid use within the past two weeks, compared to 
those with neither of these factors (Log Rank Statistic=11.08; df=1; p=0.001). This 
information was not known for 4 grafts and these were excluded from the analysis. This 
variable was retained in the multivariate analysis (see section 4.6), indicating that this is 
an independent factor significantly affecting graft survival.  
Figure 4.2.7 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No inflammation/steroid use 515 90 12 7 1 
Inflammation/steroid use 55 9 2 1 1 
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Deep Anterior Lamellar Graft Survival 
Inflammation and/or Steroid Use at Time of Graft 
 
 Probability of Graft Survival 
 No inflammation/steroid use: 0.95 at 1 year 
  Mean Survival 9.20 years 0.88 at 3 years 
  (SE= 0.73, 95% CI: 7.77, 10.62)   
  Median Survival 9.07 years   
    
 Inflammation/steroid use: 0.77 at 1 year 
  Mean Survival 8.29 years   
  (SE= 1.12, 95% CI: 6.10, 10.48)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, pre-graft inflammation and/or steroid use was shown to 
have a significant negative effect (p=0.002) on graft survival. The final model also 
accounted for the effect of graft year. 
  
 Deep Anterior Lamellar Keratoplasty 
266 Australian Corneal Graft Registry Report 2015 
4.2.8 Deep anterior lamellar graft survival: influence of previous contralateral 
graft 
 
Figure 4.2.8 shows the comparison of graft survival between grafts where the recipient 
had undergone a previous contralateral graft and those where he or she had not. No 
significant difference was found between groups (Log Rank Statistic=0.02; df=1; 
p=0.885).  
Figure 4.2.8 Previous contralateral graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No contralateral graft 511 87 12 6 2 
Previous contralateral graft 63 12 2 2 n/a 
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Deep Anterior Lamellar Graft Survival 
Previous Contralateral Graft 
 
 Probability of Graft Survival 
 No contralateral graft: 0.93 at 1 year 
  Mean Survival 9.26 years 0.87 at 3 years 
  (SE= 0.75, 95% CI: 7.75, 10.74)   
  Median Survival 9.07 years   
    
 Previous contralateral graft: 0.97 at 1 year 
  Mean Survival 6.46 years   
  (SE= 0.98, 95% CI: 4.53, 8.39)   
  Median Survival 4.73 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.3 Graft Era 
 
Table 4.3 shows the number of grafts registered and followed, in blocks of two years. 
The percentages, which should be summed vertically, total 100. 
Table 4.3 Graft Era 
 
Deep Anterior Lamellar Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  2000/2001 10 (<1%) 10 (2%) 
  2002/2003 15 (1%) 14 (2%) 
  2004/2005 28 (3%) 19 (3%) 
  2006/2007 108 (10%) 83 (15%) 
  2008/2009 235 (23%) 180 (31%) 
  2010/2011 297 (29%) 176 (31%) 
  2012/2013 337 (32%) 92 (16%) 
  2014 9 (<1%) 0 (0%) 
   
Total 1039 (100%) 574 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses and found to be significant (p<0.001). Follow-up was lower for grafts 
performed in more recent years. 
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4.3.1 Deep anterior lamellar graft survival: influence of year of graft 
 
Figure 4.3.1 shows the influence of year of graft, stratified into two-year groups (Log 
Rank Statistic=11.12; df=3; p=0.011). Grafts performed pre 2006 were excluded from 
the analysis due to low numbers in each of the two year stratifications (n=10, n=14 and 
n=19). There were no grafts performed in 2014 with follow-up. This variable was 
retained in the multivariate analysis (see section 4.6) indicating that this is an 
independent factor significantly affecting graft survival. 
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a 
replacement graft.  
Figure 4.3.1 Graft era 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
2006/2007 83 27 1 n/a n/a 
2008/2009 180 43 n/a n/a n/a 
2010/2011 176 6 n/a n/a n/a 
2012/2013 92 n/a n/a n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Era of Graft 
 
 Probability of Graft Survival 
 2006/2007: 0.95 at 1 year 
  Mean Survival 5.17 years 0.87 at 3 years 
  (SE= 0.36, 95% CI: 4.47, 5.87)   
  Median Survival n/a   
    
 2008/2009: 0.97 at 1 year 
  Mean Survival 4.47 years 0.91 at 3 years 
  (SE= 0.13, 95% CI: 4.21, 4.74)   
  Median Survival n/a   
    
 2010/2011: 0.93 at 1 year 
  Mean Survival 3.27 years   
  (SE= 0.09, 95% CI: 3.10, 3.44)   
  Median Survival n/a   
    
 2012/2013: 0.87 at 1 year 
  Mean Survival 1.87 years   
  (SE= 0.07, 95% CI: 1.73, 2.01)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
In the multivariate analysis, graft year was shown to have a significant independent 
effect (p=0.021) on graft survival. Grafts performed in 2012/2013 exhibited poorer graft 
survival than those performed in 2006/2007 (p=0.019), and 2008/2009 (p=0.002). The 
final model also accounted for the effect of the graft having pre-graft inflammation 
and/or steroid use. 
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4.4 Surgery and Surgeon Factors 
 
Table 4.4 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report. The sum of these numbers for 
each variable equals the total number of grafts (1,039 registered and 574 followed) and 
the percentages, which should be summed vertically for each variable, total 100. 
Table 4.4 Surgery and surgeon factors 
 
Deep Anterior Lamellar Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  Less than 8.0 mm 111 (11%) 57 (10%) 
  8.0 mm to <8.25 mm 195 (19%) 108 (19%) 
  8.25 mm to <8.5 mm 199 (19%) 136 (24%) 
  8.5 mm to <8.75 mm 118 (11%) 71 (12%) 
  8.75mm or more 325 (31%) 145 (25%) 
  Not advised 91 (9%) 57 (10%)  
   
Surgeon volume   
  Fewer than 25 followed grafts 401 (39%) 193 (34%) 
  25+ followed grafts 638 (61%) 354 (66%) 
   
Total 1039 (100%) 574 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly higher (p<0.001) for grafts performed by surgeons 
with 25+ followed grafts. 
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4.4.1 Deep anterior lamellar graft survival: influence of graft size 
 
Figure 4.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. This information was not 
reported for 57 of the followed grafts. No significant difference was found across groups 
(Log Rank Statistic=6.51; df=4; p=0.164).  
Figure 4.4.1 Graft size 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 8mm 57 14 4 2 1 
8 mm to < 8.25 mm 108 26 7 5 n/a 
8.25 mm to < 8.5 mm 136 29 1 n/a n/a 
8.5 mm to < 8.75 mm 71 9 1 1 1 
8.75 mm or more 145 15 1 n/a n/a 
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Deep Anterior Lamellar Graft Survival 
Graft Size 
 
 Probability of Graft Survival 
 Less than 8 mm: 0.89 at 1 year 
  Mean Survival 10.19 years   
  (SE= 0.90, 95% CI: 8.43, 11.94)   
  Median Survival n/a   
    
 8 mm to < 8.25 mm: 0.96 at 1 year 
  Mean Survival 8.01 years 0.87 at 3 years 
  (SE= 0.65, 95% CI: 6.74, 9.28)   
  Median Survival 9.07 years   
    
 8.25 mm to < 8.5 mm: 0.96 at 1 year 
  Mean Survival 6.74 years 0.90 at 3 years 
  (SE= 0.36, 95% CI: 6.03, 7.45)   
  Median Survival 7.63 years   
    
 8.5 mm to < 8.75 mm: 0.91 at 1 year 
  Mean Survival 8.92 years   
  (SE= 2.20, 95% CI: 4.60, 13.24)   
  Median Survival n/a   
    
 8.75 mm or more: 0.91 at 1 year 
  Mean Survival 5.36 years 0.83 at 3 years 
  (SE= 1.02, 95% CI: 3.37, 7.36)   
  Median Survival 4.73 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.4.2 Deep anterior lamellar graft survival: influence of the centre effect 
 
Figure 4.4.2 shows the comparison of graft survival for individual surgeons (shown in 
random order) who had followed 25 or more deep anterior lamellar keratoplasties since 
the year 2000, and all other grafts (performed by 33 surgeons) combined (Log Rank 
Statistic=17.35; df=7; p=0.015). This analysis indicates that there is a significant centre 
effect. This variable was not retained in the multivariate analysis (see section 4.6) 
indicating that this is not an independent factor significantly affecting graft survival. 
Figure 4.4.2 The centre effect 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 25 followed grafts 193 30 9 5 1 
Surgeon 1 74 21 n/a n/a n/a 
Surgeon 2 55 11 n/a n/a n/a 
Surgeon 3 28 1 n/a n/a n/a 
Surgeon 4 107 10 1 1 n/a 
Surgeon 5 38 3 n/a n/a n/a 
Surgeon 6 40 11 3 1 n/a 
Surgeon 7 39 12 1 1 1 
 
Note: to preserve anonymity, high volume surgeons are intentionally listed in no 
particular order. 
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Deep Anterior Lamellar Graft Survival 
The Centre Effect 
 
 Probability of Graft Survival 
 Less than 25 followed grafts: 0.93 at 1 year 
  Mean Survival 9.69 years 0.88 at 3 years 
  (SE= 0.94, 95% CI: 7.85, 11.53)   
  Median Survival n/a   
    
 Surgeon 1: 0.93 at 1 year 
  Mean Survival 4.37 years 0.86 at 3 years 
  (SE= 0.20, 95% CI: 3.98, 4.76)   
  Median Survival 4.73 years   
    
 Surgeon 2: 0.90 at 1 year 
  Mean Survival 3.92 years   
  (SE= 0.22, 95% CI: 3.49, 4.35)   
  Median Survival 4.43 years   
    
 Surgeon 3:   
  Mean Survival 3.18 years  n/a 
  (SE= 0.15, 95% CI: 2.88, 3.49)   
  Median Survival n/a   
    
 Surgeon 4: 0.91 at 1 year 
  Mean Survival 5.81 years   
  (SE= 0.89, 95% CI: 4.08, 7.55)   
  Median Survival 4.65 years   
    
 Surgeon 5: 0.95 at 1 year 
  Mean Survival 3.28 years   
  (SE= 0.22, 95% CI: 2.85, 3.70)   
  Median Survival n/a   
    
 Surgeon 6: 0.98 at 1 year 
  Mean Survival 8.84 years   
  (SE= 0.32, 95% CI: 8.22, 9.46)   
  Median Survival 9.07 years   
    
 Surgeon 7: 0.97 at 1 year 
  Mean Survival 12.01 years   
  (SE= 0.30, 95% CI: 11.42, 12.60)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.4.3 Deep anterior lamellar graft survival: influence of surgeon volume (25+ 
followed DALK grafts)  
 
Figure 4.4.3 shows the comparison of graft survival between grafts performed by 
surgeons with 25+ followed deep anterior lamellar keratoplasties since 2000 to those 
performed by low volume surgeons. No significant difference was found between 
groups (Log Rank Statistic=0.58; df=1; p=0.447).  
Figure 4.4.3 Surgeon volume 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 25 followed grafts 193 30 9 5 1 
25+ followed grafts 381 69 5 3 1 
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Deep Anterior Lamellar Graft Survival 
Surgeon Volume  
 
 Probability of Graft Survival 
 Less than 25 followed grafts: 0.93 at 1 year 
  Mean Survival 9.69 years 0.88 at 3 years 
  (SE= 0.94, 95% CI: 7.85, 11.53)   
  Median Survival n/a   
    
 25+ followed grafts, high follow-up: 0.93 at 1 year 
  Mean Survival 8.20 years 0.86 at 3 years 
  (SE= 0.82, 95% CI: 6.60, 9.80)   
  Median Survival 9.07 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.5 Post-graft Events 
 
Table 4.5 shows the occurrence of post graft events, and Table 4.6 shows post-graft 
surgical procedures, as reported by follow-up practitioners. Please note: post-graft data 
may be incomplete when follow-up is based on a registration of a replacement graft. 
Table 4.5 Post-graft Events 
 
Deep Anterior Lamellar Corneal Graft 
Post-graft Events 
 
 Followed (%) 
At least one rejection episode  
  No 547 (95%) 
  Yes 27 (5%) 
  
Time to removal of all sutures  
  Up to one year 50 (9%) 
  More than one year 43 (8%) 
  Not yet removed/not advised 481 (84%) 
  
Total 574 (100%) 
  
 
 
 
 
 
 
 
 
 
  
 Deep Anterior Lamellar Keratoplasty 
281 Australian Corneal Graft Registry Report 2015 
 
 
 
 
Table 4.6 Post-graft surgical procedures 
 
Deep Anterior Lamellar Corneal Graft 
Post Graft Surgical Procedures 
 
Type of procedure Number 
Regrafted 55 
Cataract removal/IOL insertion  (30 both, 2 cataract only, 1 IOL only) 33 
IOL exchange/reposition/piggyback lens 6 
Wound repair/resutured 29 
PRK laser 9 
Suture adjustment 7 
LASIK 6 
YAG laser 5 
Air bubble 5 
Keratectomy 4 
Keratotomy 4 
Relaxing incision 4 
Compression sutures 3 
Wedge resection 2 
Vitrectomy 3 
Tarsorrhaphy 2 
Other* 18 
  
Total number of surgical procedures (number of grafts) 225 (159) 
 
* Other included: bevacizumab injection (2), removal of folds/wrinkles in membrane (2), 
conjunctival autograft (1), corneal cross-linking (1), creation of flaps for glaucoma (1), 
ectropion repair (1), evisceration (1), graft rotation (1), intracameral air injection(1), 
paracentesis (1), peritomy (1), pterygium repair (1), ptosis surgery (1), removal of 
interface fluid (1), removal of superficial opacity (1), retrobulbar Chloropramazine (1).   
 Deep Anterior Lamellar Keratoplasty 
282 Australian Corneal Graft Registry Report 2015 
4.5.1 Deep anterior lamellar graft survival: influence of graft rejection episodes 
 
Figure 4.5.1 shows the survival for grafts where the eye underwent at least one 
incidence of post-graft immunological rejection, compared to those that did not have any 
rejection episodes. No significant difference was found between groups (Log Rank 
Statistic=0.33; df=1; p=0.568).  
Figure 4.5.1 Rejection episode(s) 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No rejection episodes 547 87 12 7 1 
At least one rejection episode 27 12 2 1 1 
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Deep Anterior Lamellar Graft Survival 
Rejection 
 
 Probability of Graft Survival 
 No rejection episode: 0.93 at 1 year 
  Mean Survival 9.67 years 0.87 at 3 years 
  (SE= 0.70, 95% CI: 8.31, 11.04)   
  Median Survival n/a   
    
 At least one rejection episode: 0.96 at 1 year 
  Mean Survival 7.30 years   
  (SE= 1.39, 95% CI: 4.58, 10.02)   
  Median Survival 8.34 years   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.5.2 Deep anterior lamellar graft survival: influence of time to final removal of 
sutures 
 
Figure 4.5.2 shows the comparison of graft survival depending on the time from graft to 
final suture removal. No significant difference was found between groups (Log Rank 
Statistic=0.33; df=1; p=0.556).This information was only available for 93 (16%) of 
followed grafts and therefore this variable was not included in the multivariate analyses. 
Figure 4.5.2 Time to final removal of sutures 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
1 year or less 50 20 7 5 2 
More than 1 year 43 21 6 2 n/a 
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Deep Anterior Lamellar Graft Survival 
Time to Final Removal of Sutures 
 
 Probability of Graft Survival 
 1 year or less: 0.98 at 1 year 
  Mean Survival 10.02 years 0.98 at 3 years 
  (SE= 1.14, 95% CI: 7.79, 12.26)   
  Median Survival n/a   
    
 More than 1 year: 1.00 at 1 year 
  Mean Survival 8.47 years 0.97 at 3 years 
  (SE= 0.55, 95% CI: 7.40, 9.55)   
  Median Survival n/a   
     
KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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4.6 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered deep anterior lamellar graft, 
together with its archival follow-up records, was treated as a separate and independent 
entity. Some recipients had multiple deep anterior lamellar grafts performed during the 
census period (1/1/2000 to 30/6/2014), with some having repeat grafts in a single eye, 
some grafts in both eyes and some a combination of both. To control for potential inter-
graft and/or inter-eye dependence in the multivariate analyses, the multivariate model 
was adjusted to allow for clustering by individual patient [see reference 6]. 
Variables to be included in the multivariate Cox Proportional Hazards regression model 
were identified based on the results of the univariate Kaplan-Meier analyses, with a cut-
off significance level of p<0.08 used to select variables for inclusion. Some variables 
which were found to be significant in the univariate analyses were omitted due to co-
linearity, or because of large amounts of missing data (>25%). 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in 
a stepwise manner, beginning with the least significant variable. The Kaplan-Meier 
plots, and additional appropriate STATA analyses, were used to assess whether each 
included variable met the assumption of proportional hazards. Where variables were 
found to be time-variant, they were treated as such in the multivariate model.  
Table 4.7 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained 
in the final model.  
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Table 4.7 Multivariate model 
 
Deep Anterior Lamellar Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Donor sex 
Donor age group 
Multi-organ donor 
Storage medium 
Time from death to enucleation 
Storage time in Optisol 
Storage time in organ culture 
Interstate transportation 
Recipient sex 
Recipient age group 
Previous contralateral graft 
Graft size 
Surgeon experience 
Raised intraocular pressure post-graft 
Post-graft rejection episode(s) 
Time to removal of sutures 
 
Significant in univariate analysis but excluded from the multivariate model 
due to collinearity or missing data 
Recipient State* (collinear) 
Eye Bank* (collinear) 
 
Significant in univariate analysis but not retained in the multivariate model 
    The centre effect 
Cause of donor death 
Indication for graft 
Pre-graft neovascularisation 
 
Significant in univariate analysis and retained in the multivariate model 
Graft year 
Pre-graft inflammation and/or steroid use 
 
*p<0.08  
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Table 4.8 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The first level of each categorical variable was taken as the 
referent. The hazard ratios for a given variable are adjusted for all other variables in the 
model. This model included data from the 527 deep anterior lamellar keratoplasties, 
performed in 509 recipients, for whom there were valid responses (no unknown data) 
for each of the included variables. 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (chi²=21.51, p=0.0003). The rows highlighted in blue were not significantly 
different to the referent group. 
Table 4.8 Clustered multivariate model 
 
Deep Anterior Lamellar Corneal Graft 
Clustered Multivariate Model 
 
 n 
Hazard 
Ratio 
Standard 
error 
p-
value 
Global 
p-value 
95% 
confidence 
interval 
Graft year  
2006/2007 83 1.00   0.021  
2008/2009 178 0.83 0.31 0.615  0.40 – 1.73 
2010/2011 174 1.54 0.62 0.285  0.70 – 3.39 
2012/2013 92 2.89 1.31 0.019  1.19 – 7.02 
 
Pre-graft inflammation and/or steroid use 
No 477 1.00  0.002   
Yes 50 2.97 1.05   1.49 – 5.93 
 
tvc= time varying coefficient 
  
 Deep Anterior Lamellar Keratoplasty 
289 Australian Corneal Graft Registry Report 2015 
4.7 Reasons for Graft Failure 
 
Of the 574 followed grafts, 66 (11%) were known to have failed by the census date. This 
equates to 6% of the 1,039 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration 
forms, where the reason for failure of the previous graft was provided. Table 4.9 shows 
the reasons for failure specified.  
Table 4.9 Reasons for graft failure 
 
Deep Anterior Lamellar Corneal Graft 
Reasons for Graft Failure 
 
  Scarring  11 
  Primary graft failure 10 
  Non herpetic infection 8 
  Astigmatism 5 
  Trauma 4 
  Corneal ulcer 3 
  Endothelial cell failure 3 
  Other specified* 8 
  Unspecified 14 
  
Total 66 
  
 
*Other included: lattice dystrophy (2), vascularisation (2), corneal melt (1), herpetic 
infection (1), inflammation (1), rejection (1). 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For lamellar procedures, primary graft failure is recorded as reported 
by surgeons. Additional information is collected to ascertain whether this occurred within 
28 days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Of the 10 grafts reported by surgeons to have been primary graft failures, in eight cases 
no further information was provided. Specific reasons given in the remaining two were: 
fungal keratitis (1) and oedema (1). 
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4.8 Post-graft Changes in Visual Acuity 
 
4.8.1 All indications for graft 
 
Post-graft visual acuity is also important outcome for corneal graft recipients. A desire 
for improved visual acuity was specified as a reason for graft in 957 (92%) of registered 
DALKs. In 86% of cases (895), this was the sole desired outcome indicated. It is likely 
that this was also at least part of the reason for graft in some of the further 56 (5%) 
grafts where no reason was specified. We analysed post-graft visual acuity in two ways, 
firstly in terms of the Snellen acuity post-graft and secondly, in terms of the change in 
Snellen acuity from pre-to post-graft. 
 
Table 4.10 shows the reported post-graft visual acuity for all grafts, and also specifically 
for the 530 followed DALKs for which vision was listed as one of the reasons for graft.  
Table 4.10 Post-graft visual acuity 
 
Deep Anterior Lamellar Corneal Graft: Post Graft Visual Acuity 
(as reported at last follow up) 
 
 All grafts Surviving Failed To improve VA 
6/12 or better 243 (42%) 239 (47%) 4 (6%) 229 (43%) 
6/15 - 6/36 136 (24%) 123 (24%) 13 (20%) 133 (25%) 
6/60 or worse 111 (19%) 69 (14%) 42 (64%) 94 (18%) 
Unknown 84 (15%) 77 (15%) 7 (11%) 74 (14%) 
Total 574 (100%) 508 (100%) 66 (100%) 530 (100%) 
     
VA = Visual acuity 
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Figure 4.8.1 shows the best corrected visual acuity in the grafted eye at the time of the 
most recent follow-up. Post-graft visual acuity was provided for 490 followed DALKs 
(85%). Of these, 243 (50%) had vision of 6/12 or better at their most recent follow-up, 
while 111 (23%) reported vision of 6/60 or worse.  
 
 
Figure 4.8.1 Best corrected visual acuity at time of last follow-up 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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Visual acuity data were available both pre- and post-graft for 475 (83%) followed 
DALKs. Of these, 59 (12%) had failed, while 416 (88%) were still surviving. Figure 4.8.2 
shows the number of lines of improvement or deterioration in visual acuity since graft, 
as measured in terms of Snellen acuity at the latest follow-up. 
Figure 4.8.2 Number of lines of change on a Snellen chart pre- to post-graft 
 
Table 4.11 summarises the change in visual acuity form pre- to post-graft, stratified by 
whether the graft was surviving at last follow-up. 
Table 4.11 Number of lines change on a Snellen chart, pre-to post-graft 
 
Deep Anterior Lamellar Corneal Graft 
Change in Visual Acuity from Pre Graft 
(as reported at last follow up) 
 
 Surviving Failed Total 
 n % n % n % 
VA worse by > 4 lines 3 <1% 1 2% 4 <1% 
VA worse by 2 to 4 lines 18 4% 12 18% 30 5% 
VA worse by 1 line 10 2% 7 11% 17 3% 
VA unchanged 35 7% 15 23% 50 9% 
VA better by 1 line 40 8% 6 9% 46 8% 
VA better by 2 to 4 lines 118 23% 13 20% 131 23% 
VA better by 5 to 7  lines 121 24% 4 6% 125 22% 
VA better by > 7  lines 71 14% 1 2% 72 13% 
Unknown 92 18% 7 11% 99 17% 
Total 508 100% 66 100% 574 100% 
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4.8.2 Keratoconus  
 
The data on this page show the post-graft visual acuity obtained, and the change 
in visual acuity, for grafts performed for keratoconus. 
Figure 4.8.3 Best corrected visual acuity at time of last follow-up 
 
Figure 4.8.4 Number of lines of change on a Snellen chart pre- to post-graft 
 
Post-graft vision of 6/12 or better was reported in 47% of followed DALKs performed for 
keratoconus. Visual acuity was reported both pre- and post-graft for 82% of grafts for 
keratoconus and at least one line of improvement on the Snellen chart was achieved 
after graft in 84% of these. 
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5 Traditional Lamellar Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 532 
traditional lamellar keratoplasties for which follow-up information was available. Kaplan-
Meier survival analyses were conducted using IBM SPSS for Windows (Version 21.0), 
to compare the graft survival across groups for a range of variables relating to the 
corneal donor, graft recipient, surgical procedure, surgeon, and follow-up care. 
5.1 Donor and Eye Banking Factors 
 
Table 5.1 shows the number of grafts within each of the variable sub-groups, for the 
donor factors examined in this report. The sum of these numbers for each variable 
equals the total number of grafts (699 registered and 532 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 5.1 Donor and eye banking factors 
 
Traditional Lamellar Corneal Grafts 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank R 393 (56%) 300 (56%) 
  Eye bank U 112 (16%) 78 (15%) 
  Eye bank X 94 (13%) 73 (14%) 
  Eye bank Y 57 (8%) 43 (8%) 
  Eye bank Z 42 (6%) 37 (7%) 
  Not advised1 1 (<1%) 1 (<1%) 
   
Storage medium   
  Optisol 292 (42%) 219 (42%) 
  Organ culture 53 (8%) 25 (5%) 
  Moist pot 345 (49%) 279 (52%) 
  Superseded media 6 (<1%) 6 (1%) 
  Not advised 3 (<1%) 3 (<1%) 
   
Death-to-enucleation time   
  ≤ 3 hours 60 (9%) 45 (9%) 
  4 to 6 hours 137 (20%) 105 (20%) 
  7 to 9 hours 174 (25%) 138 (26%) 
  10 to 12 hours 174 (25%) 136 (26%) 
  ≥ 13 hours 141 (20%) 96 (18%) 
  Not advised 13 (2%) 12 (2%) 
   
Interstate transportation   
  Yes 39 (6%) 31 (6%) 
  No 659 (94%) 500 (94%) 
  Not advised1 1 (<1%) 1 (<1%) 
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Sex of donor   
  Female 288 (41%) 217 (41%) 
  Male 408 (58%) 312 (59%) 
  Not Advised 3 (<1%) 3 (<1%) 
   
Age group   
  <10 years 2 (<1%) 2 (<1%) 
  10 to 19 years 8 (1%) 6 (1%) 
  20 to 29 years 11 (2%) 7 (1%) 
  30 to 39 years 14 (2%) 8 (2%) 
  40 to 49 years 36 (5%) 29 (6%) 
  50 to 59 years 93 (13%) 68 (13%) 
  60 to 69 years 172 (45%) 127 (24%) 
  70 to 79 years 242 (35%) 184 (35%) 
  80 to 89 years 115 (17%) 96 (18%) 
  90 to 99 years 5 (<1%) 4 (<1%) 
  Not advised 1 (<1%) 1 (<1%) 
   
Cause of death   
  Cardiac event 238 (34%) 180 (34%) 
  Malignancy 201 (29%) 152 (29%) 
  Trauma 37 (5%) 25 (5%) 
  Respiratory event 76 (11%) 58 (11%) 
  Intracranial/cerebral haemorrhage 111 (16%) 92 (17%) 
  Other specified 30 (4%) 24 (4%) 
  Not advised2 6 (<1%) 4 (<1%) 
   
Multi-organ donor status   
  No 648 (93%) 492 (93%) 
  Yes 51 (7%) 40 (7%) 
   
Total 699 (100%) 532 (100%) 
   
 
1 
One autograft with no eye bank given 
2 
ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly lower (p<0.05) for grafts performed using donor 
tissue stored in organ culture. 
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5.1.1 Traditional lamellar graft survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks 
around Australia. Figure 5.1.1 shows the comparison of graft survival for corneas 
provided by each of these eye banks. Data were not available for 1 case.  A significant 
difference was found across eye banks (Log Rank Statistic=17.90; df=4; p<0.001). This 
variable was not included in the multivariate analysis as it is collinear with the centre 
effect, shown in Figure 5.4.2. 
Figure 5.1.1 Australian eye bank 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Eye bank R 300 73 22 6 n/a 
Eye bank U 78 29 10 2 1 
Eye bank X 73 10 2 n/a n/a 
Eye bank Y 43 6 3 n/a n/a 
Eye bank Z 37 10 5 2 n/a 
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Traditional Lamellar Corneal Graft Survival 
Eye Bank 
 
 Probability of Graft Survival 
 Eye bank R: 0.85 at 1 year 
  Mean Survival 7.03 years 0.76 at 3 years 
  (SE= 0.49, 95% CI: 6.07, 7.99) 0.57 at 6 years 
  Median Survival 9.12 years  at 9 years 
    
 Eye bank U: 0.88 at 1 year 
  Mean Survival 7.38 years 0.80 at 3 years 
  (SE= 0.90, 95% CI: 5.62, 9.14)   
  Median Survival 8.45 years   
    
 Eye bank X: 0.68 at 1 year 
  Mean Survival 4.19 years   
  (SE= 0.57, 95% CI: 3.06, 5.31)   
  Median Survival 3.92 years   
    
 Eye bank Y: 0.68 at 1 year 
  Mean Survival 4.98 years   
  (SE= 0.74, 95% CI: 3.53, 6.43)   
  Median Survival 8.18 years   
    
 Eye bank Z: 0.91 at 1 year 
  Mean Survival 8.23 years   
  (SE= 1.10, 95% CI: 6.07, 10.39)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.2 Traditional lamellar graft survival: influence of interstate transportation 
 
In the majority of transplants, donor corneas are sourced in the same State as the 
surgery occurs, however, in some cases corneas are transported interstate via air 
freight. Figure 5.1.2 shows the comparison of graft survival for grafts where the surgery 
was performed in the same State as the donor cornea was sourced, compared to those 
where the donor cornea was from interstate. The graft where donor State data were not 
available was excluded from the analysis. No significant difference was found between 
groups (Log Rank Statistic=2.39; df=1; p=0.122).  
Figure 5.1.2 Interstate transportation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Different State 31 9 1 1 1 
Same State 500 119 41 9 n/a 
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Traditional Lamellar Corneal Graft Survival 
Interstate Transportation 
 
 Probability of Graft Survival 
 Different State: 0.76 at 1 year 
  Mean Survival 4.99 years   
  (SE= 1.33, 95% CI: 2.38, 7.61)   
  Median Survival 5.24 years   
    
 Same State: 0.82 at 1 year 
  Mean Survival 6.98 years 0.74 at 3 years 
  (SE= 0.38, 95% CI: 6.22, 7.73) 0.59 at 6 years 
  Median Survival 8.45 years   
     
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.3 Traditional Lamellar graft survival: influence of death to enucleation time 
 
Donor corneas are retrieved as soon as possible following donor death. Retrieval is 
recommended within the first 18 hours and 95% of donor eyes were enucleated within 
this time-frame. Times are rounded to the nearest hour and the median time from donor 
death to enucleation was 9 hours (range 0-24 hours). Data were not available for 12 
grafts.  
Figure 5.1.3 shows a comparison of graft survival depending on time from donor death 
to enucleation, stratified into three-hourly groups. No significant difference was found 
across groups (Log Rank Statistic=2.81; df=4; p=0.590).  
Figure 5.1.3 Time from death to enucleation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
3 hours or less 45 13 7 1 n/a 
4 to 6 hours 105 32 11 2 1 
7 to 9 hours 138 26 11 4 n/a 
10 to 12 hours 136 29 7 2 n/a 
13 hours or more 96 25 4 n/a n/a 
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Traditional Lamellar Corneal Graft Survival 
Death to Enucleation Time 
 
 Probability of Graft Survival 
 3 hours or less: 0.87 at 1 year 
  Mean Survival 6.72 years   
  (SE= 0.82, 95% CI: 5.11, 8.33)   
  Median Survival n/a   
    
 4 to 6 hours: 0.88 at 1 year 
  Mean Survival 6.93 years 0.80 at 3 years 
  (SE= 0.79, 95% CI: 5.39, 8.48)   
  Median Survival 8.45 years   
    
 7 to 9 hours: 0.81 at 1 year 
  Mean Survival 6.99 years 0.76 at 3 years 
  (SE= 0.64, 95% CI: 5.73, 8.25)   
  Median Survival 9.12 years   
    
 10 to 12 hours: 0.78 at 1 year 
  Mean Survival 7.31 years 0.67 at 3 years 
  (SE= 0.58, 95% CI: 6.16, 8.45)   
  Median Survival n/a   
    
 13 hours or more: 0.78 at 1 year 
  Mean Survival 5.09 years 0.71 at 3 years 
  (SE= 0.49, 95% CI: 4.12, 6.06)   
  Median Survival 5.37 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.4 Traditional lamellar graft survival: influence of modern corneal storage 
media 
 
In Australia, two storage media are commonly used to preserve donor corneas prior to 
transplantation. A third storage technique, where the donor eye was stored in a moist 
pot, is also still used occasionally, particularly for donor tissue to be used in a traditional 
lamellar graft. Data were not analysed for 9 donor corneas that were stored in a now 
superseded storage media (e.g. Kaysol, Dextran, M-K medium), or for which the eye 
bank did not specify the medium used.  
Figure 5.1.4 shows the comparison of graft survival for corneas stored in Optisol 
medium compared to organ culture medium and moist pot. No significant difference was 
found between media (Log Rank Statistic=5.86; df=2; p=0.054). While this difference 
was not significant at the p<0.05 level, it met the p<0.08 criterion to be included in the 
multivariate analysis (see section 5.6). This variable was not retained in the final model, 
indicating that this is not an independent factor significantly affecting graft survival. 
Figure 5.1.4 Modern corneal storage media 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Optisol 219 53 16 2 1 
Organ culture 25 3 n/a n/a n/a 
Moist pot 279 68 24 8 n/a 
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Traditional Lamellar Corneal Graft Survival 
Modern Storage Media 
 
 Probability of Graft Survival 
 Optisol: 0.77 at 1 year 
  Mean Survival 6.08 years 0.68 at 3 years 
  (SE= 0.64, 95% CI: 4.82, 7.33)   
  Median Survival 6.96 years   
    
 Organ culture:   
  Mean Survival 2.77 years  n/a 
  (SE= 0.26, 95% CI: 2.26, 3.28)   
  Median Survival n/a   
    
 Moist pot: 0.86 at 1 year 
  Mean Survival 7.41 years 0.77 at 3 years 
  (SE= 0.49, 95% CI: 6.45, 8.36) 0.59 at 6 years 
  Median Survival 9.12 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.5 Traditional lamellar graft survival: influence of storage time to graft – 
Optisol medium 
 
Corneas stored in Optisol medium are most often used within 5 days of storage and are 
rarely stored for longer than 7 days. Figure 5.1.5 shows the comparison of graft survival 
across storage time for those corneas stored in Optisol medium. Data were not provided 
for 51 grafts and these were excluded from the analysis. No significant difference was 
found across groups (Log Rank Statistic=2.94; df=2; p=0.229).  
Figure 5.1.5 Time from storage to graft, Optisol storage medium 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
5 days or less 84 22 5 1 1 
6 or 7 days 20 6 2 n/a n/a 
More than 7 days 64 13 4 n/a n/a 
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Penetrating Corneal Graft Survival 
Storage Time to Graft: Optisol 
 
 Probability of Graft Survival 
 5 days or less: 0.78 at 1 year 
  Mean Survival 6.23 years 0.67 at 3 years 
  (SE= 1.02, 95% CI: 4.23, 8.22)   
  Median Survival 6.96 years   
    
 6 or 7 days:   
  Mean Survival 5.72 years  n/a 
  (SE= 1.05, 95% CI: 3.66, 7.78)   
  Median Survival n/a   
    
 More than 7 days: 0.72 at 1 year 
  Mean Survival 4.39 years   
  (SE= 0.58, 95% CI: 3.26, 5.52)   
  Median Survival 3.92   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.6 Traditional lamellar graft survival: influence of donor sex 
 
Historically, a higher proportion of corneal donors are male and this was also the case 
in the current cohort. Data were not available for 3 grafts. Figure 5.1.6 shows the 
comparison of graft survival depending on donor sex. No significant difference was 
found between groups (Log Rank Statistic=0.68; df=1; p=0.410).  
Figure 5.1.6 Donor sex 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female 217 50 14 3 n/a 
Male 312 78 28 7 1 
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Traditional Lamellar Corneal Graft Survival 
Donor Sex 
 
 Probability of Graft Survival 
 Female: 0.82 at 1 year 
  Mean Survival 6.47 years 0.73 at 3 years 
  (SE= 0.58, 95% CI: 5.34, 7.60)   
  Median Survival5.58 years   
    
 Male: 0.82 at 1 year 
  Mean Survival 7.31 years 0.74 at 3 years 
  (SE= 0.51, 95% CI: 6.32, 8.31) 0.62 at 6 years 
  Median Survival 9.18 years   
     
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.7 Traditional lamellar graft survival: influence of donor age (years) 
 
Figure 5.1.7 shows the comparison of graft survival depending on donor age, stratified 
by 10 year age groups. Donors aged under 40 years or over 90 years are rare, and 
these data were included in the adjacent age groups due to the low numbers (n=23 and 
n=4, respectively). Data were not available for one further graft. No significant difference 
was found across groups (Log Rank Statistic=2.15; df=4; p=0.708).  
Figure 5.1.7 Donor age 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
0 to 49 years 52 18 4 1 n/a 
50 to 59 years 68 16 6 n/a n/a 
60 to 69 years 127 36 10 2 n/a 
70 to 79 years 184 36 13 4 n/a 
80 to 89 years 100 23 9 3 1 
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Traditional Lamellar Corneal Graft Survival 
Donor Age 
 
 Probability of Graft Survival 
 0 to 49 years: 0.88 at 1 year 
  Mean Survival 7.70 years   
  (SE= 0.66, 95% CI: 6.41, 9.00)   
  Median Survival n/a   
    
 50 to 59 years: 0.82 at 1 year 
  Mean Survival 5.20 years   
  (SE= 0.59, 95% CI: 4.04, 6.37)   
  Median Survival n/a   
     
 60 to 69 years: 0.81 at 1 year 
  Mean Survival 5.89 years 0.74 at 3 years 
  (SE= 0.49, 95% CI: 4.93, 6.86)   
  Median Survival 6.96 years   
     
 70 to 79 years: 0.83 at 1 year 
  Mean Survival 7.07 years 0.75 at 3 years 
  (SE= 0.58, 95% CI: 5.93, 8.21)   
  Median Survival 8.45 years   
     
 80 to 99 years: 0.78 at 1 year 
  Mean Survival 7.21 years 0.72 at 3 years 
  (SE= 0.82, 95% CI: 5.60, 8.81)   
  Median Survival 5.32 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.1.8 Traditional lamellar graft survival: influence of cause of donor death 
 
Figure 5.1.8 shows the comparison of graft survival depending on cause of donor death. 
Cause of death was unknown for 4 grafts and these were excluded from the analysis. 
No significant difference was found across groups (Log Rank Statistic=6.99; df=5; 
p=0.221). 
Figure 5.1.8 Cause of donor death 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Cardiac event 180 44 17 5 n/a 
Malignancy 152 29 6 n/a n/a 
Trauma 25 9 1 n/a n/a 
Respiratory event 58 15 7 2 1 
Intracranial/cerebral haemorrhage 92 23 9 2 n/a 
Other 21 7 2 1 n/a 
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Traditional Lamellar Corneal Graft Survival 
Cause of Donor Death 
 
 Probability of Graft Survival 
 Cardiac event: 0.84 at 1 year 
  Mean Survival 7.39 years 0.75 at 3 years 
  (SE= 0.56, 95% CI: 6.29, 8.49)   
  Median Survival 9.18 years   
    
 Malignancy: 0.79 at 1 year 
  Mean Survival 5.21 years 0.69 at 3 years 
  (SE= 0.43, 95% CI: 4.36, 6.06)   
  Median Survival 5.37 years   
    
 Trauma:   
  Mean Survival 5.53 years  n/a 
  (SE= 0.68, 95% CI: 4.18, 6.87)   
  Median Survival 6.96 years   
    
 Respiratory event: 0.77 at 1 year 
  Mean Survival 6.08 years   
  (SE= 0.97, 95% CI: 4.18, 7.98)   
  Median Survival 5.32 years   
    
 Intracranial/cerebral haemorrhage: 0.81 at 1 year 
  Mean Survival 7.33 years 0.76 at 3 years 
  (SE= 0.80, 95% CI: 5.77, 8.90)   
  Median Survival n/a   
    
 Other:   
  Mean Survival 8.95 years  n/a 
  (SE= 0.83, 95% CI: 7.32, 10.58)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
“Other” included donors who died from diseases of the liver, kidney, pancreas, gastro-
intestinal tract, encephalopathy, sepsis, and rare diseases. It also includes 7 cases 
where the donor was listed as dying from brain damage or brain death with no specific 
cause provided.  
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5.1.9 Traditional lamellar graft survival: influence of multi-organ donor status 
 
Figure 5.1.9 shows the comparison of graft survival depending on whether the donor 
cornea was obtained from a multi-organ donor. No significant difference was found 
between groups (Log Rank Statistic=1.34; df=1; p=0.247).  
Figure 5.1.9 Multi-organ donor status 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No 492 115 37 10 1 
Yes 40 13 5 n/a n/a 
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Traditional Lamellar Corneal Graft Survival 
Multi-organ Donor 
 
 Probability of Graft Survival 
 No: 0.82 at 1 year 
  Mean Survival 6.84 years 0.72 at 3 years 
  (SE= 0.40, 95% CI: 6.05, 7.64) 0.54 at 6 years 
  Median Survival 8.18 years   
     
    
 Yes: 0.83 at 1 year 
  Mean Survival 6.00 years   
  (SE= 0.55, 95% CI: 4.92, 7.08)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.2 Recipient Factors 
 
Table 5.2 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report. The sum of these numbers for each variable 
equals the total number of grafts (699 registered and 532 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 5.2 Recipient factors 
 
Traditional Lamellar Corneal Grafts 
Recipient Factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Failed previous 121 (17%) 97 (18%) 
  Keratoconus 82 (12%) 52 (10%) 
  Corneal ulcer/perforation 77 (11%) 60 (11%) 
  Herpetic eye disease 38 (5%) 32 (6%) 
  Corneal degenerations 46 (7%) 35 (7%) 
  Pterygium 69 (10%) 43 (10%) 
  Scleral necrosis 88 (13%) 74 (14%) 
  Limbal dermoid 33 (5%) 26 (5%) 
  Other* 145 (21%) 103 (19%) 
   
Australian State where graft was performed   
  State A 395 (57%) 301 (57%) 
  State B 97 (14%) 63 (12%) 
  State C 78 (11%) 62 (12%) 
  State D 70 (10%) 51 (10%) 
  State E 40 (6%) 36 (7%) 
  State F 19 (3%) 19 (4%) 
   
Recipient sex   
  Female 273 (39%) 220 (41%) 
  Male 426 (61%) 312 (59%) 
   
Recipient age group   
  <10 years 31 (4%) 26 (5%) 
  10 to 19 years 32 (5%) 22 (4%) 
  20 to 29 years 58 (8%) 39 (7%) 
  30 to 39 years 66 (9%) 47 (9%) 
  40 to 49 years 73 (10%) 52 (10%) 
  50 to 59 years 99 (14%) 76 (14%) 
  60 to 69 years 96 (14%) 65 (12%) 
  70 to 79 years 147 (21%) 125 (24%) 
  80 to 89 years 87 (12%) 73 (14%) 
  ≥ 90 years 10 (1%) 7 (1%) 
   
History of raised intraocular pressure   
  No 593 (85%) 457 (86%) 
  Yes 71 (10%) 50 (9%) 
  Not advised 35 (5%) 25 (5%) 
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Pre-graft neovascularisation   
  No 490 (70%) 359 (68%) 
  Yes 209 (30%) 173 (33%) 
   
Pre-graft inflammation and/or steroid use   
  No 387 (55%) 291 (55%) 
  Yes 291 (42%) 232 (44%) 
  Not advised 21 (3%) 9 (2%) 
   
Total 699 (100%) 532 (100%) 
   
 
*Other included: trauma (24), descemetocoele (16), non-herpetic infection (15), corneal 
dystrophy (13), bullous keratopathy (11), corneal carcinoma (11), corneal scars and 
opacities (11), wound dehiscence (10), glaucoma (9), congenital abnormality (5), 
metabolic deposits (5), astigmatism (2), conjunctival carcinoma (2), limbal carcinoma 
(2), amyloidosis (1), atopic keratoconjunctivitis (1), autograft repair (1), epithelial defect 
(1), ICE syndrome (1), ocular sarcoidosis (1), neovascularisation (1), rosacea (1), 
Sjögren’s Syndrome (1). 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly more likely (p<0.05) to have been received for 
grafts performed in female recipients, very young (under 10) and older recipients, and 
recipients with pre-graft vascularisation. Significant differences in follow-up were also 
found across groups for recipient State. 
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5.2.1 Traditional lamellar graft survival: influence of Australian State where graft 
was performed 
 
Figure 5.2.1 shows the comparison of graft survival depending on the Australian State 
in which the transplantation occurred. Data for grafts performed in one State were 
excluded due to the low number followed (n=19). A significant difference was found 
across groups (Log Rank Statistic=25.45; df=4; p<0.001). This variable was not 
included in the multivariate analysis as it is collinear with the centre effect, shown in 
Figure 5.4.2. 
Figure 5.2.1 Australian State where graft was performed 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 
State A 301 72 22 6 
State B 63 27 9 1 
State C 62 7 2 n/a 
State D 51 9 3 n/a 
State E 36 9 5 2 
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Traditional Lamellar Corneal Graft Survival 
Australian State Where Graft was Performed 
 
 Probability of Graft Survival 
 State A: 0.84 at 1 year 
  Mean Survival 6.87 years 0.75 at 3 years 
  (SE= 0.48, 95% CI: 5.92, 7.81) 0.55 at 6 years 
  Median Survival 9.12 years   
    
 State B: 0.91 at 1 year 
  Mean Survival 7.69 years 0.89 at 3 years 
  (SE= 0.48, 95% CI: 6.74, 8.64)   
  Median Survival 8.45 years   
    
 State C: 0.68 at 1 year 
  Mean Survival 3.76 years   
  (SE= 0.63, 95% CI: 2.52, 4.99)   
  Median Survival 2.83 years   
    
 State D: 0.67 at 1 year 
  Mean Survival 5.05 years   
  (SE= 0.65, 95% CI: 3.79, 6.32)   
  Median Survival 8.18 years   
    
 State E: 0.91 at 1 year 
  Mean Survival 8.80 years   
  (SE= 1.05, 95% CI: 6.75, 10.86)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.2.2 Traditional lamellar graft survival: influence of recipient sex 
 
Comparison of graft survival between male and female transplant recipients is shown in 
Figure 5.2.2. No significant difference was found between groups (Log Rank 
Statistic=0.04; df=1; p=0.833). 
Figure 5.2.2 Recipient sex 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female 220 55 17 4 n/a 
Male 312 73 25 6 1 
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Traditional Lamellar Corneal Graft Survival 
Recipient Sex 
 
 Probability of Graft Survival 
 Female: 0.84 at 1 year 
  Mean Survival 6.34 years 0.72 at 3 years 
  (SE= 0.48, 95% CI: 5.92, 7.81)   
  Median Survival 9.12 years   
    
 Male: 0.81 at 1 year 
  Mean Survival 7.69 years 0.73 at 3 years 
  (SE= 0.48, 95% CI: 6.74, 8.64) 0.54 at 6 years 
  Median Survival 8.45 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.2.3 Traditional lamellar graft survival: influence of donor/recipient sex 
match/mismatch 
 
Further analysis examined whether there was any effect of a cornea being transplanted 
into a recipient of a different sex to the donor. Data were not available for 3 grafts. 
Comparison of graft survival across groups based on donor/recipient sex combinations 
is shown in Figure 5.2.3. No significant difference was found across groups (Log Rank 
Statistic=0.83; df=3; p=0.841). 
Figure 5.2.3 Donor/recipient sex match/mismatch 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Female/female 95 24 8 2 n/a 
Female/male 122 26 6 1 n/a 
Male/female 124 31 9 2 n/a 
Male/male 188 47 19 5 1 
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Traditional Lamellar Corneal Graft Survival 
Donor/Recipient Sex Match/Mismatch 
 
 Probability of Graft Survival 
 Female/female: 0.84 at 1 year 
  Mean Survival 5.92 years 0.71 at 3 years 
  (SE= 0.59, 95% CI: 4.77, 7.08)   
  Median Survival 8.18 years   
    
 Female/male: 0.80 at 1 year 
  Mean Survival 6.87 years 0.75 at 3 years 
  (SE= 0.80, 95% CI: 5.31, 8.44)   
  Median Survival 5.24 years   
    
 Male/female: 0.83 at 1 year 
  Mean Survival 6.85 years 0.73 at 3 years 
  (SE= 0.52, 95% CI: 5.82, 7.87)   
  Median Survival 8.45 years   
    
 Male/male: 0.81 at 1 year 
  Mean Survival 7.21 years 0.74 at 3 years 
  (SE= 0.63, 95% CI: 5.98, 8.45)   
  Median Survival 9.35 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.2.4 Traditional lamellar graft survival: influence of recipient age (years) 
 
Figure 5.2.4 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for grafts where the recipient was aged over 80 years were all 
analysed together due to the low number (n=7) in the “90-99 years” group. No 
significant difference was found across groups (Log Rank Statistic=12.85; df=8; 
p=0.117).  
Figure 5.2.4 Recipient age 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
  0 to 9 years 26 8 4 1 n/a 
10 to 19 years 22 6 2 1 n/a 
20 to 29 years 39 14 5 1 n/a 
30 to 39 years 47 17 4 1 n/a 
40 to 49 years 52 18 7 3 n/a 
50 to 59 years 76 13 6 1 1 
60 to 69 years 65 14 6 n/a n/a 
70 to 79 years 125 32 6 1 n/a 
80 to 99 years 80 6 2 1 n/a 
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Traditional Lamellar Corneal Graft Survival 
Recipient Age 
 
 Probability of Graft Survival 
 0 to 9 years:   
  Mean Survival 9.74 years  n/a 
  (SE= 0.45, 95% CI: 8.86, 10.62)   
  Median Survival n/a   
    
 10 to 19 years:   
  Mean Survival 5.22 years  n/a 
  (SE= 1.22, 95% CI: 2.82, 7.61)   
  Median Survival 4.01 years   
    
 20 to 29 years: 0.81 at 1 year 
  Mean Survival 6.28 years   
  (SE= 0.75, 95% CI: 4.81, 7.75)   
  Median Survival 9.18 years   
    
 30 to 39 years: 0.87 at 1 year 
  Mean Survival 5.98 years   
  (SE= 0.73, 95% CI: 4.55, 7.40)   
  Median Survival 5.76 years   
    
 40 to 49 years: 0.76 at 1 year 
  Mean Survival 6.17 years   
  (SE= 0.85, 95% CI: 4.50, 7.84)   
  Median Survival 5.58 years   
    
 50 to 59 years: 0.82 at 1 year 
  Mean Survival 8.55 years   
  (SE= 1.11, 95% CI: 6.39, 10.72)   
  Median Survival 12.39 years   
     
 60 to 69 years: 0.83 at 1 year 
  Mean Survival 6.38 years   
  (SE= 0.50, 95% CI: 5.40, 7.35)   
  Median Survival 8.18 years   
     
 70 to 79 years: 0.79 at 1 year 
  Mean Survival 6.19 years 0.75 at 3 years 
  (SE= 0.64, 95% CI: 4.93, 7.44)   
  Median Survival 5.37 years   
     
 80 to 89 years: 0.78 at 1 year 
  Mean Survival 4.99 years   
  (SE= 1.21, 95% CI: 2.62, 7.37)   
  Median Survival 2.66 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.2.5 Traditional lamellar graft survival: influence of indication for graft 
 
Figure 5.2.5 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. A significant 
difference was found across groups (Log Rank Statistic=114.68; df=8; p<0.001). No 
traditional lamellar grafts that were performed for a limbal dermoid had been reported to 
have failed and so these grafts were excluded from the multivariate cox proportional 
hazards analysis. This variable was retained in multivariate analysis (see section 5.6) 
indicating that this is an independent factor significantly affecting graft survival.  
Figure 5.2.5 Indication for graft 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Failed previous graft 97 15 3 1 1 
Keratoconus 52 26 9 1 n/a 
Ulcer/perforation 60 8 3 n/a n/a 
Herpetic eye disease 32 4 n/a n/a n/a 
Corneal degeneration 35 11 3 1 n/a 
Pterygium 53 13 5 2 n/a 
Scleral necrosis 74 17 8 1 n/a 
Limbal dermoid 26 7 3 n/a n/a 
Other 103 27 8 4 n/a 
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Traditional Lamellar Corneal Graft Survival 
Indication for Graft 
 
 Probability of Graft Survival 
 Failed previous graft: 0.67 at 1 year 
  Mean Survival 4.35 years   
  (SE= 0.89, 95% CI: 2.60, 6.11)   
  Median Survival 2.83 years   
    
 Keratoconus: 0.98 at 1 year 
  Mean Survival 7.74 years 0.92 at 3 years 
  (SE= 0.53, 95% CI: 6.70, 8.78)   
  Median Survival 8.45 years   
     
 Ulcer/perforation: 0.66 at 1 year 
  Mean Survival 3.64 years   
  (SE= 0.60, 95% CI: 2.46, 4.83)   
  Median Survival 3.44 years   
     
 Herpetic eye disease:   
  Mean Survival 1.70 years  n/a 
  (SE= 0.47, 95% CI: 0.78, 2.63)   
  Median Survival 0.30 years   
     
 Corneal degeneration: 0.90 at 1 year 
  Mean Survival 7.35 years   
  (SE= 0.80, 95% CI: 5.78, 8.92)   
  Median Survival 9.12 years   
     
 Pterygium: 0.93 at 1 year 
  Mean Survival 9.42 years   
  (SE= 0.99, 95% CI: 7.48, 11.36)   
  Median Survival 9.58 years   
     
 Scleral necrosis: 1.00 at 1 year 
  Mean Survival 8.75 years   
  (SE= 0.68, 95% CI: 7.41, 10.09)   
  Median Survival n/a   
     
 Limbal dermoid: 1.00 at 1 year 
  Survival statistics n/a as no failures   
     
 Other: 0.80 at 1 year 
  Mean Survival 6.70 years 0.69 at 3 years 
  (SE= 0.74, 95% CI: 5.24, 8.15)   
  Median Survival 8.18 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
In the multivariate analysis, indication for graft was shown to have a significant effect 
(p<0.001) on graft survival. Repeat grafts, as well as grafts for ulcers/perforations or 
herpetic eye disease, had significantly poorer survival than those for keratoconus, 
corneal degenerations, pterygium, and scleral necrosis (all p<0.01, except corneal 
degeneration versus failed previous graft, p=0.022, and versus ulcer/perforation 
p=0.004). Grafts for “other” indications had significantly better survival than repeat 
grafts, grafts for ulcers/perforations, or graft for herpetic eye disease, and worse survival 
than grafts for keratoconus, corneal degenerations, pterygium, and scleral necrosis (all 
p<0.02). The final model also accounted for the effect of pre-graft neovascularisation.  
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5.2.6 Traditional lamellar graft survival: influence of pre-graft corneal 
neovascularisation 
 
Figure 5.2.6 shows the comparison of graft survival between those recipients with 
corneal neovascularisation pre-graft and those without (Log Rank Statistic=27.13; df=1; 
p<0.001). This variable was retained in the multivariate analysis (see section 5.6), 
indicating that this is an independent factor significantly affecting graft survival.  
Figure 5.2.6 Pre-graft corneal neovascularisation 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No neovascularisation 359 92 33 6 1 
Neovascularisation 173 36 9 4 n/a 
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Traditional Lamellar Corneal Graft Survival 
Pre-graft Neovascularisation 
 
 Probability of Graft Survival 
 No neovascularisation: 0.88 at 1 year 
  Mean Survival 7.81 years 0.80 at 3 years 
  (SE= 0.52, 95% CI: 6.80, 8.82) 0.65 at 6 years 
  Median Survival 9.18 years   
    
 Neovascularisation: 0.70 at 1 year 
  Mean Survival 5.19 years 0.59 at 3 years 
  (SE= 0.56, 95% CI: 4.09, 6.29)   
  Median Survival 4.01 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
In the multivariate analysis, pre-graft neovascularisation was shown to have a 
significant negative effect (p=0.032) on graft survival. The final model also accounted 
for the effect of indication for graft. 
 
 
A subgroup-analysis was conducted to examine the impact of the extent of 
neovascularisation on graft survival. The results can be found overleaf, on pages 
328 and 329. 
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5.2.6.1 Traditional lamellar graft survival: influence of the extent of pre-graft 
neovascularisation 
 
Figure 5.2.7 indicates that graft survival is influenced by the degree of pre-graft corneal 
neovascularisation (Log Rank Statistic=11.11; df=3; p=0.011). The Kaplan Meier curve 
also shows the survival of avascular grafts, to give context to the other survival rates, 
however these grafts are not included in the statistical comparison. 
Figure 5.2.7 Extent of pre-graft neovascularisation 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
None 359 92 33 6 1 
One quadrant 48 15 5 2 n/a 
Two quadrants 44 9 2 1 n/a 
Three quadrants 23 4 n/a n/a n/a 
Four quadrants 58 8 2 1 n/a 
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Traditional Lamellar Corneal Graft Survival 
Pre-graft Neovascularisation 
 
 Probability of Graft Survival 
 None: 0.88 at 1 year 
  Mean Survival 7.81 years 0.80 at 3 years 
  (SE= 0.52, 95% CI: 6.80, 8.82) 0.65 at 6 years 
  Median Survival 9.18 years   
    
 One quadrant: 0.82 at 1 year 
  Mean Survival 6.82 years   
  (SE= 0.83, 95% CI: 5.19, 8.44)   
  Median Survival 9.12 years   
    
 Two quadrants: 0.68 at 1 year 
  Mean Survival 4.74 years   
  (SE= 0.85, 95% CI: 3.06, 6.41)   
  Median Survival 4.01 years   
    
 Three quadrants:   
  Mean Survival 3.65 years  n/a 
  (SE= 0.59, 95% CI: 2.49, 4.81)   
  Median Survival 3.92 years   
    
 Four quadrants: 0.58 at 1 year 
  Mean Survival 4.26 years   
  (SE= 0.91, 95% CI: 2.47, 6.05)   
  Median Survival 1.65 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
This concludes the subgroup analysis. Analyses from page 330 are again 
performed on the entire cohort. 
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5.2.7 Traditional lamellar graft survival: influence of inflammation or steroid use 
at time of graft 
 
Figure 5.2.8 shows the comparison of graft survival between grafts performed in an eye 
with current inflammation and/or steroid use within the past two weeks, compared to 
those with neither of these factors (Log Rank Statistic=45.51; df=1; p<0.001). This 
information was not known for 9 grafts and these were excluded from the analysis. This 
variable was not retained in the multivariate analysis (see section 5.6), indicating that 
this is not an independent factor significantly affecting graft survival.  
Figure 5.2.8 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No inflammation/steroid use 291 83 29 7 1 
Inflammation/steroid use 232 43 12 3 n/a 
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Traditional Lamellar Corneal Graft Survival 
Inflammation and/or Steroid Use at Time of Graft 
 
 Probability of Graft Survival 
 No inflammation/steroid use: 0.92 at 1 year 
  Mean Survival 8.15 years 0.83 at 3 years 
  (SE= 0.53, 95% CI: 7.11, 9.19) 0.70 at 6 years 
  Median Survival 9.18 years   
    
 Inflammation/steroid use: 0.67 at 1 year 
  Mean Survival 5.05 years 0.58 at 3 years 
  (SE= 0.50, 95% CI: 4.07, 6.04)   
  Median Survival 3.92 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.2.8 Traditional lamellar graft survival: influence of history of raised intraocular 
pressure (IOP)  
 
Figure 5.2.9 shows the comparison of graft survival between grafts with a history of 
raised IOP and those without. “History of raised IOP” means IOP had been raised in the 
eye previously, regardless of whether it was raised at the time of the graft. This was 
unknown for 25 grafts and these data were excluded from the analysis. A significant 
difference was found across groups (Log Rank Statistic=9.69; df=1; p=0.002). This 
variable was not retained in the multivariate analysis (see section 5.6), indicating that 
this is not an independent factor significantly affecting graft survival.  
Figure 5.2.9 History of raised intraocular pressure 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
IOP never raised 457 111 39 10 1 
History of raised IOP 50 10 2 n/a n/a 
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Traditional Lamellar Corneal Graft Survival 
History of Raised IOP  
 
 Probability of Graft Survival 
 IOP never raised: 0.83 at 1 year 
  Mean Survival 7.20 years 0.74 at 3 years 
  (SE= 0.42, 95% CI: 6.37, 8.03) 0.59 at 6 years 
  Median Survival 8.45 years   
    
 History of raised IOP: 0.66 at 1 year 
  Mean Survival 4.07 years   
  (SE= 0.68, 95% CI: 2.75, 5.40)   
  Median Survival 3.44 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.3 Graft Era 
 
Table 5.3 shows the number of grafts registered and followed, in blocks of two years. 
The percentages, which should be summed vertically, total 100. 
Table 5.3 Graft era 
 
Traditional Lamellar Corneal Grafts 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  2000 52 (7%) 49 (9%) 
  2001/2002 130 (19%) 115 (22%) 
  2003/2004 111 (16%) 81 (15%) 
  2005/2006 112 (16%) 96 (18%) 
  2007/2008 98 (14%) 77 (15%) 
  2009/2010 82 (12%) 58 (11%) 
  2011/2012 66 (9%) 44 (8%) 
  2013/2014 48 (7%) 12 (2%) 
   
Total 699 (100%) 532 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses and found to be significant (p<0.001). Follow-up was lower for grafts 
performed in more recent years. 
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5.3.1 Traditional lamellar graft survival: influence of year of graft 
 
Figure 5.3.1 shows the comparison of graft survival between year of graft, stratified post 
2000 into two-year groups (Log Rank Statistic=4.49; df=6; p=0.611). Due to the low 
number of followed grafts (12), data for grafts performed in 2013\2014 were not 
included in the analysis.  
Figure 5.3.1 Graft era 
 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
2000 49 8 5 4 1 
2001/2002 115 36 18 5 n/a 
2003/2004 81 19 5 1 n/a 
2005/2006 96 30 12 n/a n/a 
2007/2008 77 26 2 n/a n/a 
2009/2010 58 8 n/a n/a n/a 
2011/2012 44 1 n/a n/a n/a 
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Traditional Lamellar Corneal Graft Survival 
Era of Graft 
 
 Probability of Graft Survival 
 2000 : 0.84 at 1 year 
  Mean Survival 7.62 years    
  (SE= 1.23, 95% CI: 5.22, 10.02)   
  Median Survival 9.12 years    
    
 2001/2002: 0.79 at 1 year 
  Mean Survival 6.76 years 0.70 at 3 years 
  (SE= 0.61, 95% CI: 5.55, 7.96)   
  Median Survival 8.18 years   
    
 2003/2004: 0.81 at 1 year 
  Mean Survival 6.32 years   
  (SE= 0.70, 95% CI: 4.94, 7.70)   
  Median Survival 8.45 years   
    
 2005/2006 : 0.81 at 1 year 
  Mean Survival 5.55 years  0.70 at 3 years 
  (SE= 0.44, 95% CI: 4.68, 6.42)   
  Median Survival n/a   
    
 2007/2008 : 0.83 at 1 year 
  Mean Survival 4.66 years  0.79 at 3 years 
  (SE= 0.34, 95% CI: 4.00, 5.35)   
  Median Survival 5.76 years    
    
 2009/2010 : 0.81 at 1 year 
  Mean Survival 3.14 years    
  (SE= 0.26, 95% CI: 2.63, 3.65)   
  Median Survival 4.39 years    
    
 2011/2012 : 0.90 at 1 year 
  Mean Survival 2.72 years    
  (SE= 0.13, 95% CI: 2.46, 2.98)   
  Median Survival n/a   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.4 Surgery and Surgeon Factors 
 
Table 5.4 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report. The sum of these numbers for 
each variable equals the total number of grafts (699 registered and 532 followed) and 
the percentages, which should be summed vertically for each variable, total 100. 
Table 5.4 Surgery and surgeon factors 
 
Traditional Lamellar Corneal Grafts 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  4 mm or less 69 (10%) 61 (12%) 
  4.1 to 5 mm 46 (7%) 33 (6%) 
  5.1 to 6 mm 61 (9%) 47 (9%) 
  6.1 to 7 mm 57 (8%) 51 (10%) 
  7.1 to 8 mm 159 (23%) 117 (22%) 
  8.1 to 9 mm 103 (15%) 77 (15%) 
  > 9 mm 46 (7%) 33 (6%) 
  Not advised 158 (23%) 113 (21%) 
   
Surgeon volume   
  Fewer than 25 followed grafts 492 (70%) 359 (68%) 
  25+ followed grafts, ≥76% follow-up 82 (12%) 57 (22%) 
  25+ followed grafts, <76% follow-up 125 (18%) 116 (11%) 
     
Total 699 (100%) 532 (100%) 
   
 
76% was selected as the cut-off point for the follow-up categories as this (76.1%) was 
the average percentage of follow-up for all penetrating grafts, regardless of surgeon 
experience. 
Comparisons between the percentages of grafts registered and followed in each 
category showed some differences. These differences were examined using Chi² 
analyses. Follow-up was significantly lower (p<0.05) for larger grafts. Due to the nature 
of the variable, follow-up was, logically, significantly higher for grafts performed by 
surgeons with 100+ followed grafts and ≥76% follow-up. 
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5.4.1 Traditional lamellar graft survival: influence of graft size 
 
Figure 5.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. This information was not 
reported for 113 (21%) of the followed grafts and these were excluded from the 
analysis. A significant difference was found across groups (Log Rank Statistic=16.57; 
df=4; p=0.011). This variable was not retained in the final model, indicating that this is 
not an independent factor significantly affecting graft survival. 
Figure 5.4.1 Graft size 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
≤ 4 mm 61 9 2 n/a n/a 
> 4 mm to 5 mm 33 3 1 n/a n/a 
> 5 mm to 6 mm 47 15 3 1 n/a 
> 6 mm to 7 mm 51 8 5 n/a n/a 
> 7 mm to 8 mm 117 34 14 4 n/a 
> 8 mm to 9 mm 77 29 8 3 1 
> 9 mm 33 7 1 1 n/a 
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Traditional Lamellar Corneal Graft Survival 
Graft Size 
 
 Probability of Graft Survival 
 ≤ 4 mm: 0.64 at 1 year 
  Mean Survival 3.79 years   
  (SE= 0.62, 95% CI: 2.57, 5.00)   
  Median Survival 4.39 years   
    
 > 4 mm to 5 mm:   
  Mean Survival 5.95 years  n/a 
  (SE= 0.94, 95% CI: 4.10, 7.79)   
  Median Survival n/a   
    
 > 5 mm to 6 mm: 0.88 at 1 year 
  Mean Survival 7.01 years   
  (SE= 0.86, 95% CI: 5.33, 8.69)   
  Median Survival n/a   
    
 > 6 mm to 7 mm: 0.88 at 1 year 
  Mean Survival 6.36 years   
  (SE= 0.65, 95% CI: 5.08, 7.63)   
  Median Survival n/a   
    
 > 7 mm to 8 mm: 0.88 at 1 year 
  Mean Survival 7.06 years 0.75 at 3 years 
  (SE= 0.65, 95% CI: 5.78, 8.34)   
  Median Survival 8.45 years   
    
 > 8 mm to 9 mm: 0.84 at 1 year 
  Mean Survival 7.19 years 0.77 at 3 years 
  (SE= 0.85, 95% CI: 5.52, 8.86)   
  Median Survival 9.12 years   
    
 > 9 mm:   
  Mean Survival 5.88 years  n/a 
  (SE= 1.27, 95% CI: 3.39, 8.36)   
  Median Survival 5.76 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.4.2 Traditional lamellar graft survival: influence of the centre effect  
 
Figure 5.4.2 shows the comparison of graft survival for individual surgeons (shown in 
random order) for which there was follow-up information provided for 25 or more 
traditional lamellar keratoplasties since the year 2000, and all other grafts (performed by 
69 surgeons) combined (Log Rank Statistic=28.94; df=4; p<0.001). This variable was 
not retained in multivariate analysis (see section 5.6) indicating that this is not an 
independent factor significantly affecting graft survival.  
Figure 5.4.2 The centre effect 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Less than 25 followed grafts 359 81 25 5 1 
Surgeon 1 29 3 1 n/a n/a 
Surgeon 2 41 16 7 2 n/a 
Surgeon 3 46 13 6 2 n/a 
Surgeon 4 57 15 3 1 n/a 
 
Note: to preserve anonymity, high volume surgeons are intentionally listed in no 
particular order. 
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Traditional Lamellar Corneal Graft Survival 
The Centre Effect 
 
 Probability of Graft Survival 
 Less than 25 followed grafts: 0.82 at 1 year 
  Mean Survival 6.81 years 0.72 at 3 years 
  (SE= 0.52, 95% CI: 5.80, 7.83) 0.54 at 6 years 
  Median Survival 8.18 years   
    
 Surgeon 1:   
  Mean Survival 3.00 years  n/a 
  (SE= 0.78, 95% CI: 1.46, 4.53)   
  Median Survival 0.62 years   
    
 Surgeon 2: 0.95 at 1 year 
  Mean Survival 9.07 years   
  (SE= 1.01, 95% CI: 6.38, 10.33)   
  Median Survival 9.35 years   
    
 Surgeon 3: 0.85 at 1 year 
  Mean Survival 9.04 years   
  (SE= 1.06, 95% CI: 5.65, 9.82)   
  Median Survival 9.12 year   
    
 Surgeon 4: 0.85 at 1 year 
  Mean Survival 7.13 years   
  (SE= 0.83, 95% CI: 5.50, 8.76)   
  Median Survival 9.58 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
This variable is not retained in the multivariate analysis. Further statistical exploration 
indicates that this is due the inclusion of the variable relating to indication for graft – 
surgeon 1 performed the majority of their grafts for the high risk indication of corneal 
ulcer/perforation or as a repeat graft, while the majority of grafts performed by the other 
individual surgeons were for pterygium and scleral necrosis.  
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5.4.3 Traditional lamellar graft survival: influence of surgeon volume (25+ 
followed traditional lamellar grafts) grouped by level of follow-up  
 
Figure 5.4.3 shows the comparison of graft survival between grafts performed by 
surgeons with 25+ followed traditional lamellar keratoplasties since 2000 with average 
or better (≥76%) follow-up, to those with lower than average follow-up (<76%), and to 
low volume surgeons. No significant difference was found (Log Rank Statistic=1.56; 
df=2; p=0.459).  
Figure 5.4.3 Surgeon volume and level of follow-up 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Fewer than 25 followed grafts 359 81 25 5 1 
25+ followed TLK, low follow-up 57 15 3 1 n/a 
25+ followed TLK, high follow-up 116 32 14 4 n/a 
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Traditional Lamellar Corneal Graft Survival 
Surgeon Volume and Level of Follow-up  
 
 Probability of Graft Survival 
 Fewer than 25 followed grafts: 0.82 at 1 year 
  Mean Survival 6.81 years 0.72 at 3 years 
  (SE= 0.52, 95% CI: 5.80, 7.83) 0.54 at 6 years 
  Median Survival 8.18 years   
    
 25+ followed TLK, low follow-up: 0.85 at 1 year 
  Mean Survival 7.13 years   
  (SE= 0.83, 95% CI: 5.50, 8.76)   
  Median Survival 9.58 years   
    
 25+ followed TLK, high follow-up: 0.80 at 1 year 
  Mean Survival 6.99 years 0.70 at 3 years 
  (SE= 0.68, 95% CI: 5.66, 8.32)   
  Median Survival 9.12 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.5 Post-graft Events 
 
Table 5.5 shows the occurrence of post graft events, and Table 5.6 shows post-graft 
surgical procedures, as reported by follow-up practitioners. Please note: post-graft data 
may be incomplete when follow-up is based on a registration for a replacement graft. 
Table 5.5 Post-graft events 
 
Traditional Lamellar Corneal Grafts 
Post-graft Events 
 
 Followed (%) 
Post-graft rise in IOP  
  No 498 (94%) 
  Yes 34 (6%) 
  
Post graft microbial keratitis  
  No 512 (96%) 
  Yes 20 (4%) 
  
Time to removal of all sutures  
  Up to one year 93 (18%) 
  More than one year 43 (8%) 
  Not yet removed/not advised 396 (74%) 
  
Total 532 (100%) 
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Table 5.6 Post-graft surgical procedures 
 
Traditional Lamellar Corneal Grafts 
Post-graft Surgical Procedures 
 
Type of procedure Number 
Regrafted 100 
Additional concurrent graft 5 
IOL insertion      (49 with cataract removal, 1 without) 50 
YAG laser 8 
Suture adjustment 5 
Relaxing incision 4 
PRK laser 5 
LASIK 2 
Wedge resection 2 
Gunderson flap 5 
Enucleation 5 
Wound repair/resutured 4 
Tarsorrhaphy 4 
Keratotomy 3 
Other* 10 
  
Total number of surgical procedures (number of grafts) 261 (179) 
  
 
* Other included: additional penetrating keratoplasty (2), additional lamellar keratoplasty 
(1), amniotic membrane transplant (1), evisceration (1), lash epilation (1), IOL exchange 
(1), iridoplasty (1), removal of Gunderson flap (1), removal of small cell carcinoma (1).  
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5.5.1 Traditional lamellar graft survival: influence of post-graft microbial keratitis 
 
Figure 5.5.1 shows the survival for grafts where the eye had microbial keratitis post-
graft, compared to those where there was no such infection. A significant difference was 
found between groups (Log Rank Statistic=22.09; df=1; p<0.001). This variable was not 
retained in the multivariate analysis (see section 5.6), indicating that this is not an 
independent factor significantly affecting graft survival. 
Figure 5.5.1 Post-graft microbial keratitis 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No microbial keratitis 512 126 42 10 1 
Microbial keratitis 20 2 n/a n/a n/a 
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Traditional Lamellar Corneal Graft Survival 
Post-graft Microbial Keratitis 
 
 Probability of Graft Survival 
 No microbial keratitis: 0.83 at 1 year 
  Mean Survival 7.17 years 0.74 at 3 years 
  (SE= 0.41, 95% CI: 6.38, 7.97) 0.58 at 6 years 
  Median Survival 8.45 years   
     
    
 Microbial keratitis:   
  Mean Survival 1.86 years  n/a 
  (SE= 0.43, 95% CI: 1.01, 2.71)   
  Median Survival 1.15 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.5.2 Traditional lamellar graft survival: influence of post-graft raised IOP  
 
Figure 5.5.2 shows the comparison of graft survival for grafts where the eye was 
reported to have had raised intraocular pressure post-graft to those where the IOP 
remained in the normal range. No significant difference was found between groups (Log 
Rank Statistic=2.95; df=1; p=0.086).  
Figure 5.5.2 Post-graft raised intraocular pressure 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
No raised IOP 498 114 37 9 1 
Raised IOP 34 14 5 1 n/a 
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Traditional Lamellar Corneal Graft Survival 
Post-graft Raised IOP 
 
 Probability of Graft Survival 
 No raised IOP: 0.81 at 1 year 
  Mean Survival 6.90 years 0.72 at 3 years 
  (SE= 0.42, 95% CI: 6.07, 7.72) 0.55 at 6 years 
  Median Survival 8.18 years   
    
 Raised IOP: 0.94 at 1 year 
  Mean Survival 7.39 years   
  (SE= 0.81, 95% CI: 5.75, 8.91)   
  Median Survival 9.18 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.5.3 Traditional lamellar graft survival: influence of time to final removal of 
sutures 
 
Figure 5.5.3 shows the comparison of graft survival depending on the time from graft to 
final suture removal. No significant difference was found between groups (Log Rank 
Statistic=0.238; df=1; p=0.625).This information was only available for 136 (26%) of 
followed grafts and therefore this variable was not included in the multivariate analyses. 
Figure 5.5.3 Time to final removal of sutures 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
1 year or less 93 36 14 4 n/a 
More than 1 year 43 21 10 2 1 
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Traditional Lamellar Corneal Graft Survival 
Time to Final Removal of Sutures 
 
 Probability of Graft Survival 
 1 year or less: 0.98 at 1 year 
  Mean Survival 9.12 years 0.94 at 3 years 
  (SE= 0.63, 95% CI: 7.89, 10.35)   
  Median Survival n/a   
    
 More than 1 year: 1.00 at 1 year 
  Mean Survival 9.64 years 0.96 at 3 years 
  (SE= 1.23, 95% CI: 7.24, 12.05)   
  Median Survival 9.12 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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5.6 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
traditional lamellar graft survival, adjusted for all other variables in the model. This 
analysis was performed using STATA version 11. 
In the preceding univariate analyses, each registered traditional lamellar graft, together 
with its archival follow-up records, was treated as a separate and independent entity. To 
control for potential inter-graft and/or inter-eye dependence in the multivariate analyses, 
the multivariate model was adjusted to allow for clustering by individual patient [see 
reference 6]. 
Variables to be included in the multivariate Cox Proportional Hazards regression model 
were identified based on the results of the univariate Kaplan-Meier analyses, with a cut-
off significance level of p<0.08 used to select variables for inclusion. Some variables 
which were found to be significant in the univariate analyses were omitted due to co-
linearity, or because of large amounts of missing data (>25%). 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in 
a stepwise manner, beginning with the least significant variable. The Kaplan-Meier 
plots, and additional appropriate STATA analyses, were used to assess whether each 
included variable met the assumption of proportional hazards. Where variables were 
found to be time-variant, they were treated as such in the multivariate model.  
Table 5.7 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained 
in the final model.  
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Table 5.7 Multivariate model 
 
Traditional Lamellar Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Donor sex 
Donor age group 
Cause of donor death 
Multi-organ donor 
Time from death to enucleation 
Storage time in Optisol 
Interstate transportation 
Recipient sex 
Recipient age group 
Previous contralateral graft 
Graft year 
Raised intraocular pressure post-graft 
Surgeon experience and level of follow-up 
Time to removal of sutures 
 
Significant in univariate analysis but excluded from multivariate model due 
to collinearity or missing data 
Eye Bank (collinear) 
Recipient State (collinear) 
 
Significant in univariate analysis but not retained in multivariate model 
Storage medium* 
Pre-graft inflammation and/or steroid use 
History of raised intraocular pressure 
Graft size 
Post-graft microbial keratitis 
The centre effect 
 
Significant in univariate analysis and retained in multivariate model 
Indication for graft 
Pre-graft neovascularisation 
 
*p<0.08  
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Table 5.8 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The first level of each categorical variable was taken as the 
referent. The hazard ratios for a given variable are adjusted for all other variables in the 
model. This model included data from 506 traditional lamellar keratoplasties, performed 
in 459 recipients. Grafts performed for the indication of “Limbal dermoid” (26 grafts) 
were not included in the model, as none of these grafts had failed and therefore it was 
not possible to analyse survival likelihood for these grafts. 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (chi²=89.47, p<0.0001). The rows highlighted in blue were not significantly 
different to the referent group. 
Table 5.8 Clustered multivariate model 
 
Traditional Lamellar Corneal Graft 
Clustered Multivariate Model 
 
 n Hazard Ratio 
Standard 
error 
p-
value 
Global 
p-value 
95% 
confidence 
interval 
Indication for graft  
Keratoconus 52 1.00   <0.001  
Failed previous graft 97 4.50 1.70 <0.001  2.15 – 9.43 
Corneal ulcer/perforation 60 5.10 2.08 <0.001  2.29 – 11.32 
Herpetic eye disease 32 8.79 3.96 <0.001  3.63 – 21.27 
Corneal degeneration 35 1.44 0.75 0.481  0.52 – 4.00 
Pterygium 53 0.78 0.42 0.645  0.27 – 2.25 
Scleral necrosis 74 0.41 0.31 0.265  0.15 – 1.67 
Other 103 2.43 1.00 0.030  1.09 – 5.43 
 
Pre-graft neovascularisation 
No 339 1.00     
Yes 167 1.51 0.29 0.32  1.04 – 2.21 
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5.7 Reasons for Graft Failure 
 
Of the 532 followed grafts, 132 (25%) were known to have failed by the census date. 
This equates to 19% of the 699 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration 
forms, where the reason for failure of the previous graft was given. Table 5.9 shows the 
reasons for failure given.  
Table 5.9 Reasons for graft failure 
 
Traditional Lamellar Corneal Grafts 
Reasons for Graft Failure 
 
  Corneal melt 19 
  Corneal ulcer/perforation 17 
  Non herpetic infection 16 
  Primary graft failure 11 
  Herpetic infection 7 
  Rejection 6 
  Scarring  5 
  Endothelial cell failure 3 
  Other specified* 23 
  Unspecified 25 
  
Total 132 
  
 
*Other included: astigmatism (2), ectasia (2), scleral necrosis (2), small cell carcinoma 
(2), Stevens-Johnson syndrome (2), trauma (2), neovascularisation (2), wound 
dehiscence (2), atopic keratoconjunctivitis (1), band keratopathy (1), cataract (1), 
descemetocoele (1), ocular pemphigoid (1), pterygium recurrence (1), symblepharon 
(1). 
Of the 11 grafts reported by surgeons to have been primary graft failures, seven had no 
further information provided. Specific reasons given were: corneal melt (2), surgical 
trauma (1), and persistent wound leakage (1). 
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5.8 Post-graft Changes in Visual Acuity 
 
5.8.1 All indications for graft 
 
A desire for improved visual acuity was specified as a reason for graft in 229 (33%) of 
registered tectonic lamellar grafts. In 21% of cases (148), this was the sole desired 
outcome indicated. We analysed post-graft visual acuity in two ways, firstly in terms of 
the Snellen acuity post-graft and secondly, in terms of the change in Snellen acuity from 
pre-to post-graft. 
Table 5.10 shows the reported post-graft visual acuity for all grafts, and also specifically 
for the 171 followed traditional lamellar grafts which listed vision as one of the reasons 
for graft.  
Table 5.10 Post graft visual acuity 
 
Deep Anterior Lamellar Corneal Graft: Post Graft Visual Acuity 
(as reported at last follow up) 
 
 All grafts Surviving Failed To improve VA 
6/4 or better 196 (37%) 183 (46%) 13 (10%) 61 (36%) 
6/15 - 6/36 72 (14%) 63 (16%) 9 (7%) 39 (23%) 
6/60 or worse 155 (29%) 54 (14%) 91 (69%) 42 (25%) 
Unknown 109 (20%) 100 (25%) 19 (14%) 27 (16%) 
Total 532 (100%) 400 (100%) 132 (100%) 171 (100%) 
     
VA = Visual acuity 
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Figure 5.8.1 shows the best corrected visual acuity in the grafted eye at the time of the 
most recent follow-up. Post-graft visual acuity was provided for 423 followed traditional 
lamellar grafts (80%). Of these, 196 (46%) had vision of 6/12 or better at their most 
recent follow-up, while 155 (37%) reported vision of 6/60 or worse.  
 
Figure 5.8.1 Best corrected visual acuity at time of last follow-up 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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Visual acuity data were available both pre- and post-graft for 381 (72%) followed 
traditional lamellar grafts. Of these, 104 (27%) had failed, while 277 (73%) were still 
surviving. Figure 5.8.2 shows the number of lines of improvement or deterioration in 
visual acuity since graft, as measured in terms of Snellen acuity at the latest follow-up. 
Figure 5.8.2 Number of lines change on a Snellen chart pre- to post-graft 
 
Table 5.11 summarises the change in visual acuity form pre- to post-graft, stratified by 
whether the graft was surviving at last follow-up. 
Table 5.11 Number of lines of change on a Snellen chart pre- to post-graft 
 
Traditional Lamellar Corneal Grafts 
Change in Visual Acuity from Pre Graft 
(as reported at last follow up) 
 
 Surviving Failed Total 
 n % n % n % 
VA worse by > 4 lines 3 <1% 6 5% 9 2% 
VA worse by 2 to 4 lines 22 6% 17 13% 39 7% 
VA worse by 1 line 32 8% 21 16% 53 10% 
VA unchanged 63 16% 32 24% 95 18% 
VA better by 1 line 32 8% 13 10% 45 8% 
VA better by 2 to 4 lines 83 21% 12 9% 95 18% 
VA better by 5 to 7  lines 32 8% 1 <1% 33 6% 
VA better by > 7  lines 10 3% 2 2% 12 2% 
Unknown 123 31% 28 21% 151 28% 
Total 400 100% 132 100% 532 100% 
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6 Comparisons Across Graft Types 
 
6.1 Post-graft Factors Affecting Visual Acuity 
 
Surgeons reported additional factors affecting visual acuity in the grafted eye. These are 
shown in Table 6.1. 
Table 6.1 Factors affecting visual acuity in the grafted eye at last follow-up 
 
PK TLK DALK DS(A)EK 
Major astigmatism (≥5 dioptres) 1665 (20.1%) 24 (4.5%) 53 (9.2%) 20 (1.1%) 
Anisometropia 1093 (13.2%) 10 (1.9%) 2 (0.3%) 3 (0.2%) 
Glaucoma 743 (9.0%) 11 (2.1%) 7 (1.2%) 110 (6.1%) 
Macular degeneration 465 (5.6%) 9 (1.7%) 3 (0.5%) 80 (4.4%) 
Opacity/scar 381 (4.6%) 34 (6.4%) 26 (4.5%) 61 (3.4%) 
Cataract 329 (4.0%) 16 (3.0%) 21 (3.7%) 4 (0.2%) 
Myopia 310 (3.7%) 8 (1.5%)  13 (2.3%) 2 (0.1%) 
Cystoid macular oedema 170 (2.0%) 3 (0.6%) 2 (0.3%) 14 (0.8%) 
Amblyopia 134 (1.6%) 19 (3.6%) 11 (1.9%) 10 (0.6%) 
Retinal detachment 105 (1.3%) 3 (0.6%) 0 (0.0%) 15 (0.8%) 
Diabetic retinopathy 46 (0.6%) 2 (0.4%) 1 (0.2%) 11 (0.6%) 
     
 
In grafts performed for keratoconus, 614 penetrating keratoplasties (25%) were reported 
to have major astigmatism at last follow-up, compared to 48 deep anterior lamellar 
keratoplasties (11%). This difference was statistically significant, Chi²=38.82 p<0.001. 
The specific amount of astigmatism, in dioptres, was provided for 1,279 penetrating 
keratoplasties (476 in grafts performed for keratoconus) and 37 deep anterior lamellar 
keratoplasties (32 in grafts performed for keratoconus). The severity of major 
astigmatism in eyes grafted for keratoconus did not differ between penetrating 
keratoplasties and deep anterior lamellar keratoplasties (p=0.713). 
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6.2 Post-operative Visual Correction 
 
Surgeons reported whether graft recipients used visual aids (spectacles and/or a 
contact lens) to attain the best corrected visual acuity at the time of last follow-up.  
Table 6.2 shows the proportion of followed grafts for each graft type for which the 
recipient wore spectacles and/or a contact lens. It also shows the proportions of 
followed recipients who had an IOL in place. Note: this group does not include those 
known to have an IOL inserted at time of graft but for whom no follow-up information 
has been received. 
Table 6.2 Post-graft visual correction 
 
PK TLK DALK DS(A)EK 
     
IOL 4686 (56%) 177 (33%) 64 (11%) 1729 (96%) 
Spectacles 2095 (25%) 129 (24%) 160 (28%) 599 (33%) 
Contact lens 400 (5%) 12 (2%) 33 (6%) 6 (<1%) 
     
 
In some cases, recipients were reported to use both spectacles and a contact lens, or to 
use these in conjunction with an existing IOL. Table 6.3 shows the combinations used 
following the different types of graft.  
Table 6.3 Post-graft combinations for visual correction 
 
PK TLK DALK DS(A)EK 
None 1860 (22%) 271 (51%) 344 (60%) 53 (3%) 
     
IOL only 2623 (32%) 122 (23%) 41 (7%) 1145 (64%) 
Spectacles & IOL 1969 (24%) 54 (10%) 22 (4%) 578 (32%) 
Spectacles only 1387 (17%) 73 (14%) 134 (23%) 19 (1%) 
Contact lens only 274 (3%) 9 (2%) 28 (5%) 0 (0%) 
Spectacles & contact lens 94 (1%) 2 (<1%) 4 (<1%) 0 (0%) 
Contact lens & IOL 62 (<1%) 1 (<1%) 1 (<1%) 4 (<1%) 
     
All three 32 (0.4%) 0 (0%) 0 (0%) 2 (<1%) 
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6.3 Outcomes for Specific Indications for Graft 
 
This chapter presents the results of analyses which compare the outcomes of different 
types of grafts, performed for the same indications, across the same time period.  
 
6.3.1 Keratoconus: PK and DALK 
 
Two types of graft are primarily performed for keratoconus: penetrating keratoplasty and 
deep anterior lamellar keratoplasty. The latter technique has increased in use over 
recent years, as shown in Figure 6.3.1. 
Figure 6.3.1 Number of grafts performed each year, by type of graft performed, for 
keratoconus, 2000 to 2013 
 
Note: the majority of grafts performed in 2014 had not been entered into the registry at 
the censor date and so these data are not shown. At 30th April 2015, 266 grafts for 
keratoconus, which had been performed in 2014, were registered. A further eight grafts 
that had been performed in 2012 and 2013 (one and seven, respectively) for this 
indication, had also been registered.  
 
  
 Comparisons Across Graft Types 
365 Australian Corneal Graft Registry Report 2015 
6.3.1.1 Survival of grafts for keratoconus: influence of graft type 
 
Figure 6.3.2 shows the comparison of survival between penetrating keratoplasties and 
deep anterior lamellar keratoplasties performed for keratoconus since the year 2000, to 
the censor date. 
Figure 6.3.2 Type of graft for keratoconus, 2000 onwards 
 
 
Number at risk (at years post graft) 
Identity Initially 3 6 9 12 
Penetrating 2462 1020 399 114 10 
DALK 431 61 9 5 1 
 
There were unequal numbers followed at each time point, and a quick drop-off in the 
number of DALK being followed over this time period. This is due to the very low 
number of followed DALK (<10 per year) performed for keratoconus prior to 2006. A 
comparison of survival between penetrating keratoplasties and deep anterior lamellar 
keratoplasties performed for keratoconus since 2006 was felt to be more appropriate, 
see Figure 6.3.3. 
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Figure 6.3.3 shows the comparison of graft survival between penetrating keratoplasties 
and deep anterior lamellar keratoplasties performed for keratoconus since 2006 up to 
the censor date. A significant difference was found between groups (Log Rank 
Statistic=18.88; df=1; p<0.001). 
Figure 6.3.3 Type of graft for keratoconus, 2006 onwards 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Penetrating 998 898 567 317 171 68 
DALK 404 309 125 48 20 4 
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Corneal Graft Survival for Keratoconus, 2006 Onwards: 
Graft Type 
 
 Probability of Graft Survival 
 Penetrating: 0.98 at 1 year 
  Mean Survival 6.78 years 0.96 at 2 years 
  (SE= 0.13, 95% CI: 6.52, 7.04) 0.94 at 3 years 
  Median Survival n/a 0.92 at 4 years 
   0.91 at 5 years 
    
 DALK: 0.95 at 1 year 
  Mean Survival 5.47 years 0.91 at 2 years 
  (SE= 0.24, 95% CI: 5.00, 5.94) 0.88 at 3 years 
  Median Survival n/a 0.81 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
There was no significant difference (p=0.328) in the pre-graft visual acuity reported for 
eyes undergoing penetrating keratoplasty for keratoconus compared to those 
undergoing deep anterior lamellar keratoplasty. 
Post-graft vision of 6/12 or better was reported in 66% of followed penetrating grafts 
performed for keratoconus, compared to 47% of followed DALKs performed for 
keratoconus. This was a statistically significantly difference (p<0.001). 
Visual acuity was reported both pre- and post-graft for 91% of penetrating grafts for 
keratoconus and at least one line of improvement on the Snellen chart was achieved 
after graft in 88% of these. Visual acuity was reported both pre- and post-graft for 82% 
of DALKs for keratoconus and at least one line of improvement on the Snellen chart 
was achieved after graft in 84% of these. These results were not significantly different 
(p=0.07). 
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6.3.2 Bullous Keratopathy: PK and DS(A)EK 
 
Two types of graft are primarily performed for bullous keratopathy: penetrating 
keratoplasty and Descemet’s stripping (automated) endothelial keratoplasty. 
Descemet’s membrane endothelial keratoplasties have also been performed for this 
indication, in smaller numbers.  The DS(A)EK technique was introduced in Australia in 
2006 and its use in treating bullous keratopathy has continuously increased since then, 
so that it is now the more common technique used to treat this condition. This has 
accompanied a small increase in recent years, in the total number of transplants being 
performed for bullous keratopathy, as shown in Figure 6.3.4.  
Figure 6.3.4 Number of grafts performed each year, by type of graft performed, for 
bullous keratopathy, 2000 to 2013 
 
Note: the majority of grafts performed in 2014 had not been entered into the registry at 
the censor date and so these data are not shown. At 30th April 2015, 219 grafts for 
bullous keratopathy, which had been performed in 2014, were registered. A further five 
grafts that had been performed in 2012 and 2013 (two and three, respectively) for this 
indication, had also been registered.  
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6.3.2.1 Survival of grafts for bullous keratopathy: influence of graft type 
 
Figure 6.3.5 shows the comparison of survival between penetrating keratoplasties and 
Descemet’s stripping (automated) endothelial keratoplasties performed for bullous 
keratopathy since the introduction of the latter technique in 2006 up to the censor date. 
A significant difference was found between the two groups (Log Rank Statistic=9.17; 
df=1; p=0.002). 
Figure 6.3.5 Type of graft for bullous keratopathy, 2006 onwards 
 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Penetrating 498 371 242 148 86 34 
DS(A)EK 558 288 138 58 19 5 
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Corneal Graft Survival for Bullous Keratopathy, 2006 Onwards: 
Graft Type 
 
 Probability of Graft Survival 
 Penetrating: 0.93 at 1 year 
  Mean Survival 4.69 years 0.84 at 2 years 
  (SE= 0.16, 95% CI: 4.39, 5.00) 0.74 at 3 years 
  Median Survival 4.84 years 0.62 at 4 years 
   0.48 at 5 years 
    
 DS(A)EK: 0.85 at 1 year 
  Mean Survival 3.74 years 0.78 at 2 years 
  (SE= 0.14, 95% CI: 3.46, 4.03) 0.69 at 3 years 
  Median Survival 4.27 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
There was a significant difference (p<0.001) in the pre-graft visual acuity reported for 
eyes undergoing penetrating keratoplasty for bullous keratopathy compared to those 
undergoing Descemet’s stripping (automated) endothelial keratoplasty. Eyes 
undergoing PK had poorer pre-graft vision. This was the case when comparing both the 
entire cohort and grafts performed from 2006 onwards. 
Post-graft vision of 6/12 or better was reported in 15% of followed penetrating grafts 
performed for bullous keratopathy, compared with 20% of followed DS(A)EKs 
performed for bullous keratopathy. This was a statistically significantly difference 
(p=0.001). 
Visual acuity was reported both pre- and post-graft for 77% of penetrating grafts for 
bullous keratopathy and at least one line of improvement on the Snellen chart was 
achieved after graft in 60% of these. Visual acuity was reported both pre- and post-graft 
for 75% of DS(A)EKs for bullous keratopathy and at least one line of improvement on 
the Snellen chart was achieved after graft in 66% of these. This was a statistically 
significantly difference (p=0.03). 
Note: Grafts for bullous keratopathy are often performed for pain relief.  
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6.3.2.2 Survival of grafts for bullous keratopathy: influence of graft type and early 
failures 
 
A greater proportion of Descemet’s stripping (automated) endothelial keratoplasties 
than penetrating keratoplasties, failed within three months (90 days) of graft 
(47/558=8.4% vs. 10/498=2.0%). 
Figure 6.3.6 shows the comparison of survival between penetrating keratoplasties and 
Descemet’s stripping (automated) endothelial keratoplasties performed for bullous 
keratopathy since the introduction of the latter technique in 2006, excluding these early 
failures. No significant difference was found between the two groups (Log Rank 
Statistic=0.54; df=1; p=0.464). 
Figure 6.3.6 Type of graft for bullous keratopathy, 2006 onwards, excluding early 
failures 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Penetrating 488 371 242 148 86 34 
DS(A)EK 511 288 138 58 19 5 
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Corneal Graft Survival for Bullous Keratopathy, 2006 Onwards, 
Excluding Early Failures: Graft Type 
 
 Probability of Graft Survival 
 Penetrating: 0.95 at 1 year 
  Mean Survival 4.80 years 0.86 at 2 years 
  (SE= 0.16, 95% CI: 4.49, 5.11) 0.75 at 3 years 
  Median Survival 4.96 years 0.63 at 4 years 
   0.49 at 5 years 
    
 DS(A)EK: 0.94 at 1 year 
  Mean Survival 4.11 years 0.86 at 2 years 
  (SE= 0.15, 95% CI: 3.82, 4.40) 0.76 at 3 years 
  Median Survival 5.42 years   
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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6.3.3 Fuchs’ Dystrophy: PK and DS(A)EK 
 
Two types of graft are primarily performed for Fuchs’ dystrophy: penetrating 
keratoplasty and Descemet’s stripping (automated) endothelial keratoplasty. 
Descemet’s membrane endothelial keratoplasties have also been performed for this 
indication, in smaller numbers.  The DS(A)EK technique has increased in use in recent 
years, and is now performed in the majority of Fuchs’ dystrophy cases. This has 
accompanied a large increase in recent years, in the total number of transplants being 
performed for Fuchs’ dystrophy, as shown in Figure 6.3.7. 
Figure 6.3.7 Number of grafts performed each year, by type of graft performed, for 
Fuchs’ dystrophy, 2000 to 2013 
 
 
Note: the majority of grafts performed in 2014 had not been entered into the registry at 
the censor date and so these data are not shown. At 30th April 2015, 395 grafts for 
Fuchs’ dystrophy, which had been performed in 2014, were registered. A further twelve 
grafts that had been performed in 2012 and 2013 (four and eight, respectively) for this 
indication, had also been registered.  
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6.3.3.1 Survival of grafts for Fuchs’ dystrophy: influence of graft type 
 
Figure 6.3.8 shows the comparison of survival between penetrating keratoplasties and 
Descemet’s stripping (automated) endothelial keratoplasties performed for Fuchs’ 
dystrophy since the introduction of the latter technique in 2006 up to the censor date. A 
significant difference was found between the two groups (Log Rank Statistic=9.17; df=1; 
p=0.002). 
Figure 6.3.8 Type of graft for Fuchs' dystrophy, 2006 onwards 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Penetrating 382 329 246 165 109 57 
DS(A)EK 867 468 233 111 34 12 
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Corneal Graft Survival for Fuchs’ Dystrophy, 2006 Onwards: 
Graft Type 
 
 Probability of Graft Survival 
 Penetrating: 0.97 at 1 year 
  Mean Survival 6.18 years 0.95 at 2 years 
  (SE= 0.16, 95% CI: 5.86, 6.50) 0.90 at 3 years 
  Median Survival n/a 0.87 at 4 years 
   0.81 at 5 years 
    
 DS(A)EK: 0.85 at 1 year 
  Mean Survival 4.28 years 0.80 at 2 years 
  (SE= 0.15, 95% CI: 3.98, 4.57) 0.73 at 3 years 
  Median Survival 5.10 years 0.67 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
 
There was a significant difference (p<0.001) in the pre-graft visual acuity reported for 
eyes undergoing penetrating keratoplasty for Fuchs’ dystrophy compared to those 
undergoing Descemet’s stripping (automated) endothelial keratoplasty. Eyes 
undergoing PK had poorer pre-graft vision. This was the case when comparing both the 
entire cohort and grafts performed from 2006 onwards. 
Post-graft vision of 6/12 or better was reported in 46% of followed penetrating grafts 
performed for Fuchs’ dystrophy, compared to 41% of followed DS(A)EKs performed for 
Fuchs’ dystrophy. This was not a statistically significantly difference (p=0.48). 
Visual acuity was reported both pre- and post-graft for 86% of penetrating grafts for 
Fuchs’ dystrophy and at least one line of improvement on the Snellen chart was 
achieved after graft in 71% of these. Visual acuity was reported both pre- and post-graft 
for 81% of DS(A)EKs for Fuchs’ dystrophy and at least one line of improvement on the 
Snellen chart was achieved after graft in 65% of these. This was a statistically 
significantly difference (p=0.01). 
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6.3.3.2 Survival of grafts for Fuchs’ dystrophy: influence of graft type and early 
failures 
 
A greater proportion of Descemet’s stripping (automated) endothelial keratoplasties 
than penetrating keratoplasties, failed within three months (90 days) of grafting 
(73/867=8.4% vs. 5/382=1.3%).  
Figure 6.3.9 shows the comparison of survival between penetrating keratoplasties and 
Descemet’s stripping (automated) endothelial keratoplasties performed for Fuchs’ 
dystrophy since the introduction of the latter technique in 2006, excluding these early 
failures. A significant difference was found between the two groups (Log Rank 
Statistic=26.82; df=1; p<0.001). 
Figure 6.3.9 Type of graft for Fuchs' dystrophy, 2006 onwards, excluding early 
failures 
 
 
Number at risk (at years post graft) 
Identity Initially 1 2 3 4 5 
Penetrating 377 329 246 165 109 57 
DS(A)EK 794 468 233 111 34 12 
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Corneal Graft Survival for Fuchs’ Dystrophy, 2006 Onwards,  
Excluding Early Failures: Graft Type 
 
 Probability of Graft Survival 
 Penetrating: 0.98 at 1 year 
  Mean Survival 6.26 years 0.96 at 2 years 
  (SE= 0.16, 95% CI: 5.95, 6.58) 0.91 at 3 years 
  Median Survival n/a 0.89 at 4 years 
   0.82 at 5 years 
    
 DS(A)EK: 0.93 at 1 year 
  Mean Survival 4.68 years 0.87 at 2 years 
  (SE= 0.16, 95% CI: 4.37, 4.99) 0.80 at 3 years 
  Median Survival 5.31 years 0.73 at 4 years 
     
 KEY: n/a = not applicable, SE = standard error, CI = confidence interval, df = degrees of freedom, p = probability 
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7 Summary 
 
Between 1st January 2000 and 30th March 2014, 16,334 grafts were registered with the 
Australian Corneal Graft Registry. 11,471 (70.2%) of these had follow-up received by 
the census date. The introduction of partial-thickness lamellar keratoplasty techniques 
has resulted in a shift away from full-thickness penetrating keratoplasties.  
 
7.1 Donor and Eye Banking Factors 
 
No donor or eye banking factors were found to be significant independent risk factors 
for failure of deep anterior lamellar or traditional lamellar grafts. Interstate transportation 
of corneas for penetrating grafts was shown to result in a higher risk of failure. Donor 
age group was retained in multivariate analysis relating to penetrating grafts, with grafts 
performed using tissue from donors aged over 60 years exhibiting poorer survival. 
Endothelial cell density was excluded from the initial multivariate model for Descemet’s 
stripping (automated) endothelial grafts due to a high proportion of missing data, but 
was retained in a subsequent model, with grafts performed using donor tissue with 
<2500 cells/mm² exhibiting poorer survival. 
 
7.2 Recipient Factors 
 
Indication for graft was found to be a significant independent risk factor for failure of 
penetrating and traditional lamellar grafts. Pre-graft inflammation or steroid use was a 
significant independent risk factor for failure of penetrating, traditional and deep anterior 
lamellar keratoplasty. The change in lens status from pre- to post-graft was a significant 
risk factor for both penetrating and Descemet’s stripping (automated) endothelial grafts. 
In both cohorts, poor survival occurred in eyes that were aphakic post-graft. Further pre-
graft recipient factors found to be significant for penetrating graft failure were a history of 
raised intraocular pressure and pre-graft vascularisation. Recipient age group was a 
significant independent risk factor for failure of Descemet’s stripping (automated) 
endothelial keratoplasty, with poorest survival seen in recipients aged under 40 years, 
followed by those aged 50 to 59 years. 
 
7.3 Surgery and Surgeon Factors 
 
Surgeon experience and level of follow-up was shown to be a significant independent 
risk factor in the survival of penetrating and Descemet’s stripping (automated) 
endothelial grafts, with less experienced surgeons exhibiting poorer survival in both 
analyses. Graft size was a significant risk factor for penetrating grafts, with grafts 
outside of the range of 7.75 mm to 8.5 mm, exhibiting significantly poorer survival. 
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7.4 Graft Era 
 
Graft era, stratified by two-year groups, was a significant independent risk factor for 
survival of penetrating grafts, with improved outcomes in more recent years. 
Descemet’s stripping (automated) endothelial grafts that had been performed in earlier 
years, were also found to have significantly poorer survival, while the most recent cohort 
of deep anterior lamellar grafts exhibited poorer survival. The effect of lag time on these 
analyses is acknowledged, the effect of this being most pronounced in the early years 
following graft registration and more likely to affect the data relating to grafts from the 
most recent cohorts. 
 
7.5 Post-graft Events 
 
In multivariate analyses, significantly poorer graft survival was found for penetrating and 
endothelial grafts that had undergone at least one episode of post-graft rejection. Post 
graft rejection occurred most frequently following penetrating keratoplasty and very few 
lamellar grafts underwent more than one post-graft rejection episode (see Table 7.1). 
Table 7.1 Number of post-graft rejection episodes stratified by graft type 
 
None One Two Three or more 
PK 6948 (84%) 1006 (12%) 229 (3%) 118 (1%) 
TLK 516 (97%) 14 (3%) 2 (<1%) 0 (0%) 
DALK 547 (95%) 23 (4%) 4 (<1%) 0 (0%) 
DS(A)EK 1684 (94%) 104 (6%) 9 (<1%) 4 (<1%) 
     
 
Higher risk of graft failure was also found for penetrating grafts that had suffered post-
graft microbial keratitis. 
 
7.6 Comparisons Across Graft Types 
 
Primary graft failure was reported most often following Descemet’s membrane 
endothelial keratoplasty (13.6% of registered grafts) and least often following 
penetrating keratoplasty (0.5% of registered grafts). 
Penetrating grafts performed for keratoconus exhibited significantly better survival than 
deep anterior lamellar grafts performed for the same reason over the same time period. 
Descemet’s stripping (automated) endothelial grafts performed for bullous keratopathy 
exhibited significantly poorer survival than penetrating grafts performed for the same 
indication during the same time period. The difference was non-significant when early 
failures (within 1 month) were removed from the analysis. Descemet’s stripping 
(automated) endothelial grafts performed for Fuchs’ dystrophy exhibited significantly 
poorer survival than penetrating grafts performed for the same indication during the 
same time period. This difference remained significant after early failures (within 1 
month) had been removed. 
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8 Methods and Definitions 
 
8.1 Registration and Follow-up 
 
Grafts are registered by contributing surgeons a soon as possible after the graft. Follow-
up information is requested at intervals of about 12 months. Information is provided by 
mail, with missing data routinely sought via follow-up letter or via phone. Each graft is 
followed until graft failure or until the death or loss to follow-up of the patient. Data-
linkage with the National Death Index is performed on a five yearly basis, the last 
linkage being completed in 2014. The study period for the analyses in this report were 
January 2000 to March 2014 (13.25 years), except where otherwise stated. 
8.2 Definition of Variables, Complications and Events 
 
All information regarding diagnoses, ocular history and treatment are provided to the 
Registry by the operating surgeons. Information on donor factors is provided by eye 
banks. Multiple processes are in place to cross-check data consistency. 
A history of past inflammation is recorded if the individual is specifically reported to have 
had such an episode or if there is a history of the use of topical corticosteroids in that 
eye in the weeks immediately preceding the graft.  
Vessel ingrowth into the cornea at the time of graft is scored on a scale of 0-4, with 0 
representing no growth in any quadrant extending to the graft-host junction, 1 
representing such growth in 1 quadrant, 2 representing growth in 2 quadrants, 3 being 
vessel ingrowth in 3 quadrants and 4 being vessel ingrowth in 4 quadrants. No 
distinction is made between superficial or deep vessels, patent or ghost vessels, or 
single or multiple vessel leashes. After corneal transplantation, the presence of even 
one vessel leash extending into the graft is considered enough to classify that graft as 
vascularized.  
The intraocular pressure (IOP) is generally considered to be raised if a reading of 25 
mm of mercury or greater is made by applanation tonometry, but the decision is at the 
discretion of the ophthalmologist.  
Original pathology, current indications for graft, post-operative complications and 
reasons for graft failure are provided by individual surgeons and are coded by Registry 
staff using the ICD.9.CM system (US Department of Health and Human Services). 
Original pathologies for repeat grafts are cross-checked with previous information 
provided to the Registry. 
Information is collected on both recipient bed size, incision size and donor button size, 
as relevant. For the purpose of examining the influence of graft size, the latter is used. 
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Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For penetrating grafts, the time from graft to failure is as reported by 
the surgeon. It is usually 1-2 days but no more than 7 days. For lamellar procedures, 
primary graft failure can occur after a longer period of time and is analysed as reported 
by surgeons. Additional information is collected to ascertain whether this occurred within 
28 days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Any existing graft that is replaced by another in the same eye, irrespective of graft 
clarity and for whatever reason, is classified as a failed graft. An example in this 
category would be a clear graft with an unacceptably high degree of irregular 
astigmatism, not improved by refractive surgery, which is then replaced. In other cases, 
graft failure is defined as oedema and irremediable loss of clarity in a previously thin, 
clear graft. The day of failure is the first day the patient is seen with an oedematous, 
opaque graft that subsequently fails to thin and clear. 
In some cases, partial-thickness grafts are performed in eyes that have undergone 
previous full-thickness grafts. The original penetrating grafts are still considered to have 
failed in these cases and are recorded as such. In a very small number of cases, 
recipients have multiple concurrent grafts in the same eye (e.g. a deep anterior lamellar 
graft and a Descemet’s stripping (automated) endothelial keratoplasty). In these cases, 
both grafts are considered to be surviving, regardless of the order they were performed. 
Rejection is defined as the development of a rejection line (epithelial or endothelial) or a 
unilateral anterior chamber reaction with corneal infiltrates and spreading corneal 
oedema in a previously thin, clear graft. 
Any development with the potential to compromise graft outcome is considered to be a 
complication.  Post-operative complications are collected in two ways.  First, a number 
of specified complications (e.g. stitch abscess, microbial keratitis, neovascularization of 
the graft, synechiae, uveitis, rise in IOP, rejection episode, herpetic recurrence, early 
changes of bullous keratopathy), refractive and related errors (e.g. anisometropia, 5 
dioptres astigmatism) and factors potentially affecting visual outcome but unrelated to 
the graft (e.g. cataract, amblyopia, retinal detachment, age related macular 
degeneration and diabetic retinopathy) are listed, requiring a yes/no answer. The factors 
specified vary depending on whether the graft was a penetrating or lamellar 
keratoplasty. Second, contributors are asked to specify any other relevant 
complications, information or departures from their preferred treatment. 
For surviving grafts, trial time was calculated as the time between the date of graft and 
the date on which the patient was last seen. For failed grafts, trial time was calculated 
as the time between the date of graft and the date of failure, specified on a daily basis. 
Although data were collected centrally within the registry at least once yearly, individual 
patient data were collected at source according to a frequency determined by the 
ophthalmic surgeon. 
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8.3 Statistical Analyses 
 
The Australian Corneal Graft Registry database is constructed in Microsoft Access, and 
was designed by Ms Sandra Bobleter. This has subsequently been modified by Mrs 
Helene Holland, Ms Ngaere Hornsby, Ms Carmel McCarthy, Mrs Chris Bartlett, Mrs 
Marie Lowe and Dr Rachel Galettis.  
For this report, data were extracted from the Access database, via an automated import 
process, into SPPS version 22 (SPSS Inc). Univariate Kaplan–Meier survival analyses 
(see reference 2) were performed in IBM SPSS for Windows (Version 21.0) with 
significance set at p<0.05 (Mantel–Cox log-rank² statistic – see references 3 & 4). 
Corresponding survival curves were generated in SPSS, for use in the report. The 
SPSS database was also saved as a STATA data file and multivariate Cox-proportional 
hazards regression analyses were performed using STATA version 11 (see reference 
5). The report was prepared using Microsoft Office 2010. 
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